Document And Entity Information (USD $) In Billions, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Jun. 30, 2011	Jan. 31, 2012 Class A Common [Member]	Jan. 31, 2012 Class B Common [Member]	Jan. 31, 2012 Class C Common [Member]	Jan. 31, 2012 Class D Common [Member]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2011
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2011
Trading Symbol	uhs
Entity Registrant Name	UNIVERSAL HEALTH SERVICES INC
Entity Central Index Key	0000352915
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding			6,625,708	89,408,941	664,000	33,084
Entity Well-known Seasoned Issuer	Yes
Entity Public Float		$ 4.61
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No

Consolidated Statements Of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Consolidated Statements Of Income [Abstract]
Net revenues	$ 7,500,198	$ 5,568,185	$ 5,202,379
Operating charges:
Salaries, wages and benefits	3,394,967	2,423,102	2,204,422
Other operating expenses	1,385,680	1,005,288	994,923
Supplies expense	821,811	733,093	699,249
Provision for doubtful accounts	613,619	546,909	508,603
Depreciation and amortization	295,228	223,915	204,703
Lease and rental expense	91,765	76,961	69,947
Transaction costs	0	53,220	0
Total operating expenses	6,603,070	5,062,488	4,681,847
Income from operations	897,128	505,697	520,532
Interest expense, net	200,792	77,600	45,810
Income before income taxes	696,336	428,097	474,722
Provision for income taxes	247,466	152,302	170,475
Net income	448,870	275,795	304,247
Less: Net income attributable to noncontrolling interests	50,703	45,612	43,874
Net income attributable to UHS	$ 398,167	$ 230,183	$ 260,373
Basic earnings per share attributable to UHS	$ 4.09	$ 2.37	$ 2.65
Diluted earnings per share attributable to UHS	$ 4.04	$ 2.34	$ 2.64
Weighted average number of common shares-basic	97,199	96,786	97,794
Add: Other share equivalents	1,338	1,187	481
Weighted average number of common shares and equivalents-diluted	98,537	97,973	98,275

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Assets
Cash and cash equivalents	$ 41,229	$ 29,474
Accounts receivable, net	969,802	837,820
Supplies	96,775	94,330
Deferred income taxes	108,324	120,834
Other current assets	99,859	130,060
Assets of facilities held for sale	48,916	118,598
Total current assets	1,364,905	1,331,116
Property and Equipment
Land	377,984	376,567
Buildings and improvements	3,244,117	3,057,313
Equipment	1,256,165	1,165,635
Property under capital lease	37,037	38,711
Property and equipment, gross	4,915,303	4,638,226
Accumulated depreciation	(1,818,180)	(1,601,005)
Property and equipment, excluding construction in progress, net	3,097,123	3,037,221
Construction-in-progress	190,857	215,746
Property and equipment, net, total	3,287,980	3,252,967
Other assets:
Goodwill	2,627,602	2,589,914
Deferred charges	111,780	108,660
Other	272,978	245,279
Other assets, total	3,012,360	2,943,853
Total assets	7,665,245	7,527,936
Liabilities and Stockholders' Equity
Current maturities of long-term debt	2,479	3,449
Accounts payable	228,043	252,487
Liabilities of facilities held for sale	2,329	3,516
Accrued liabilities
Compensation and related benefits	233,583	249,429
Interest	10,622	14,160
Taxes other than income	45,359	35,175
Other	314,518	268,083
Total current liabilities	836,933	826,299
Other noncurrent liabilities	401,908	380,649
Long-term debt	3,651,428	3,912,102
Deferred income taxes	209,592	173,354
Commitments and contingencies (Note 8)
Reedemable noncontrolling interest	218,266	211,761
Equity:
Cumulative dividends	(147,515)	(128,049)
Retained earnings	2,494,076	2,125,989
Accumulated other comprehensive loss	(51,175)	(20,139)
Universal Health Services, Inc. common stockholders' equity	2,296,352	1,978,772
Noncontrolling interest	50,766	44,999
Total Equity	2,347,118	2,023,771
Total liabilities and stockholders' equity	7,665,245	7,527,936
Class A Common [Member]
Equity:
Common Stock	66	67
Class B Common [Member]
Equity:
Common Stock	893	897
Class C Common [Member]
Equity:
Common Stock	7	7
Class D Common [Member]
Equity:
Common Stock

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2011	Dec. 31, 2010
Class A Common [Member]
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	12,000,000	12,000,000
Common stock, shares issued	6,625,708	6,656,308
Common stock, shares outstanding	6,625,708	6,656,308
Class B Common [Member]
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	89,286,305	90,093,562
Common stock, shares outstanding	89,286,305	90,093,562
Class C Common [Member]
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	1,200,000	1,200,000
Common stock, shares issued	664,000	665,400
Common stock, shares outstanding	664,000	665,400
Class D Common [Member]
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	5,000,000	5,000,000
Common stock, shares issued	33,164	35,218
Common stock, shares outstanding	33,164	35,218

- Definition

Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.

+ References+ Details

Consolidated Statements Of Changes In Equity (USD $) In Thousands, unless otherwise specified	Redeemable Interest [Member]	Class A Common [Member]	Class B Common [Member]	Class C Common [Member]	Class D Common [Member]	Capital In Excess Of Par Value [Member]	Cumulative Dividends [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	UHS Common Stockholders' Equity [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2008	$ 186,097	$ 33	$ 458	$ 3	$ 0	$ 0	$ (91,921)	$ 1,666,973	$ (31,696)	$ 1,543,850	$ 40,638	$ 1,584,488
Common Stock
Issued/(converted) including tax benefits from exercise of stock options			2					3,285		3,287		3,287
Repurchased			(15)					(63,275)		(63,290)		(63,290)
Restricted share-based compensation expense								3,174		3,174		3,174
Dividends paid							(16,706)			(16,706)		(16,706)
Stock dividend		34	451	4				(489)
Stock option expense								9,940		9,940		9,940
Distributions to noncontrolling interests	(23,130)										(6,736)	(6,736)
Capital contributions from noncontrolling interests											121	121
Purchase of noncontrolling interests in majority owned businesses											(229)	(229)
Other											(2,160)	(2,160)
Comprehensive income:
Net income	34,185							260,373		260,373	9,689	270,062
Amortization of terminated hedge (net of income tax effect)									(216)	(216)		(216)
Unrealized derivative losses on cash flow hedges (net of income tax effect)									1,477	1,477		1,477
Minimum pension liability (net of income tax effect)									9,182	9,182		9,182
Subtotal-comprehensive income	34,185							260,373	10,443	270,816	9,689	280,505
Balance at Dec. 31, 2009	197,152	67	896	7			(108,627)	1,879,981	(21,253)	1,751,071	41,323	1,792,394
Common Stock
Issued/(converted) including tax benefits from exercise of stock options			4					10,890		10,894		10,894
Repurchased			(3)					(11,525)		(11,528)		(11,528)
Restricted share-based compensation expense								3,139		3,139		3,139
Dividends paid							(19,422)			(19,422)		(19,422)
Stock option expense								13,321		13,321		13,321
Distributions to noncontrolling interests	(23,777)										(8,662)	(8,662)
Capital contributions from noncontrolling interests
Purchase of noncontrolling interests in majority owned businesses											(600)	(600)
Other	4,512
Comprehensive income:
Net income	33,874							230,183		230,183	11,738	241,921
Amortization of terminated hedge (net of income tax effect)									(216)	(216)		(216)
Unrealized derivative losses on cash flow hedges (net of income tax effect)									868	868		868
Minimum pension liability (net of income tax effect)									462	462		462
Subtotal-comprehensive income	33,874							230,183	1,114	231,297	11,738	243,035
Balance at Dec. 31, 2010	211,761	67	897	7			(128,049)	2,125,989	(20,139)	1,978,772	44,999	2,023,771
Common Stock
Issued/(converted) including tax benefits from exercise of stock options		(1)	12					12,622		12,633		12,633
Repurchased			(16)					(60,466)		(60,482)		(60,482)
Restricted share-based compensation expense								1,957		1,957		1,957
Dividends paid							(19,466)			(19,466)		(19,466)
Stock option expense								15,807		15,807		15,807
Distributions to noncontrolling interests	(31,016)										(7,416)	(7,416)
Purchase of noncontrolling interests in majority owned businesses
Other
Comprehensive income:
Net income	37,521							398,167		398,167	13,183	411,350
Amortization of terminated hedge (net of income tax effect)									(216)	(216)		(216)
Unrealized derivative losses on cash flow hedges (net of income tax effect)									(23,114)	(23,114)		(23,114)
Minimum pension liability (net of income tax effect)									(7,706)	(7,706)		(7,706)
Subtotal-comprehensive income	37,521							398,167	(31,036)	367,131	13,183	380,314
Balance at Dec. 31, 2011	$ 218,266	$ 66	$ 893	$ 7	$ 0	$ 0	$ (147,515)	$ 2,494,076	$ (51,175)	$ 2,296,352	$ 50,766	$ 2,347,118

Consolidated Statements Of Changes In Equity (Parenthetical) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Consolidated Statements Of Changes In Equity [Abstract]
Amortization of terminated hedge, income tax effect	$ 120	$ 120	$ 126
Unrealized derivative losses on cash flow hedges, income tax effect	14,363	528	899
Minimum pension liability, income tax effect	$ 4,691	$ (281)	$ 5,667

- Definition

The tax effect of the amount of the change in the additional minimum pension liability not yet recognized pursuant to FAS 87 as a net periodic pension cost. If the additional pension liability required to be recognized exceeds the unrecognized prior service costs, then the excess (which is the net loss not yet recognized as net periodic pension cost) is to be recorded as a separate component in other comprehensive income, before adjusting for tax effects. In a subsequent measurement, the elimination or adjustment to the amount of the minimum pension liability recorded in accumulated other comprehensive income is included in this line. Eliminated upon adoption of FAS 158.

+ References+ Details

- Definition

Tax effect on reclassification adjustment for accumulated gains and losses from derivative instrument designated and qualifying as the effective portion of cash flow hedges included in accumulated comprehensive income that was realized in net income during the period.

+ References+ Details

- Definition

Tax effect on the change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.

+ References+ Details

Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Cash Flows from Operating Activities:
Net income	$ 448,870	$ 275,795	$ 304,247
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation & amortization	295,861	223,997	204,703
Gains on sales of assets and businesses, net of losses	(452)	(1,993)	(1,346)
Stock based compensation expense	18,225	16,799	13,096
Changes in assets & liabilities, net of effects from acquisitions and dispositions:
Accounts receivable	(134,838)	22,726	(1,402)
Construction management and other receivable			29,519
Accrued interest	(3,577)	8,408	357
Accrued and deferred income taxes	85,792	132	14,930
Other working capital accounts	(28,382)	(26,437)	(18,828)
Other assets and deferred charges	37,160	11,539	6,699
Other	(1,387)	812	755
Accrued insurance expense, net of commercial premiums paid	83,612	19,739	44,314
Payments made in settlement of self-insurance claims	(82,633)	(50,173)	(55,782)
Net cash provided by operating activities	718,251	501,344	541,262
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(285,682)	(239,274)	(379,748)
Acquisition of property and businesses	(29,466)	(1,958,298)	(12,499)
Proceeds received from sales of assets and businesses	67,592	21,460	9,770
Costs incurred for purchase and implementation of electronic health records application	(38,249)	(17,971)	(7,957)
Net cash used in investing activities	(285,805)	(2,194,083)	(390,434)
Cash Flows from Financing Activities:
Reduction of long-term debt	(381,517)	(1,392,086)	(66,499)
Additional borrowings	98,100	3,266,146	26,069
Financing costs	(23,608)	(101,815)
Repurchase of common shares	(60,482)	(11,528)	(63,288)
Dividends paid	(19,466)	(19,422)	(16,706)
Issuance of common stock	4,779	3,594	3,290
Profit distributions to noncontrolling interests	(38,497)	(32,456)	(29,866)
Proceeds from sale of noncontrolling interests in majority owned business		600
Capital contributions from noncontrolling interests			121
Purchase of noncontrolling interests in majority owned businesses		(600)	(229)
Net cash (used in) provided by financing activities	(420,691)	1,713,033	(147,108)
Increase in cash and cash equivalents	11,755	20,294	3,720
Cash and cash equivalents, beginning of period	29,474	9,180	5,460
Cash and cash equivalents, end of period	41,229	29,474	9,180
Supplemental Disclosures of Cash Flow Information:
Interest paid	176,328	76,900	57,018
Income taxes paid, net of refunds	$ 163,029	$ 152,088	$ 155,368

Business And Summary Of Significant Accounting Policies

12 Months Ended

Dec. 31, 2011

Business And Summary Of Significant Accounting Policies [Abstract]

Business And Summary Of Significant Accounting Policies

1) BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Services provided by our hospitals, all of which are operated by subsidiaries of ours include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. We, through our subsidiaries, provide capital resources as well as a variety of management services to our facilities, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations.

The more significant accounting policies follow:

A) Principles of Consolidation: The consolidated financial statements include the accounts of our majority-owned subsidiaries and partnerships controlled by us or our subsidiaries as the managing general partner. All significant intercompany accounts and transactions have been eliminated.

B) Revenue Recognition: We record revenues and related receivables for health care services at the time the services are provided. Medicare and Medicaid revenues represented 37% of our net patient revenues during 2011 and 38% of our net patient revenues during each of 2010 and 2009. Revenues from managed care entities, including health maintenance organizations and managed Medicare and Medicaid programs accounted for 43% of our net patient revenues during 2011 and 46% during each of 2010 and 2009.

We report net patient service revenue at the estimated net realizable amounts from patients and third-party payors and others for services rendered. We have agreements with third-party payors that provide for payments to us at amounts different from our established rates. Payment arrangements include prospectively determined rates per discharge, reimbursed costs, discounted charges and per diem payments. Estimates of contractual allowances under managed care plans are based upon the payment terms specified in the related contractual agreements. We closely monitor our historical collection rates, as well as changes in applicable laws, rules and regulations and contract terms, to assure that provisions are made using the most accurate information available. However, due to the complexities involved in these estimations, actual payments from payors may be different from the amounts we estimate and record.

We estimate our Medicare and Medicaid revenues using the latest available financial information, patient utilization data, government provided data and in accordance with applicable Medicare and Medicaid payment rules and regulations. The laws and regulations governing the Medicare and Medicaid programs are extremely complex and subject to interpretation and as a result, there is at least a reasonable possibility that recorded estimates will change by material amounts in the near term. Certain types of payments by the Medicare program and state Medicaid programs (e.g. Medicare Disproportionate Share Hospital, Medicare Allowable Bad Debts and Inpatient Psychiatric Services) are subject to retroactive adjustment in future periods as a result of administrative review and audit and our estimates may vary from the final settlements. Such amounts are included in accounts receivable, net, on our Consolidated Balance Sheets. The funding of both federal Medicare and state Medicaid programs are subject to legislative and regulatory changes. As such, we can not provide any assurance that future legislation and regulations, if enacted, will not have a material impact on our future Medicare and Medicaid reimbursements. Adjustments related to the final settlement of these retrospectively determined amounts did not materially impact our results in 2011, 2010 or 2009.

We provide care to patients who meet certain financial or economic criteria without charge or at amounts substantially less than our established rates. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in net revenues or in accounts receivable, net. Our acute care hospitals provided charity care and uninsured discounts, based on charges at established rates, amounting to $956 million, $807 million and $671 million during 2011, 2010 and 2009, respectively.

C) Provision for Doubtful Accounts: Collection of receivables from third-party payers and patients is our primary source of cash and is critical to our operating performance. Our primary collection risks relate to uninsured patients and the portion of the bill which is the patient's responsibility, primarily co-payments and deductibles. We estimate our provisions for doubtful accounts based on general factors such as payer mix, the agings of the receivables and historical collection experience. We routinely review accounts receivable balances in conjunction with these factors and other economic conditions which might ultimately affect the collectability of the patient accounts and make adjustments to our allowances as warranted. At our acute care hospitals, third party liability accounts are pursued until all payment and adjustments are posted to the patient account. For those accounts with a patient balance after third party liability is finalized or accounts for uninsured patients, the patient receives statements and collection letters. Patients that express an inability to pay are reviewed for potential sources of financial assistance including our charity care policy. If the patient is deemed unwilling to pay, the account is written-off as bad debt and transferred to an outside collection agency for additional collection effort.

Uninsured patients that do not qualify as charity patients are extended an uninsured discount of at least 20% of total charges. During the collection process the hospital establishes a partial reserve in the allowance for doubtful accounts for self-pay balances outstanding for greater than 60 days from the date of discharge. All self-pay accounts at the hospital level are fully reserved if they have been outstanding for greater than 90 days from the date of discharge. Third party liability accounts are fully reserved in the allowance for doubtful accounts when the balance ages past 180 days from the date of discharge. Potential charity accounts are fully reserved when it is determined the patient may be unable to pay.

As of December 31, 2011, our accounts receivable includes $54 million due from Illinois, the collection of which has been delayed due to budgetary and funding pressures experienced by the state. Although approximately $41 million of the receivables due from Illinois have been outstanding in excess of 60 days (as of December 31, 2011), and a large portion will likely remain outstanding for the foreseeable future, we expect to eventually collect all amounts due to us and therefore no related reserves have been established in our consolidated financial statements. However, we can provide no assurance that we will eventually collect all amounts due to us from Illinois. Failure to ultimately collect all outstanding amounts due from Illinois would have an adverse impact on our future consolidated results of operations and cash flows.

On a consolidated basis, we monitor our total self-pay receivables to ensure that the total allowance for doubtful accounts provides adequate coverage based on historical collection experience. Our accounts receivable are recorded net of allowance for doubtful accounts of $253 million and $249 million at December 31, 2011 and 2010, respectively.

D) Concentration of Revenues: Our five majority owned acute care hospitals in the Las Vegas, Nevada market contributed, on a combined basis, 16% in 2011, 21% in 2010 and 22% in 2009, of our consolidated net revenues. On a combined basis, our facilities in the McAllen/Edinburg, Texas market (consisting of three acute care facilities, a children's hospital and a behavioral health facility) contributed 5% in 2011, 6% in 2010 and 7% in 2009, of our consolidated net revenues.

E) Cash and Cash Equivalents: We consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents.

F) Property and Equipment: Property and equipment are stated at cost. Expenditures for renewals and improvements are charged to the property accounts. Replacements, maintenance and repairs which do not improve or extend the life of the respective asset are expensed as incurred. We remove the cost and the related accumulated depreciation from the accounts for assets sold or retired and the resulting gains or losses are included in the results of operations. Construction-in-progress includes both construction projects and equipment not yet placed into service.

We capitalize interest expense on major construction projects while in progress. We capitalized interest on major construction projects amounting to $400,000 during 2011, $7.6 million during 2010 and $11.6 million during 2009.

Depreciation is provided on the straight-line method over the estimated useful lives of buildings and improvements (twenty to forty years) and equipment (three to fifteen years). Depreciation expense (excluding discontinued operations) was $268.5 million during 2011, $202.8 million during 2010 and $184.6 million during 2009.

G) Long-Lived Assets: We review our long-lived assets, including amortizable intangible assets, for impairment whenever events or circumstances indicate that the carrying value of these assets may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value of our asset based on our estimate of its undiscounted future cash flow. If the analysis indicates that the carrying value is not recoverable from future cash flows, the asset is written down to its estimated fair value and an impairment loss is recognized. Fair values are determined based on estimated future cash flows using appropriate discount rates.

H) Goodwill: Goodwill is reviewed for impairment at the reporting unit level on an annual basis or sooner if the indicators of impairment arise. Our judgments regarding the existence of impairment indicators are based on market conditions and operational performance of each reporting unit. We have designated September 1^st as our annual impairment assessment date and performed an impairment assessment as of September 1, 2011 which indicated no impairment of goodwill. There were also no goodwill impairments during 2010 or 2009. Future changes in the estimates used to conduct the impairment review, including profitability and market value projections, could indicate impairment in future periods potentially resulting in a write-off of a portion or all of our goodwill.

Changes in the carrying amount of goodwill for the two years ended December 31, 2011 were as follows (in thousands):


	Acute Care Services			Behavioral Health Services			Total Consolidated
Balance, January 1, 2010	$	389,845		$	342,840		$	732,685
Goodwill acquired during the period		510			1,895,276			1,895,786
Goodwill divested during the period		(871	)		—			(871	)
Adjustments to goodwill (a)		—			(37,686	)		(37,686	)

Balance, January 1, 2011		389,484			2,200,430			2,589,914
Adjustments to goodwill (b)		—			37,688			37,688

Balance, December 31, 2011	$	389,484		$	2,238,118		$	2,627,602

(a)	The reduction to the Behavioral Health Services' goodwill consists primarily of a reclassification to "assets of facilities held for sale" and represents the goodwill attributable to a legacy facility which we agreed to divest pursuant to our agreement with the Federal Trade Commission.

(b)	Consists of adjustments to prior year purchase price allocations

I) Other Assets: Other assets consist primarily of amounts related to: (i) intangible assets acquired in connection with our acquisition of Psychiatric Solutions, Inc. ("PSI") in November, 2010 consisting of Medicare licenses, certificates of need and contracts to manage the operations of behavioral health services owned by third-parties; (ii) prepaid fees for various software and other applications used by our hospitals; (iii) costs incurred in connection with the purchase and implementation of an electronic health records application for each of our acute care facilities; (iv) deposits; (v) investments in various businesses, including Universal Health Realty Income Trust; (vi) the invested assets related to a deferred compensation plan that is held by an independent trustee in a rabbi-trust and that has a related payable included in other noncurrent liabilities; (vii) the estimated future payments related to physician-related contractual commitments, as discussed below, and; (viii) other miscellaneous assets. As of December 31, 2011 and 2010, other intangible assets, net of accumulated amortization, were approximately $97 million and $100 million, respectively.

J) Physician Guarantees and Commitments: As of December 31, 2011 and 2010, our accrued liabilities-other, and our other assets included $7 million and $8 million, respectively, of estimated future payments related to physician-related contractual commitments. Pursuant to contractual guarantees outstanding as of December 31, 2011 that are applicable to future years, we have $6 million of potential future financial obligations of which $4 million are potential obligations during 2012 and $2 million are potential obligations during 2013 and later.

K) Self-Insured Risks: We provide for self-insured risks, primarily general and professional liability claims and workers' compensation claims. Our estimated liability for self-insured professional and general liability claims is based on a number of factors including, among other things, the number of asserted claims and reported incidents, estimates of losses for these claims based on recent and historical settlement amounts, estimate of incurred but not reported claims based on historical experience, and estimates of amounts recoverable under our commercial insurance policies. All relevant information, including our own historical experience is used in estimating the expected amount of claims. While we continuously monitor these factors, our ultimate liability for professional and general liability claims could change materially from our current estimates due to inherent uncertainties involved in making this estimate. Our estimated self-insured reserves are reviewed and changed, if necessary, at each reporting date and changes are recognized currently as additional expense or as a reduction of expense. See Note 8 for discussion of revisions to prior year general and professional liability reserves and self-insurance liability assumed in connection with our acquisition of PSI in November, 2010. Based on the results of workers' compensation reserves analyses, we recorded reductions of prior year reserves of $4 million during 2010 and $7 million during 2009. Adjustments to prior year workers' compensation reserves did not have a material impact on our 2011 consolidated financial statements or results of operations.

L) Income Taxes: Deferred tax assets and liabilities are recognized for the amount of taxes payable or deductible in future years as a result of differences between the tax bases of assets and liabilities and their reported amounts in the financial statements. We believe that future income will enable us to realize our deferred tax assets net of recorded valuation allowances relating to state net operating loss carry-forwards.

We operate in multiple jurisdictions with varying tax laws. We are subject to audits by any of these taxing authorities. Our tax returns have been examined by the Internal Revenue Service ("IRS") through the year ended December 31, 2006. We believe that adequate accruals have been provided for federal, foreign and state taxes.

See Note 6 for additional disclosure regarding income taxes.

M) Other Noncurrent Liabilities: Other noncurrent liabilities include the long-term portion of our professional and general liability, workers' compensation reserves, pension and deferred compensation liabilities, liability incurred in connection with split-dollar life insurance agreements on the lives of our chief executive officer and his wife and interest rate swap liabilities.

N) Redeemable Noncontrolling Interests and Noncontrolling Interest: Outside owners hold noncontrolling, minority ownership interests of: (i) approximately 28% in our five acute care facilities located in Las Vegas, Nevada; (ii) 20% in an acute care facility located in Washington, D.C.; (iii) approximately 11% in an acute care facility located in Laredo, Texas, and; (iv) 20% in a behavioral health care facility located in Philadelphia, Pennsylvania, the majority ownership interest of which was acquired by us as result of our acquisition of PSI in November, 2010. The redeemable noncontrolling interests balances of $218 million and $212 million as of December 31, 2011 and 2010, respectively, and the noncontrolling interests balances of $51 million and $45 million as of December 31, 2011 and 2010, respectively, consist primarily of the third-party ownership interests in these hospitals.

In connection with the five acute care facilities located in Las Vegas, Nevada, the minority ownership interests of which are reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owners have certain "put rights", that are currently exercisable, that if exercised, require us to purchase the minority member's interests at fair market value. The put rights are exercisable upon the occurrence of: (i) certain specified financial conditions falling below established thresholds; (ii) breach of the management contract by the managing member (a subsidiary of ours), or; (iii) if the minority member's ownership percentage is reduced to less than certain thresholds. In connection with the behavioral health care facility located in Philadelphia, Pennsylvania, the minority ownership interest of which is also reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owner has a "put option" to put its entire ownership interest to us at any time. If exercised, the put option requires us to purchase the minority member's interest at fair market value. As of December 31, 2011, we believe the fair market value of the minority ownership interests in these facilities approximates the book value of the redeemable noncontrolling interests.

O) Comprehensive Income and Accumulated Other Comprehensive Income: Comprehensive income or loss is comprised of net income, changes in unrealized gains or losses on derivative financial instruments and a pension liability.

The accumulated other comprehensive income ("AOCI") component of stockholders' equity includes: net unrealized gains and losses on effective cash flow hedges; and the net minimum pension liability of a non-contributory defined benefit pension plan which covers employees at one of our subsidiaries. See Note 10, "Pension Plan" for additional disclosure regarding the defined benefit pension plan.

The amounts recognized in AOCI for the two years ended December 31, 2011 were as follows (in thousands):


	Net Unrealized Gains (Losses) on Effective Cash Flow Hedges			Minimum Pension Liability			Total AOCI
Balance, January 1, 2010, net of income tax	$	(5,782	)	$	(15,471	)	$	(21,253	)
2010 activity:
Pre tax amount		1,060			743			1,803
Income tax effect		(408	)		(281	)		(689	)

Change, net of income tax		652			462			1,114

Balance, December 31, 2010, net of income tax		(5,130	)		(15,009	)		(20,139	)
2011 activity:
Pre tax amount		(37,813	)		(12,397	)		(50,210	)
Income tax effect		14,483			4,691			19,174

Change, net of income tax		(23,330	)		(7,706	)		(31,036	)

Balance, December 31, 2011, net of income tax	$	(28,460	)	$	(22,715	)	$	(51,175	)

P) Accounting for Derivative Financial Investments and Hedging Activities: We manage our ratio of fixed to floating rate debt with the objective of achieving a mix that management believes is appropriate. To manage this risk in a cost-effective manner, we, from time to time, enter into interest rate swap agreements in which we agree to exchange various combinations of fixed and/or variable interest rates based on agreed upon notional amounts.

We account for our derivative and hedging activities using the Financial Accounting Standard Board's ("FASB") guidance which requires all derivative instruments, including certain derivative instruments embedded in other contracts, to be carried at fair value on the balance sheet. For derivative transactions designated as hedges, we formally document all relationships between the hedging instrument and the related hedged item, as well as its risk-management objective and strategy for undertaking each hedge transaction.

Derivative instruments designated in a hedge relationship to mitigate exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Cash flow hedges are accounted for by recording the fair value of the derivative instrument on the balance sheet as either an asset or liability, with a corresponding amount recorded in accumulated other comprehensive income ("AOCI") within stockholders' equity. Amounts are reclassified from AOCI to the income statement in the period or periods the hedged transaction affects earnings.

We use interest rate derivatives in our cash flow hedge transactions. Such derivatives are designed to be highly effective in offsetting changes in the cash flows related to the hedged liability. For derivative instruments designated as cash flow hedges, the ineffective portion of the change in expected cash flows of the hedged item are recognized currently in the income statement.

Derivative instruments designated in a hedge relationship to mitigate exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Fair value hedges are accounted for by recording the changes in the fair value of both the derivative instrument and the hedged item in the income statement.

For hedge transactions that do not qualify for the short-cut method, at the hedge's inception and on a regular basis thereafter, a formal assessment is performed to determine whether changes in the fair values or cash flows of the derivative instruments have been highly effective in offsetting changes in cash flows of the hedged items and whether they are expected to be highly effective in the future.

Q) Stock-Based Compensation: At December 31, 2011, we have a number of stock-based employee compensation plans. Pursuant to the FASB's guidance, we expense the grant-date fair value of stock options and other equity-based compensation pursuant to the straight-line method over the stated vesting period of the award using the Black-Scholes option-pricing model.

The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities. The applicable FASB guidance requires that cash flows resulting from tax deductions in excess of compensation cost recognized be classified as financing cash flows. During 2011, 2010 and 2009, there were no net excess tax benefits generated.

R) Earnings per Share: Basic earnings per share are based on the weighted average number of common shares outstanding during the year. Diluted earnings per share are based on the weighted average number of common shares outstanding during the year adjusted to give effect to common stock equivalents.

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:


	Twelve Months Ended December 31,
	2011			2010			2009
Basic and diluted:
Net Income	$	448,870		$	275,795		$	304,247
Less: Net income attributable to noncontrolling interest		(50,703	)		(45,612	)		(43,874	)
Less: Net income attributable to unvested restricted share grants		(521	)		(918	)		(1,146	)

Net income attributable to UHS—basic and diluted	$	397,646		$	229,265		$	259,227

Basic earnings per share attributable to UHS:
Weighted average number of common shares—basic		97,199			96,786			97,794

Total basic earnings per share	$	4.09		$	2.37		$	2.65

Diluted earnings per share attributable to UHS:
Weighted average number of common shares		97,199			96,786			97,794
Net effect of dilutive stock options and grants based on the treasury stock method		1,338			1,187			481

Weighted average number of common shares and equivalents—diluted		98,537			97,973			98,275

Total diluted earnings per share	$	4.04		$	2.34		$	2.64

The "Net effect of dilutive stock options and grants based on the treasury stock method", for all years presented above, excludes certain outstanding stock options applicable to each year since the effect would have been anti-dilutive. The excluded weighted-average stock options totaled 1.4 million during 2011, 1,000 during 2010 and 3.6 million during 2009.

S) Fair Value of Financial Instruments: The fair values of our registered debt and investments are based on quoted market prices. The fair values of other long-term debt, including capital lease obligations, are estimated by discounting cash flows using period-end interest rates and market conditions for instruments with similar maturities and credit quality. The carrying amounts reported in the balance sheet for cash, accounts receivable, accounts payable, and short-term borrowings approximates their fair values due to the short-term nature of these instruments. Accordingly, these items have been excluded from the fair value disclosures included elsewhere in these notes to consolidated financial statements.

T) Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

U) Mergers and Acquisitions: The acquisition method of accounting for business combinations requires that the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective fair values with limited exceptions. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Any excess of the purchase price (consideration transferred) over the estimated fair values of net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired company are expensed as incurred. The fair value of intangible assets, including Medicare Licenses, Certificates of Need, and certain contracts, is based on significant judgments made by our management, and accordingly, for significant items we typically obtain assistance from third party valuation specialists.

V) Accounting Standards:

Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities: In July 2011, the FASB issued Accounting Standards Update ("ASU") No. 2011-07, "Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities," which requires health care entities to change the presentation in their statement of operations by reclassifying the provision for bad debts associated with patient service revenue from an operating expense to a deduction from patient service revenue (net of contractual allowances and discounts). The guidance provided in this ASU is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2011, with early adoption permitted. While this standard will have no impact on our financial position or results of operations, it will require us to reclassify our provision for doubtful accounts from operating expenses to a component of net revenues beginning with the first quarter of 2012, with retrospective application required.

Measuring Charity Care for Disclosures: In August 2010, the FASB issued ASU 2010-23, "Health Care Entities (Topic 954): Measuring Charity Care for Disclosure," which prescribes a specific measurement basis of charity care for disclosure. The guidance provided in this ASU is effective for fiscal years beginning after December 15, 2010. The adoption of this standard did not have a material impact on our consolidated financial position or results of operations.

A significant portion of the patients treated throughout our portfolio of acute care hospitals are uninsured patients which, in part, has resulted from an increase in the number of patients who are employed but do not have health insurance or who have policies with relatively high deductibles. We provide care to patients who meet certain financial or economic criteria without charge or at amounts substantially less than our established rates. Because we do not pursue collection of amounts that qualify as charity care, they are not reported in net revenues or in accounts receivable, net. Our acute care hospitals provided charity care and uninsured discounts, based on charges at established rates, amounting to $956 million during 2011 and $807 million during 2010.

The estimated cost of providing the charity services was $173 million during 2011 and $158 million during 2010. The estimated costs were based on a calculation which multiplied the percentage of operating expenses for our acute care hospitals to gross charges for those hospitals by the above-mentioned gross charity care and uninsured discount amounts. The percentage of cost to gross charges is calculated based on the total operating expenses for our acute care facilities (excluding provision for doubtful accounts) divided by gross patient service revenue for those facilities. An increase in the level of uninsured patients to our facilities and the resulting adverse trends in the provision for doubtful accounts and charity care provided could have a material unfavorable impact on our future operating results.

Fair Value Measurements and Disclosures: The Financial Accounting Standards Board ("FASB") has issued Accounting Standards Update No. 2010-06, Fair Value Measurements and Disclosures about Fair Value Measurements ("ASU 2010-06"). ASU 2010-06 affects all entities that are required to make disclosures about recurring and nonrecurring fair value measurements under FASB ASC Topic 820, originally issued as FASB Statement No. 157, Fair Value Measurements. This ASU requires certain new disclosures and clarifies two existing disclosure requirements. The new disclosures and clarifications of existing disclosures are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances, and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years beginning after December 15, 2010 and for interim periods within those fiscal years. ASU No. 2010-06 did not have a significant impact on our disclosures.

Presentation of Comprehensive Income: In June 2011, the FASB amended its guidance governing the presentation of comprehensive income. The amended guidance eliminates the option to report other comprehensive income and its components in the statement of changes in equity. Under the new guidance, an entity can elect to present items of net income and other comprehensive income in one continuous statement referred to as the statement of comprehensive income or in two separate, but consecutive, statements. While the options for presenting other comprehensive income change under the guidance, other portions of the current guidance will not change. For public entities, these changes are effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of this standard is not expected to have a material impact on our consolidated financial position or results of operations.

Multiemployer Pension Plan Disclosures: In September 2011, the FASB issued ASU 2011-09 which requires enhanced disclosures around an employer's participation in multiemployer pension plans. The standard is intended to provide more information about an employer's financial obligations to a multiemployer pension plan to help financial statement users better understand the financial health of the significant plans in which the employer participates. This guidance is effective for fiscal 2011 year-end reporting. The adoption of this standard is not expected to have a significant impact on our disclosures.

Goodwill Impairment Assessment: In September 2011, the FASB issued ASU 2011-08 which provides an entity the option to first assess qualitative factors to determine whether it is necessary to perform the current two-step test for goodwill impairment. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is required. Otherwise, no further testing is required. The revised standard is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. However, an entity can choose to early adopt even if its annual test date is before the issuance of the final standard, provided that the entity has not yet performed its 2011 annual impairment test or issued its financial statements. The adoption of this ASU is not expected to have a material impact on our consolidated financial position or results of operations.

Presentation of Insurance Claims and Related Insurance Recoveries: In August 2010, the FASB issued Accounting Standard Updates ("ASU") 2010-24, "Health Care Entities (Topic 954): Presentation of Insurance Claims and Related Insurance Recoveries," which clarifies that a health care entity should not net insurance recoveries against a related claim liability. The guidance provided in this ASU is effective for the fiscal years, and interim periods within those years, beginning after December 15, 2010. The adoption of this standard did not have a material impact on our consolidated financial position or results of operations.

Acquisitions And Divestitures

12 Months Ended

Dec. 31, 2011

Acquisitions And Divestitures [Abstract]

Acquisitions And Divestitures

2) ACQUISITIONS AND DIVESTITURES

Year ended December 31, 2011:

2011 Acquisitions of Assets and Businesses:

During 2011, we spent $29 million on the acquisition of businesses and real property, including the following:

•

the acquisition of administrative office buildings located in Pennsylvania, Tennessee and a multi-tenant office building located in Washington D.C. (which was acquired by a limited partnership in which we hold an 80% ownership interest);

•

a deposit in connection with execution of a definitive agreement, which is subject to regulatory approvals and closing conditions, to acquire the Knapp Medical Center, including a 226-bed acute care hospital, a surgery center, physician practices and other related assets located in Weslaco, Texas, and;

•

the acquisition of a cardiology practice in Texas

The aggregate net cash expenditure related to the properties and/or businesses was allocated to assets and liabilities based on their estimated fair values as follows:


	Amount (000s)
Property, plant & equipment	$	35,000
Other assets/deposits		11,000
Debt		(17,000	)

Cash paid in 2011 for acquisitions and deposits	$	29,000

2011 Divestitures of Assets and Businesses:

During 2011, we received $68 million from the divestiture of assets and businesses, including the following:

•

the sale of three behavioral healthcare facilities (one located in Delaware and two located in Nevada) pursuant to our agreement with the Federal Trade Commission ("FTC") in connection with our acquisition of PSI;

•

sale of our majority ownership interest in a radiation oncology center located in Nevada, and;

•

the real property of a closed acute care hospital

The operating results for the three former PSI facilities located in Delaware and Nevada are reflected as discontinued operations during 2011 and 2010 (from the November 15^th dates of acquisition). Since the aggregate income from discontinued operations before income tax expense for these facilities is not material to our 2011 or 2010 consolidated financial statements, it is included as a reduction to other operating expenses. The aggregate pre-tax net gain on the divestitures of the above-mentioned facilities located in Delaware and Nevada did not have a material impact on our consolidated results of operations.

In addition, also pursuant to our agreement with the FTC in connection with our acquisition of PSI, in January, 2012, we divested the Hospital San Juan Capestrano, a 108-bed facility located in Rio Piedras, Puerto Rico. The assets and liabilities for the Hospital San Juan Capestrano are reflected as "held for sale" on our Consolidated Balance Sheet as of December 31, 2011. The pre-tax gain on the divestiture of the Hospital San Juan Capestrano, which will not have a material impact on our 2012 consolidated results of operations, will be reflected in our consolidated results of operations during the first quarter of 2012. The assets and liabilities for each of the above-mentioned facilities were reflected as "held for sale" on our Consolidated Balance Sheet as of December 31, 2010.

The following table shows the results of operations for the former PSI facilities located in Delaware and Nevada, on a combined basis, which are reflected as discontinued operations (amounts in thousands):


	Year Ended December 31,
	2011			2010			2009
Net revenues	$	33,884		$	4,155		$	—
Income from discontinued operations		7,904			859			—
Gain on divestiture		442			—			—

Income from discontinued operations, before income tax expense		8,346			859			—
Income tax expense		(3,160	)		(318	)		—

Income from discontinued operations, net of income tax expense	$	5,186		$	541		$	—

Year ended December 31, 2010:

2010 Acquisitions of Assets and Businesses:

During 2010, we spent $1.96 billion and assumed $1.08 billion of debt on the acquisition of businesses and real property, including the following:

•

the acquisition of PSI on November 15, 2010 for a total purchase price of $3.04 billion consisting of $1.96 billion in cash plus the assumption of approximately $1.08 billion of PSI's debt, the majority of which has since been refinanced, and;

•

the acquisition of substantially all of the assets of an outpatient surgery center located in Florida in which we previously held a 20% minority ownership interest. The purchase price consideration in connection with this transaction, which occurred during the first quarter, consisted of acquisition of the net assets less the assumption of the outstanding liabilities and third-party debt.

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their estimated fair values as follows:


	Amount (000s)
Working capital, net	$	60,000
Assets held for sale		67,000
Property, plant & equipment		932,000
Goodwill		1,921,000
Other assets		132,000
Income tax assets, net of deferred tax liabilities		(14,000	)
Debt		(1,082,000	)
Liabilities held for sale		(1,000	)
Redeemable noncontrolling interests		(5,000	)
Other liabilities		(52,000	)

Cash paid in 2010 for acquisitions	$	1,958,000

Goodwill of the facilities acquired is computed, pursuant to the residual method, by deducting the fair value of the acquired assets and liabilities from the total purchase price. The factors that contribute to the recognition of goodwill, which may also influence the purchase price, include the following for each of the acquired facilities: (i) the historical cash flows and income levels; (ii) the reputations in their respective markets; (iii) the nature of the respective operations, and; (iv) the future cash flows and income growth projections.

Assuming the acquisition of PSI occurred on January 1, 2009, our 2009 pro forma net revenues would have been approximately $7.01 billion and our pro forma net income attributable to UHS and pro form net income attributable to UHS per diluted share would have been $211 million and $2.14 per diluted share, respectively. The 2009 pro forma net income attributable to UHS and net income attributable to UHS per diluted share include the after-tax impact of the transaction costs incurred by us in connection with the acquisition of PSI amounting to $79 million or $.81 per diluted share.

Our 2010 pro forma net revenues would have been approximately $7.30 billion and our pro forma net income attributable to UHS and pro forma net income attributable to UHS per diluted share would have been $342 million and $3.47 per diluted share, respectively.

During the period of November 16, 2010 through December 31, 2010, the facilities acquired from PSI generated $227 million of net revenues which are included in our consolidated net revenues for the year ended December 31, 2010. The aggregate effect of the earnings generated by these facilities since the date of acquisition, less the cost on the borrowings utilized to finance the acquisition, was not material to our 2010 net income attributable to UHS and net income attributable to UHS per diluted share.

2010 Divestitures of Assets and Businesses:

During 2010, we received $21 million from the divestiture of assets and businesses, including the following:

•

the sale of our minority ownership interest in a healthcare technology company;

•

the sale of a portion of our ownership interest in an outpatient surgery center located in Texas, and;

•

the sale of the real property of Methodist Hospital located in Louisiana that was severely damaged and closed in 2005 as a result of Hurricane Katrina.

The pre-tax gain, net of losses, resulting from the above-mentioned transactions did not have a material impact on our 2010 financial statements.

Year ended December 31, 2009:

2009 Acquisitions of Assets and Businesses:

During 2009, we spent $12 million on the acquisition of businesses and real property, including the following:

•

the acquisition of a 72-bed behavioral health care facility located in Louisville, Colorado, and;

•

the acquisition of the real property assets of a medical office building located on the campus of one of our acute care hospitals located in Texas.

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their estimated fair values as follows:


	Amount (000s)
Working capital, net	$	1,000
Property, plant & equipment		11,000

Cash paid in 2009 for acquisitions	$	12,000

Assuming the acquisition of the behavioral health facility located in Colorado occurred on January 1, 2009, the pro forma effect on our 2009 net revenues, income from continuing operations, income from continuing operations per basic and diluted share, net income attributable to UHS and net income attributable to UHS per basic and diluted share was immaterial.

2009 Divestitures of Assets and Businesses:

During 2009, we received $10 million from the divestiture of assets and businesses, including the following:

•

the sale of the real property assets of a medical office building on the campus of a previously divested acute care facility located in Pennsylvania, and;

•

the sale of our ownership interest in an outpatient surgery center

Financial Instruments	12 Months Ended
Financial Instruments	Dec. 31, 2011
Financial Instruments [Abstract]
Financial Instruments	3) FINANCIAL INSTRUMENTS *Fair Value Hedges:* During 2011, 2010 and 2009, we had no fair value hedges outstanding. *Cash Flow Hedges:* We manage our ratio of fixed to floating rate debt with the objective of achieving a mix that management believes is appropriate. To manage this risk in a cost-effective manner, we, from time to time, enter into interest rate swap agreements in which we agree to exchange various combinations of fixed and/or variable interest rates based on agreed upon notional amounts. We account for our derivative and hedging activities using the Financial Accounting Standard Board's ("FASB") guidance which requires all derivative instruments, including certain derivative instruments embedded in other contracts, to be carried at fair value on the balance sheet. For derivative transactions designated as hedges, we formally document all relationships between the hedging instrument and the related hedged item, as well as its risk-management objective and strategy for undertaking each hedge transaction. Derivative instruments designated in a hedge relationship to mitigate exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Cash flow hedges are accounted for by recording the fair value of the derivative instrument on the balance sheet as either an asset or liability, with a corresponding amount recorded in accumulated other comprehensive income ("AOCI") within stockholders' equity. Amounts are reclassified from AOCI to the income statement in the period or periods the hedged transaction affects earnings. We use interest rate derivatives in our cash flow hedge transactions. Such derivatives are designed to be highly effective in offsetting changes in the cash flows related to the hedged liability. For derivative instruments designated as cash flow hedges, the ineffective portion of the change in expected cash flows of the hedged item are recognized currently in the income statement. For hedge transactions that do not qualify for the short-cut method, at the hedge's inception and on a regular basis thereafter, a formal assessment is performed to determine whether changes in the fair values or cash flows of the derivative instruments have been highly effective in offsetting changes in cash flows of the hedged items and whether they are expected to be highly effective in the future. The fair value of interest rate swap agreements approximates the amount at which they could be settled, based on estimates obtained from the counterparties. We assess the effectiveness of our hedge instruments on a quarterly basis. We performed periodic assessments of the cash flow hedge instruments during 2011 and 2010 and determined the hedges to be highly effective. We also determined that no portion of the hedges is ineffective and therefore there was no material effect on our consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose us to credit risk in the event of nonperformance. However, at December 31, 2011, each swap agreement entered into by us was in a net liability position which would require us to make the net settlement payments to the counterparties. We do not anticipate nonperformance by those counterparties. We do not hold or issue derivative financial instruments for trading purposes. During the first quarter of 2011, we entered into an interest rate cap on a total notional amount of $275 million whereby we paid a premium of $30,000 in exchange for the counterparty agreeing to pay the difference between 2.25% and three-month LIBOR if the three-month LIBOR rate rises above 2.25% during the term of the cap, which expired in December, 2011. The three-month LIBOR never reached 2.25% during the term of the cap. Therefore, no payment was made to us. We also entered into a forward starting interest rate cap on a total notional amount of $450 million from December, 2011 to December, 2012 reducing to $400 million from December, 2012 to December, 2013 whereby we paid a premium of $740,000 in exchange for the counterparty agreeing to pay the difference between 7.00% and three-month LIBOR if the three-month LIBOR rate rises above 7.00% during the term of the cap. If the three-month LIBOR does not reach 7.00% during the term of the cap, no payment is made to us. We also entered into six additional forward starting interest rate swaps in the first quarter of 2011 whereby we pay a fixed rate on a total notional amount of $425 million and receive three-month LIBOR. Three of these swaps with a total notional amount of $225 million became effective in March, 2011 and will mature in May, 2015. The average fixed rate payable on these swaps is 1.91%. The three remaining interest rate swaps with total notional amounts of $100 million, $25 million and $75 million became effective in December, 2011 and have fixed rates of 2.50%, 1.96% and 1.32%, and maturity dates in December, 2014, December, 2013 and December, 2012, respectively. During the fourth quarter of 2010, we entered into three interest rate caps on a total notional amount of $1 billion whereby we paid a premium of $240,000 in exchange for the counterparties agreeing to pay the difference between 2.25% and three-month LIBOR if the three-month LIBOR rate rises above 2.25% during the term of the caps. All of these caps expired in December, 2011. The three-month LIBOR rate never rose above 2.25% during the term of the caps. Therefore, no payments were made to us. We also entered into four forward starting interest rate swaps in the fourth quarter of 2010 whereby we pay a fixed rate on a total notional amount of $600 million and receive three-month LIBOR. Each of the four swaps became effective in December, 2011 and will mature in May, 2015. The average fixed rate payable on these swaps is 2.38%. During the fourth quarter of 2007, we entered into two interest rate swaps whereby we pay a fixed rate on a total notional principal amount of $150 million and receive three-month LIBOR. Each of the two interest rate swaps had an initial notional principal amount of $75 million. The notional amount of the first interest rate swap reduced to $50 million in October, 2010.The fixed rate payable is 4.76% and it matures in October, 2012. The fixed rate payable on the second interest rate swap was 4.87% and it matured in October, 2011. We measure our interest rate swaps at fair value on a recurring basis. The fair value of our interest rate swaps is based primarily on quotes from banks. We consider those inputs to be "level 3" in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with derivative instruments and hedging activities. The fair value of our interest rate swaps was a liability of $48 million at December 31, 2011, of which $4 million is included in other current liabilities and $44 million is included in other noncurrent liabilities on the accompanying balance sheet. The fair value of our interest rate swaps was a liability of $10 million at December 31, 2010, of which $2 million is included in other current liabilities and $8 million is included in other noncurrent liabilities.

Long-Term Debt

12 Months Ended

Dec. 31, 2011

Long-Term Debt [Abstract]

Long-Term Debt

4) LONG-TERM DEBT

A summary of long-term debt follows:


	December 31,
	2011			2010
	(amounts in thousands)
Long-term debt:
Notes payable and Mortgages payable (including obligations under capitalized leases of $9,982 in 2011 and $11,962 in 2010) and term loans with varying maturities through 2038; weighted average interest at 6.1% in 2011 and 6.5% in 2010 (see Note 7 regarding capitalized leases)	$	51,841		$	49,355
Revolving credit and demand notes		249,600			187,500
Term Loan A, net of unamortized discount of $6,103		1,020,375			1,042,322
Term Loan B, net of unamortized discount of $19,500		1,436,772			1,576,500
Revenue bonds, interest at floating rates of 0.2% and 0.3% at December 31, 2011 and 2010, respectively, with varying maturities through 2015		5,300			5,300
Accounts receivable securitization program		240,000			204,000
6.75% Senior Secured Notes due 2011, net of the unamortized discount of $9 in 2010, and fair market value adjustment of $559 in 2010.		—			200,550
7.125% Senior Secured Notes due 2016, including unamortized net premium of $19 in 2011 and $24 in 2010		400,019			400,024
7.00% Senior Unsecured Notes due 2018		250,000			250,000

		3,653,907			3,915,551
Less-Amounts due within one year		(2,479	)		(3,449	)

	$	3,651,428		$	3,912,102

On November 15, 2010, we entered into a credit agreement (the "Credit Agreement") with various financial institutions. The Credit Agreement is a senior secured facility which provided an initial aggregate commitment amount of $3.45 billion, comprised of a new $800 million revolving credit facility, a $1.05 billion Term Loan A facility and a $1.6 billion Term Loan B facility. Prior to the effectiveness of the Credit Agreement Amendment in March, 2011 (as discussed below), we prepaid the principal amount and permanently reduced the Term Loan B commitment by $125 million. During 2011, we made scheduled principal payments of $16 million on the Term Loan B and $26 million on the Term Loan A. The revolving credit facility and the Term Loan A mature on November 15, 2015 and the Term Loan B matures on November 15, 2016. The revolving credit facility includes a $125 million sub-limit for letters of credit. The Credit Agreement is secured by substantially all of the assets of the Company and our material subsidiaries and guaranteed by our material subsidiaries.

On March 15, 2011, we entered into a first amendment to the Credit Agreement (the "Amendment") which became effective immediately and provides, among other things, for a reduction in the interest rates payable in connection with borrowings under the Credit Agreement. Upon the effectiveness of the Amendment, borrowings under the Credit Agreement bear interest at the ABR rate which is defined as the rate per annum equal to, at our election (1) the greatest of (a) the lender's prime rate, (b) the weighted average of the federal funds rate, plus 0.5% and (c) one month Eurodollar rate plus 1%, in each case, plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 0.50% to 1.25% for revolving credit and Term Loan A borrowings and 1.75% to 2.00% for Term Loan B borrowings or (2) the one, two, three or six month Eurodollar rate (at our election), plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 1.50% to 2.25% for revolving credit and Term Loan A borrowings and ranging from 2.75% to 3.00% for Term Loan B borrowings. The current applicable margins are 0.75% for ABR-based loans, 1.75% for Eurodollar-based loans under the revolving credit and Term Loan A facilities and 2.75% under the Term Loan B facility. Upon the effectiveness of the Amendment, the minimum Eurodollar rate for the Term Loan B facility was reduced from 1.50% to 1.00%. In connection with the Amendment, we paid a fee of 1.00% of the amounts outstanding under the Term Loan B in accordance with the terms of the Credit Agreement.

In October, 2010, we amended our accounts receivable securitization program ("Securitization") with a group of conduit lenders and liquidity banks. We increased the size of the Securitization to $240 million (the "Commitments"), from $200 million, and extended the maturity date to October 25, 2013. Substantially all of the patient-related accounts receivable of our acute care hospitals ("Receivables") serve as collateral for the outstanding borrowings. The interest rate on the borrowings is based on the commercial paper rate plus a spread of 0.475% and there is a facility fee of 0.375% required on 102% on the Commitments. We have accounted for this Securitization as borrowings. We maintain effective control over the Receivables since, pursuant to the terms of the Securitization, the Receivables are sold from certain of our subsidiaries to special purpose entities that are wholly-owned by us. The Receivables, however, are owned by the special purpose entities, can be used only to satisfy the debts of the wholly-owned special purpose entities, and thus are not available to us except through our ownership interest in the special purpose entities. The wholly-owned special purpose entities use the Receivables to collateralize the loans obtained from the group of third-party conduit lenders and liquidity banks. The group of third-party conduit lenders and liquidity banks do not have recourse to us beyond the assets of the wholly-owned special purpose entities that securitize the loans. At December 31, 2011, we had $240 million of outstanding borrowings and no additional capacity pursuant to the terms of our accounts receivable securitization program.

As of December 31, 2011, we had $9 million outstanding borrowings under a short-term, on-demand credit facility. Outstanding borrowings, if any, pursuant to this facility are classified as long-term debt on our Consolidated Balance Sheet since they can be refinanced through available borrowings under the terms of our Credit Agreement.

As of December 31, 2011, we had an aggregate of $482 million of available borrowing capacity pursuant to the terms of our Credit Agreement and Securitization, net of $69 million of outstanding letters of credit and $9 million of outstanding borrowings under a short-term, on-demand credit facility.

On September 29, 2010, we issued $250 million of 7.00% senior unsecured notes (the "Unsecured Notes") which are scheduled to mature on October 1, 2018. The Unsecured Notes were registered in April, 2011. Interest on the Unsecured Note is payable semiannually in arrears on April 1st and October 1st of each year. The Unsecured Notes can be redeemed in whole at anytime subject to a make-whole call at treasury rate plus 50 basis points prior to October 1, 2014. They are also redeemable in whole or in part at a price of: (i) 103.5% on or after October 1, 2014; (ii) 101.75% on or after October 1, 2015, and; (iii) 100% on or after October 1, 2016. These Unsecured Notes are guaranteed by a group of subsidiaries (each of which is a 100% directly owned subsidiary of Universal Health Services, Inc.) which fully and unconditionally guarantee the Unsecured Notes on a joint and several basis, subject to certain customary automatic release provisions.

On June 30, 2006, we issued $250 million of senior notes which have a 7.125% coupon rate and mature on June 30, 2016 (the "7.125% Notes"). Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year. In June, 2008, we issued an additional $150 million of 7.125% Notes which formed a single series with the original 7.125% Notes issued in June, 2006. Other than their date of issuance and initial price to the public, the terms of the 7.125% Notes issued in June, 2008 are identical to and trade interchangeably with, the 7.125% Notes which were originally issued in June, 2006.

During 2001, we issued $200 million of senior notes which have a 6.75% coupon rate and which matured and were paid in full on November 15, 2011 (the "6.75% Notes"). The interest on the 6.75% Notes was paid semiannually in arrears on May 15th and November 15th of each year.

In connection with the entering into of the Credit Agreement on November 15, 2010, and in accordance with the Indenture dated January 20, 2000 governing the rights of our existing notes, we entered into a supplemental indenture pursuant to which our 7.125% Notes (due in 2015) and our 6.75% Notes (which matured in November, 2011) were equally and ratably secured with the lenders under the Credit Agreement with respect to the collateral for so long as the lenders under the Credit Agreement are so secured.

The average amounts outstanding during 2011, 2010, and 2009 are under the current and prior Credit Agreements, demand notes and accounts receivable securitization programs were $2.9 billion, $610 million and $287 million, respectively, with corresponding interest rates of 3.4%, 3.4%, and 1.7% including commitment and facility fees. The maximum amounts outstanding at any month-end were $3.03 billion in 2011, $3.11 billion in 2010, and $356 million in 2009. The effective interest rate on our current and prior Credit Agreements, accounts receivable securitization programs, and demand notes, which includes the respective interest expense, commitment and facility fees, designated interest rate swaps expense and amortization of deferred financing costs and original issue discounts, was 4.6% in 2011, 5.0% in 2010 and 3.9% in 2009.

Our Credit Agreement includes a material adverse change clause that must be represented at each draw. The Credit Agreement contains covenants that include a limitation on sales of assets, mergers, change of ownership, liens and indebtedness, transactions with affiliates and dividends; and requires compliance with financial covenants including maximum leverage and minimum interest coverage ratios. We are in compliance with all required covenants as of December 31, 2011.

The carrying values of our debt at December 31, 2011 and 2010 are reflected above. The fair values of our debt at December 31, 2011 and 2010 were $3.70 billion and $3.96, respectively. The fair value of our debt was computed based upon quotes received from financial institutions.

Aggregate maturities follow:


	(000s)
2012	$	2,479
2013		242,638
2014		3,970
2015		1,290,085
2016		1,840,693
Later		274,042

Total	$	3,653,907

Common Stock

12 Months Ended

Dec. 31, 2011

Common Stock [Abstract]

Common Stock

5) COMMON STOCK

In November, 2009, we declared a two-for-one stock split in the form of a 100% stock dividend which was paid on December 15, 2009 to stockholders of record as of December 1, 2009. All classes of common stock participated on a pro rata basis and, as required, references to share quantities, share prices and earnings per share for all periods presented or discussed have been adjusted to reflect the two-for-one stock split.

Dividends

Cash dividends of $.20 per share ($19 million in the aggregate) were declared and paid during each of 2011 and 2010, and $.17 per share ($17 million in the aggregate) were declared and paid during 2009.

Stock Repurchase Programs

In various prior years, our Board of Directors has approved stock repurchase programs authorizing us to purchase shares of our outstanding Class B Common Stock on the open market at prevailing market prices or in negotiated transactions off the market. There is no expiration date for our stock repurchase programs. The most recent approval occurred during 2007 at which time our Board of Directors authorized the purchase of up to 10 million shares, a portion of which (as reflected below) remains available for purchase as of December 31, 2011. The following schedule provides information related to our stock repurchase programs for each of the three years ended December 31, 2011:


	Additional Shares Authorized For Repurchase		Total number of shares purchased(a)		Average price paid per share for forfeited restricted shares		Total number of shares purchased as part of publicly announced programs		Average price paid per share for shares purchased as part of publicly announced program		Aggregate purchase price paid (in thousands)		Maximum number of shares that may yet be purchased under the program
Balance as of January 1, 2009														4,713,548
2009		—		2,574,209	$	0.01		2,561,209	$	24.71	$	63,288		2,152,339
2010		—		301,933	$	0.01		293,933	$	39.22	$	11,528		1,858,406
2011		—		1,602,286	$	0.01		1,602,286	$	37.75	$	60,482		256,120

Total for three year period ended December 31, 2011		—		4,478,428	$	0.01		4,457,428	$	30.35	$	135,298

(a)	During 2010 and 2009, there were 8,000 and 13,000, respectively, of restricted shares that were forfeited by former employees pursuant to the terms of our restricted stock purchase plan which are included in the total number of shares purchased. No such forfeitures occurred during 2011.

Stock-based Compensation Plans

At December 31, 2011, we have a number of stock-based employee compensation plans. Pursuant to the FASB's guidance, we expense the grant-date fair value of stock options and other equity-based compensation pursuant to the straight-line method over the stated vesting period of the award using the Black-Scholes option-pricing model.

Compensation costs related to outstanding stock options were recognized as follows: (i) a pre-tax charge of $15.8 million ($9.8 million after-tax) or $.10 per diluted share during 2011; (ii) a pre-tax charge of $13.3 million ($8.3 million after-tax) or $.08 per diluted share during 2010, and; (ii) $9.9 million ($6.2 million after-tax) or $.06 per diluted share during 2009. In addition, during the years ended 2011, 2010 and 2009, compensation costs of $2.0 million ($1.2 million after-tax), $3.1 million ($2.0 million after-tax) and$2.8 million ($1.8 million after-tax) , respectively, were recognized related to restricted stock.

We adopted the 2005 Stock Incentive Plan, as amended in 2008 and 2010, (the "Stock Incentive Plan") which replaced our Amended and Restated 1992 Stock Option Plan which expired in July of 2005. An aggregate of twenty-three million shares of Class B Common Stock has been reserved under the Stock Incentive Plan. There were 2,747,500, 82,750 and 2,400,500 stock options, net of cancellations, granted during 2011, 2010 and 2009, respectively. The per option weighted-average grant-date fair value of options granted during 2011, 2010 and 2009, was $11.62, $7.84 and $7.93, respectively. Stock options to purchase Class B Common Stock have been granted to our officers, key employees and directors under our above referenced stock option plans. All stock options were granted with an exercise price equal to the fair market value on the date of the grant. Options are exercisable ratably over a four-year period beginning one year after the date of the grant. All outstanding options expire five years after the date of the grant.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions derived from averaging the number of options granted during the most recent five-year period that were granted or have vestings after January 1, 2006. The 2009 weighted-average assumptions were based upon nineteen option grants, the 2010 weighted-average assumptions were based upon seventeen option grants and the 2011 weighted-average assumptions were based upon eighteen option grants.


Year Ended December 31,	2011			2010			2009
Volatility		29	%		27	%		28	%
Interest rate		2	%		3	%		3	%
Expected life (years)		3.5			3.6			3.6
Forfeiture rate		9	%		10	%		10	%
Dividend yield		0.7	%		0.7	%		0.7	%

The risk-free rate is based on the U.S. Treasury zero coupon four year yield in effect at the time of grant. The expected life of the stock options granted was estimated using the historical behavior of employees. Expected volatility was based on historical volatility for a period equal to the stock option's expected life. Expected dividend yield is based on our actual dividend yield at the time of grant.

The table below summarizes our stock option activity during each of the last three years:


Outstanding Options	Number of Shares			Average Option Price		Range (High-Low)
Balance, January 1, 2009		8,116,326		$	22.68	$	31.70 -$16.22
Granted		2,635,000		$	31.18	$	31.18 -$31.18
Exercised		(1,582,376	)	$	23.71	$	29.89 -$16.22
Cancelled		(366,500	)	$	22.84	$	29.89 -$16.22

Balance, January 1, 2010		8,802,450		$	25.03	$	31.70 -$16.22
Granted		94,000		$	30.40	$	32.28 -$30.32
Exercised		(2,000,250	)	$	24.87	$	31.70 -$16.22
Cancelled		(301,250	)	$	24.91	$	31.18 -$16.22

Balance, January 1, 2011		6,594,950		$	25.16	$	32.28 -$16.22
Granted		2,894,500		$	43.66	$	54.79 -$38.12
Exercised		(1,563,255	)	$	26.38	$	32.28 -$16.22
Cancelled		(367,250	)	$	32.60	$	46.97 -$16.22

Balance, December 31, 2011		7,558,945		$	31.63	$	54.79 -$16.22

Outstanding options vested and exercisable as of December 31, 2011		2,979,945		$	23.82	$	31.18 -$16.22

The following table provides information about unvested options for the year December 31, 2011:


	Shares			Weighted Average Grant Date Fair Value
Unvested options as of January 1, 2011		3,799,250		$	5.80
Granted		2,894,500		$	11.62
Vested		(1,757,500	)	$	5.26
Cancelled		(357,250	)	$	8.19

Unvested options as of December 31, 2011		4,579,000		$	9.50

The following table provides information about all outstanding options, and exercisable options, at December 31, 2011:


	Options Outstanding		Options Exercisable
Number		7,558,945		2,979,945
Weighted average exercise price	$	31.63	$	23.82
Aggregate intrinsic value as of December 31, 2011	$	67,870,455	$	44,833,019
Weighted average remaining contractual life		2.8		1.8

The total in-the-money value of all stock options exercised during the years ended December 31, 2011, 2010 and 2009 were $28.9 million, $26.8 million and $10.2 million, respectively.

The weighted average remaining contractual life for options outstanding and weighted average exercise price per share for exercisable options at December 31, 2011 were as follows:


	Options Outstanding						Exercisable Options				Expected to Vest Options(a)
Exercise Price	Shares		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in Years)		Shares		Weighted Average Exercise Price Per Share		Shares		Weighted Average Exercise Price Per Share
$16.22 – $24.45		2,642,825	$	19.56		1.5		2,050,825	$	20.53		537,891	$	16.22
$25.32 – $29.26		29,500		26.80		1.1		17,750		26.59		10,676		27.12
$29.60 – $32.28		2,139,120		31.15		2.9		911,370		31.16		1,115,534		31.14
$38.12 – $43.67		2,728,000		43.59		4.1		—		N/A		2,478,661		43.59
$46.79 – $54.79		19,500		52.99		4.3		—		N/A		17,718		52.99

Total		7,558,945	$	31.63		2.8		2,979,945	$	23.82		4,160,480	$	36.71

(a)	Assumes a weighted average forfeiture rate of 9.14%.

In addition to the Stock Incentive Plan, we have the following stock incentive and purchase plans: (i) the 2010 Employees' Restricted Stock Purchase Plan ("2010 Plan"), which replaced the Second Amended and Restated 2001 Employees' Restricted Stock Purchase Plan ("2001 Plan"), which allows eligible participants to purchase shares of Class B Common Stock at par value, subject to certain restrictions. During 2011, pursuant to the 2010 Plan, the Compensation Committee of the Board of Directors (the "Committee") approved the issuance of 21,500 restricted shares of our Class B Common Stock at a weighted average price of $53.21 per share ($1.1 million in the aggregate) to various employees. These shares have various vesting schedules. and; (ii) a 2005 Employee Stock Purchase Plan which allows eligible employees to purchase shares of Class B Common Stock at a ten percent discount. There were 98,366, 94,955 and 138,870 shares issued pursuant to the Employee Stock Purchase Plan during 2011, 2010 and 2009, respectively. Compensation expense recorded in connection with this plan was $461,000, $339,000 and $316,000 during 2011, 2010 and 2009, respectively.

We have reserved 6.0 million shares of Class B Common Stock for issuance under these various plans (excluding terminated plans) and have issued approximately 700,000 shares, net of cancellations, pursuant to the terms of these plans (excluding terminated plans) as of December 31, 2011.

During 2011, pursuant to the 2010 Plan, the Compensation Committee of the Board of Directors (the "Committee") approved the issuance of 21,500 restricted shares of our Class B Common Stock at a weighted average price of $53.21 per share ($1.1 million in the aggregate) to various employees. These shares have various vesting schedules. We recorded compensation expense of $198,000 during 2011 in connection with these grants. The remaining expense associated with these awards (estimated at $947,000 as of December 31, 2011) will be recorded over the remaining vesting periods of the awards, assuming the recipients remain employed by us.

The 2001 Plan, as described above, expired in March, 2010. Under this plan, we had 2.4 million shares of Class B Common Stock reserved for issuance and have issued approximately 1.2 million shares, net of cancellations, pursuant to the terms of this plan as of December 31, 2010, of which 78,133 became fully vesting during 2011, 313,770 became fully vested during 2010 and 31,638 became fully vested during 2009.

During the first quarter of 2010, pursuant to the 2001 Plan and prior to its expiration, the Committee approved the issuance of 49,472 restricted shares of our Class B Common Stock at $30.32 per share ($1.5 million in the aggregate) to our Chief Executive Officer ("CEO") and Chairman of the Board. These shares, which were issued pursuant to a provision in our CEO's employment agreement, are scheduled to vest ratably on the first, second, third and fourth anniversary dates of the grant, assuming our CEO remains employed by us. In the event that our CEO's employment is terminated by reason of disability, death, without proper cause or due to breach of the CEO's employment agreement by us, the vesting of these awards will occur immediately. 12,368 of these shares became fully vested in 2011. In connection with this grant, we recorded compensation expense of $375,000 and $355,000 during 2011 and 2010, respectively, and the remaining expense associated with this award (estimated at $770,000 as of December 31, 2011) will be recorded over the remaining vesting periods of the award.

During the first quarter of 2009, pursuant to the 2001 Plan, the Committee approved the issuance of 109,850 restricted shares of our Class B Common Stock at $20.26 per share ($2.2 million in the aggregate) to our CEO. These shares are scheduled to vest ratably on the first, second, third and fourth anniversary dates of the grant and are subject to the same conditions and terms as mentioned above in connection with the grant of restricted shares during the first quarter of 2010. 27,462 and 27,463 of these shares became fully vested in 2011 and 2010, respectively. In connection with this grant, we recorded compensation expense of $556,000 during each of 2011 and 2010 and $482,000 during 2009. The remaining expense associated with this award (estimated at $630,000 as of December 31, 2011) will be recorded over the remaining vesting periods of the award.

During the first quarter of 2008, pursuant to the 2001 Plan, the Committee approved the issuance of 62,190 restricted shares of our Class B Common Stock at $24.12 per share ($1.5 million in the aggregate) to our CEO. These shares are scheduled to vest ratably on the first, second, third and fourth anniversary dates of the grant and are subject to the same conditions and terms as mentioned above in connection with the grant of restricted shares during the first quarter of 2010. 15,546 of these shares became fully vesting during 2011 and 15,548 of these shares became fully vested in each of 2010 and 2009. In connection with this grant, we recorded compensation expense of $375,000 during each of 2011, 2010 and 2009. The remaining expense associated with this award (estimated at $15,000 as of December 31, 2011) was recorded over the remaining vesting periods of the award.

During the fourth quarter of 2007, pursuant to the 2001 Plan, the Committee approved the issuance of 61,362 restricted shares of our Class B Common Stock at $24.45 per share ($1.5 million in the aggregate) to our CEO. These shares are scheduled to vest ratably on the first, second, third and fourth anniversary dates of the grant and are subject to the same conditions and terms as mentioned above in connection with the grant of restricted shares during the first quarter of 2010. 15,341 of these shares became fully vested in each of 2011 and 2010 and 15,340 of these shares became fully vested in each of 2009 and 2008. In connection with this grant, we recorded compensation expense of $333,000 during 2011 and $375,000 during each of 2010 and 2009.

Additionally, during 2007, pursuant to the 2001 Plan, the Committee approved the issuance of 22,250 restricted shares of our Class B Common stock at a weighted average of $29.62 per share ($659,000 in the aggregate) to various employees. These shares have various vesting schedules. We recorded compensation expense of $120,000 during 2011 and $135,000 during each of 2010 and 2009, in connection with these grants. The remaining expense associated with these awards (estimated at $42,000 as of December 31, 2011) will be recorded over the remaining vesting periods of the awards, assuming the recipients remain employed by us.

During the fourth quarter of 2006, pursuant to the 2001 Plan, the Committee approved the issuance of 247,000 restricted shares (net of cancellations) of our Class B Common Stock at $25.71 per share ($6.4 million in the aggregate) to various officers and employees. These shares became fully vested in November, 2010. In connection with this grant, we recorded compensation expense of $1.3 million and $1.5 million during 2010 and 2009, respectively.

At December 31, 2011, 31,167,268 shares of Class B Common Stock were reserved for issuance upon conversion of shares of Class A, C and D Common Stock outstanding, for issuance upon exercise of options to purchase Class B Common Stock and for issuance of stock under other incentive plans. Class A, C and D Common Stock are convertible on a share for share basis into Class B Common Stock.

In connection with the long-term incentive plans described above, we recorded compensation expense of $2.4 million in 2011, $3.5 million in 2010 and $3.2 million in 2009. Including the compensation expense recognized related to outstanding stock options of $15.8 million in 2011, $13.3 million in 2010 and $9.9 million in 2009, we recorded a total stock compensation expense of $18.2 million in 2011, $16.8 million in 2010 and $13.1 million in 2009.

Income Taxes

12 Months Ended

Dec. 31, 2011

Income Taxes [Abstract]

Income Taxes

6) INCOME TAXES

Components of income tax expense/(benefit) are as follows (amounts in thousands):


	Year Ended December 31,
	2011		2010		2009
Current
Federal	$	165,409	$	105,077	$	130,798
Foreign		300		2,555		—
State		22,901		16,547		18,976

		188,610		124,179		149,774
Deferred
Federal and foreign		53,056		26,419		18,524
State		5,800		1,704		2,177

		58,856		28,123		20,701

Total	$	247,466	$	152,302	$	170,475

Deferred taxes are required to be classified based on the financial statement classification of the related assets and liabilities which give rise to temporary differences. Deferred taxes result from temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities. The components of deferred taxes are as follows (amounts in thousands):


	Year Ended December 31,
	2011			2010
Deferred income tax assets:
Self-insurance reserves	$	115,201		$	121,249
Compensation accruals		49,717			53,855
State and foreign net operating loss carryforwards and other state and foreign deferred tax assets		52,506			46,338
Other currently non-deductible accrued liabilities		19,699			19,016
Net pension liability—OCI only		13,959			9,268
Doubtful accounts and other reserves		17,345			31,046
Other combined items—OCI only		17,684			3,196

		286,111			283,968
Less: Valuation Allowance		(42,143	)		(32,352	)

Net deferred income tax assets:		243,968			251,616
Deferred income tax liabilities:
Depreciable and amortizable assets		(342,655	)		(299,566	)
Other deferred tax liabilities		(2,581	)		(4,570	)

Net deferred income tax liabilities	$	(101,268	)	$	(52,520	)

The effective tax rates, as calculated by dividing the provision for income taxes by income before income taxes, were as follows for each of the years ended December 31, 2011, 2010 and 2009 (dollar amounts in thousands):


	2011			2010			2009
Provision for income taxes	$	247,466		$	152,302		$	170,475
Income before income taxes		696,336			428,097			474,722

Effective tax rate		35.5	%		35.6	%		35.9	%

Impacting the effective tax rates during 2011 was approximately $1 million favorable discrete tax item recorded to adjust the estimated liabilities for uncertain tax positions. Impacting the effective tax rates during 2010 were the following items: (i) $5 million unfavorable discrete tax item recorded to adjust the non-deductible portion of certain transaction costs incurred during 2010 in connection with our acquisition of PSI; (ii) a $4 million unfavorable discrete tax item recorded to adjust for the non-deductible, $9 million charge incurred from split-dollar life insurance agreements entered into during 2010 on the lives of our chief executive officer and his wife, partially offset by; (iii) a $4 million favorable discrete tax item recorded during 2010 to adjust the estimated non-deductible portion of the previously disclosed South Texas Health System settlement with the government based upon the final agreement.

A reconciliation between the federal statutory rate and the effective tax rate is as follows:


	Year Ended December 31,
	2011			2010			2009
Federal statutory rate		35.0	%		35.0	%		35.0	%
State taxes, net of federal income tax benefit		2.9			3.1			3.2
Nondeductible transaction costs		—			1.3			—
Other items		0.4			0.4			1.4
Impact of income attributable to noncontrolling interests		(2.8	)		(4.2	)		(3.7	)

Effective tax rate		35.5	%		35.6	%		35.9	%

Included in "Other current assets" on our Consolidated Balance Sheet are prepaid federal, foreign, and state income taxes amounting to approximately $25 million and $51 million as of December 31, 2011 and 2010, respectively.

The net deferred tax assets and liabilities are comprised as follows (amounts in thousands):


	Year Ended December 31,
	2011			2010
Current deferred taxes
Assets	$	109,297		$	123,362
Liabilities		(973	)		(2,528	)

Total deferred taxes-current		108,324			120,834

Noncurrent deferred taxes
Assets		135,189			128,254
Liabilities		(344,781	)		(301,608	)

Total deferred taxes-noncurrent		(209,592	)		(173,354	)

Total deferred tax liabilities	$	(101,268	)	$	(52,520	)

The assets and liabilities classified as current relate primarily to the allowance for uncollectible patient accounts, compensation-related accruals and the current portion of the temporary differences related to self- insurance reserves. At December 31, 2011, state net operating loss carryforwards (expiring in years 2012 through 2031), and credit carryforwards available to offset future taxable income approximated $881 million, representing approximately $44 million in deferred state tax benefit (net of the federal benefit). At December 31, 2011, related to the acquisition of PSI, there were federal net operating losses of approximately $2 million expiring in 2022 representing approximately $1 million in deferred federal tax benefits and foreign net operating loss carryforwards of approximately $8 million expiring through 2021 representing approximately $3 million in deferred foreign tax benefit.

A valuation allowance is required when it is more likely than not that some portion of the deferred tax assets will not be realized. Based on available evidence, it is more likely than not that certain of our state tax benefits will not be realized. Therefore, valuation allowances of approximately $39 million and $28 million have been reflected as of December 31, 2011 and 2010, respectively. During 2011, the valuation allowance on these state tax benefits increased by approximately $11 million due to additional net operating losses incurred. In addition, valuation allowances of approximately $3 million and $4 million have been reflected as of December 31, 2011 and 2010, respectively, related to foreign net operating losses.

We adopted the provisions of Accounting for Uncertainty in Income Taxes effective January 1, 2007. During 2011 and 2010, the estimated liabilities for uncertain tax positions (including accrued interest and penalties) were increased in the amount of approximately $1 million and $3 million, respectively, due to tax positions taken in the current and prior years. The increase in 2010 is primarily attributable to tax positions taken by PSI on pre-acquisition tax return years. Also during 2011, the estimated liabilities for uncertain tax positions (including accrued interest and penalties) were reduced due to the lapse of the statute of limitations resulting in a net income tax benefit of approximately $2 million. The balance at each of December 31, 2011 and 2010, if subsequently recognized, that would favorably affect the effective tax rate and the provision for income taxes is approximately $5 million.

We recognize accrued interest and penalties associated with uncertain tax positions as part of the tax provision. As of December 31, 2011 and 2010, we have approximately $1 million of accrued interest and penalties. The U.S. federal statute of limitations remains open for the 2008 and subsequent years. Foreign and U.S. state and local jurisdictions have statutes of limitations generally ranging for 3 to 4 years. The statute of limitations on certain jurisdictions could expire within the next twelve months. It is reasonably possible that the amount of unrecognized tax benefits will change during the next 12 months however it is anticipated that any such change, if it were to occur, would not have a material impact on our results of operations.

The tabular reconciliation of unrecognized tax benefits for the years ended December 31, 2011, 2010 and 2009 is as follows (amounts in thousands).


	As of December 31,
	2011			2010			2009
Balance at January 1,	$	7,923		$	5,754		$	3,759
Additions based on tax positions related to the current year		750			1,219			750
Additions for tax positions of prior years		419			2,076			1,245
Reductions for tax positions of prior years		(1,628	)		(907	)		—
Settlements		(61	)		(219	)		—

Balance at December 31,	$	7,403		$	7,923		$	5,754

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 136, 172

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43, 44, 45, 46, 47, 48, 49

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

+ Details

Lease Commitments

12 Months Ended

Dec. 31, 2011

Lease Commitments [Abstract]

Lease Commitments

7) LEASE COMMITMENTS

Four of our hospital facilities are held under operating leases with Universal Health Realty Income Trust with terms expiring in 2014 and 2016 (see Note 9 for additional disclosure). We also lease the real property of certain facilities acquired by us in connection with the acquisition of PSI in November, 2010 (see Item 2. Properties for additional disclosure).

A summary of property under capital lease follows (amounts in thousands):


	As of December 31,
	2011			2010
Land, buildings and equipment	$	37,037		$	38,712
Less: accumulated amortization		(35,264	)		(35,627	)

	$	1,773		$	3,085

Future minimum rental payments under lease commitments with a term of more than one year as of December 31, 2011, are as follows (amounts in thousands):


Year	Capital Leases			Operating Leases
	(000s)
2012	$	2,425		$	58,388
2013		2,277			42,717
2014		1,299			32,777
2015		1,212			26,806
2016		1,077			21,687
Later years		7,787			24,053

Total minimum rental	$	16,077		$	206,428

Less: Amount representing interest		(6,095	)

Present value of minimum rental commitments		9,982
Less: Current portion of capital lease obligations		(1,680	)

Long-term portion of capital lease obligations	$	8,302

In the ordinary course of business, our facilities routinely lease equipment pursuant to month-to-month lease arrangements that will likely result in future lease & rental expense in excess of the amounts indicated above. Capital lease obligations of $7.1 million in 2010 and $700,000 in 2009 were incurred when we assumed capital lease obligations upon the acquisition of facilities or entered into capital leases for new equipment. We incurred no additional capital lease obligations during 2011.

- Definition

The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.

+ References+ Details

Commitments And Contingencies	12 Months Ended
Commitments And Contingencies	Dec. 31, 2011
Commitments And Contingencies [Abstract]
Commitments And Contingencies	8) COMMITMENTS AND CONTINGENCIES *Professional and General Liability Claims and Property Insurance* Professional and General Liability Effective January 1, 2008, most of our subsidiaries became self-insured for professional and general liability exposure up to $10 million per occurrence (as compared to $20 million per occurrence prior to 2008). Prior to our acquisition of PSI in November, 2010, our subsidiaries purchased several excess policies through commercial insurance carriers which provide for coverage in excess of $10 million up to $200 million per occurrence and in the aggregate. However, we are liable for 10% of the claims paid pursuant to the commercially insured coverage in excess of $10 million up to $60 million per occurrence and in the aggregate. Prior to our acquisition in November, 2010, the PSI subsidiaries were commercially insured for professional and general liability insurance claims in excess of a $3 million self-insured retention to a limit of $75 million. PSI utilized its captive insurance company and that captive insurance company remains in place after our acquisition of PSI to manage the self-insured retention for all former PSI subsidiaries for claims incurred prior to January 1, 2011. The captive insurance company also continues to manage the applicable self-insured retention for all professional and general liability claims, regardless of date incurred, for the former PSI subsidiaries located in Florida and Puerto Rico. Since our acquisition of PSI on November 15, 2010, the former PSI subsidiaries are self-insured for professional and general liability exposure up to $3 million per occurrence and our legacy subsidiaries (which are not former PSI subsidiaries) are self-insured for professional and general liability exposure up to $10 million per occurrence. Effective November, 2010, our subsidiaries (including the former PSI subsidiaries) were provided with several excess policies through commercial insurance carriers which provide for coverage in excess of the applicable per occurrence self-insured retention (either $3 million or $10 million) up to $200 million per occurrence and in the aggregate. We remain liable for 10% of the claims paid pursuant to the commercially insured coverage in excess of $10 million up to $60 million per occurrence and in the aggregate. Our estimated liability for self-insured professional and general liability claims is based on a number of factors including, among other things, the number of asserted claims and reported incidents, estimates of losses for these claims based on recent and historical settlement amounts, estimates of incurred but not reported claims based on historical experience, and estimates of amounts recoverable under our commercial insurance policies. While we continuously monitor these factors, our ultimate liability for professional and general liability claims could change materially from our current estimates due to inherent uncertainties involved in making this estimate. Given our significant self-insured exposure for professional and general liability claims, there can be no assurance that a sharp increase in the number and/or severity of claims asserted against us will not have a material adverse effect on our future results of operations. As of December 31, 2011, the total accrual for our professional and general liability claims, including the estimated claims related to the facilities acquired from PSI, was $292 million, of which $60 million is included in current liabilities. As of December 31, 2010, the total accrual for our professional and general liability claims was $289 million, of which $60 million is included in other current liabilities. Based upon the results of reserve analyses, we recorded reductions to our professional and general liability self-insurance reserves (relating to prior years) amounting to $11 million during 2011, $49 million during 2010 and $23 million during 2009. The favorable change recorded during 2011 consisted primarily of third-party recoveries and reserve reductions in connection with PHICO–related claims which we became liable for upon PHICO's (a former commercial insurance carrier) liquidation in 2002. The favorable changes in our estimated future claims payments recorded during 2010 and 2009 were due to: (i) an increased weighting given to company-specific metrics (to 75% from 50%), and decreased general industry metrics (to 25% from 50%), related to projected incidents per exposure, historical claims experience and loss development factors; (ii) historical data which measured the realized favorable impact of medical malpractice tort reform experienced in several states in which we operate, and; (iii) a decrease in claims related to certain higher risk specialties (such as obstetrical) due to a continuation of the company-wide patient safety initiative undertaken during the last several years. As the number of our facilities and our patient volumes have increased, thereby providing for a statistically significant data group, and taking into consideration our long-history of company-specific risk management programs and claims experience, our reserve analyses have included a greater emphasis on our historical professional and general liability experience which has developed favorably as compared to general industry trends. Property Insurance We have commercial property insurance policies covering catastrophic losses, including windstorm damage, up to a $1 billion policy limit per occurrence, subject to a $250,000 deductible. Losses resulting from named windstorms are subject to deductibles between 3% and 5% of the declared total insurable value of the property. In addition, we have commercial property insurance policies covering catastrophic losses resulting from earthquake and flood damage, each subject to aggregated loss limits (as opposed to per occurrence losses). Our earthquake limit is $250 million, subject to a deductible of $250,000, except for facilities located within documented fault zones. Earthquake losses that affect facilities located in fault zones within the United States are subject to a $100 million limit and will have applied deductibles ranging from 1% to 5% of the declared total insurable value of the property. The earthquake limit in Puerto Rico is $25 million. Flood losses have either a $250,000 or $500,000 deductible, based upon the location of the facility. Our property insurance coverage is scheduled for renewal on June 1, 2012. Due to an increase in property losses experienced nationwide in recent years, the cost of commercial property insurance has increased. As a result, catastrophic coverage for earthquake and flood has been limited to annual aggregate losses (as opposed to per occurrence losses). Given these insurance market conditions, there can be no assurance that a continuation of these unfavorable trends, or a sharp increase in uninsured property losses sustained by us, will not have a material adverse effect on our future results of operations. *Legal Proceedings* U.S. v. Marion and UHS: In November, 2009, the United States Department of Justice ("DOJ") and the Virginia Attorney General intervened in a qui tam case that had been filed by former employees of Marion Youth Center under seal in 2007 against Universal Health Services, Inc. ("UHS"), and Keystone Marion, LLC ("Marion") and Keystone Education and Youth Services, LLC ("Keystone"). The intervention by the DOJ followed the issuance of a series of subpoenas from the Office of the Inspector General for the Department of Health and Human Services seeking documents related to the treatment of Medicaid beneficiaries at Marion. The amended complaint filed by the DOJ and Virginia Attorney General alleged causes of action pursuant to the federal and state false claims acts and the Virginia fraud statute. The former employees filed a separate amended complaint alleging employment and retaliation claims as well as false claim act violations. During the third quarter of 2011, we reached an agreement in principle to settle all of the claims. We have established a reserve in connection with this matter which did not have a material impact on our results of operations for any of the periods presented herein. Should we be unable to finalize a definitive settlement agreement in this matter, we will continue to defend ourselves vigorously against the government's and the former employees' allegations. There can be no assurance that we will prevail should this matter be litigated. Martin v. UHS of Delaware: UHS of Delaware, Inc., a wholly-owned subsidiary of ours, has been named as defendants in a state False Claim Act case in Sacramento County Superior Court. Plaintiffs are a former student and employees of the Elmira School who claim that the UHS schools in California unlawfully retained public education funding from the state of California for the operation of these schools but failed to meet state requirements pertaining to the operation of non-public schools. We deny liability and intend to defend this case vigorously. We have established a reserve in connection with this matter which did not have a material impact on our consolidated financial statements. Department of Justice ICD Investigation: In September, 2010, we, along with many other companies in the healthcare industry, received a letter from the United States Department of Justice ("DOJ") advising of a False Claim Act investigation being conducted in connection with the implantation of implantable cardioverter defibrillators ("ICDs") from 2003 to the present at several of our acute care facilities. The DOJ alleges that ICDs were implanted and billed by our facilities in contravention of a National Claims Determination regarding these devices. We have established a reserve in connection with this matter which did not have a material impact on our consolidated financial statements. Two Rivers Psychiatric Hospital: On April 11, 2011, the Centers for Medicare and Medicaid Services ("CMS") issued notice of its decision terminating Two Rivers Psychiatric Hospital ("Two Rivers") in Kansas City, Missouri from participation in the Medicare and Medicaid program. The termination notice was issued as a result of surveys conducted which allegedly found Two Rivers to be out of compliance with the conditions of participation required for participation in the Medicare program and for Two Rivers' alleged failure to alleviate an "immediate jeopardy" situation. Two Rivers filed an administrative appeal with the U.S. Department of Health and Human Services, Departmental Appeal Board, Civil Remedies Division, seeking review and reversal of that decision. In addition, Two Rivers filed a complaint in the U.S. District Court for the Western District of Missouri seeking a temporary restraining order and preliminary injunction against CMS rescinding the termination action. On April 22, 2011, the District Court issued a temporary restraining order abating the termination action pending a preliminary injunction hearing or an agreement with CMS. On May 17, 2011, Two Rivers and CMS entered into a settlement agreement which resulted in the rescission of the termination notice and actions by CMS. Pursuant to the terms of the agreement, Two Rivers was required to submit an acceptable plan of correction relative to the immediate jeopardy citation and engage independent experts in various disciplines to analyze and develop implementation plans for Two Rivers to meet the applicable Medicare conditions of participation. Both of these actions have occurred. CMS will conduct an initial survey of Two Rivers, expected to occur in early 2012, to determine if the Medicare conditions of participation have been met. During the term of this agreement, Two Rivers remains eligible to receive reimbursements for services rendered to Medicare and Medicaid beneficiaries. Two Rivers remains fully committed to providing high-quality healthcare to their patients and the community it serves. We therefore intend to work expeditiously and collaboratively with CMS in an effort to resolve these matters. We can provide no assurance that Two Rivers will not ultimately lose its Medicare certification. The operating results of Two Rivers did not have a material impact on our consolidated results of operations or financial condition for the years ended December 31, 2011 or 2010. Matters Relating to PSI: The following matters pertain to PSI or former PSI facilities (owned by subsidiaries of Psychiatric Solutions, Inc.) for which we have assumed the defense as a result of our acquisition of PSI which was completed in November, 2010: Garden City Employees' Retirement System v. PSI: This is a purported shareholder class action lawsuit filed in the United States District Court for the Middle District of Tennessee against PSI and the former directors in 2009 alleging violations of federal securities laws. We intend to defend the case vigorously. Should we be deemed liable in this matter, we believe we would be entitled to commercial insurance recoveries for amounts paid by us, subject to certain limitations and deductibles. Included in our consolidated balance sheet as of December 31, 2011, is an estimated reserve (current liability) and corresponding commercial insurance recovery (current asset) which did not have a material impact on our financial statements. Although we believe the commercial insurance recoveries are adequate to satisfy potential liability in this matter, we can provide no assurance that the ultimate liability will not exceed the commercial insurance recoveries which would make us liable for the excess. Department of Justice Investigation of Sierra Vista: In 2009, Sierra Vista Hospital in Sacramento, California learned of an investigation by the U.S. Department of Justice ("DOJ") relating to Medicare services provided by the facility. The DOJ ultimately notified the facility that with respect to partial hospitalization and outpatient services, the DOJ believed that the medical record documentation did not adequately support the claims submitted for reimbursement by Medicare. We reached a tentative financial settlement with the DOJ which is subject to the negotiation of a definitive settlement agreement. As part of that agreement, the facility will be subject to a corporate integrity agreement. The reserve established in connection with this matter did not have a material impact on our consolidated financial statements. Department of Justice Investigation of Friends Hospital: In October, 2010, Friends Hospital in Philadelphia, Pennsylvania, received a subpoena from the DOJ requesting certain documents from the facility. The requested documents have been collected and provided to the DOJ for review and examination. Another subpoena was issued to the facility in July 2011 requesting additional documents. Those documents are being collected and will be provided to the DOJ. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter. Department of Justice Investigation of Riveredge Hospital: In 2008, Riveredge Hospital in Chicago, Illinois received a subpoena from the DOJ requesting certain information from the facility. Additional requests for documents were also received from the DOJ in 2009 and 2010. The requested documents have been provided to the DOJ and we continue to cooperate with the DOJ with respect to this investigation. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter. Virginia Department of Medical Assistance Services Recoupment Claims: The Virginia Department of Medical Assistance Services ("DMAS") has conducted audits at seven former PSI Residential Treatment Centers operated in the Commonwealth of Virginia to confirm compliance with provider rules under the state's Medicaid Provider Services Manual ("Manual"). As a result of those audits, DMAS claims the facilities failed to comply with the requirements of the Manual and has requested repayment of Medicaid payments to those facilities. PSI had previously filed appeals to repayment demands at each facility which are currently pending. The aggregate refund of Medicaid payments made to those facilities, as requested by DMAS, and the corresponding reserve established on our Consolidated Balance Sheet as of December 31, 2011 and December 31, 2010, was not material to our consolidated financial position or results of operations. General: The healthcare industry is subject to numerous laws and regulations which include, among other things, matters such as government healthcare participation requirements, various licensure, certifications, and accreditations, reimbursement for patient services, and Medicare and Medicaid fraud and abuse. Government action has increased with respect to investigations and/or allegations concerning possible violations of fraud and abuse and false claims statutes and/or regulations by healthcare providers. Currently, and from time to time, some of our facilities are subjected to inquiries and/or actions and receive notices of potential non-compliance of laws and regulations from various federal and state agencies. Providers that are found to have violated these laws and regulations may be excluded from participating in government healthcare programs, subjected to potential licensure, certification, and/or accreditation revocation, subjected to fines or penalties or required to repay amounts received from the government for previously billed patient services. We monitor all aspects of our business and have developed a comprehensive ethics and compliance program that is designed to meet or exceed applicable federal guidelines and industry standards. Because the law in this area is complex and constantly evolving, governmental investigation or litigation may result in interpretations that are inconsistent with industry practices, including ours. Although we believe our policies, procedures and practices comply with governmental regulations, there is no assurance that we will not be faced with sanctions, fines or penalties in connection with such inquiries or actions, including with respect to the investigations and other matters discussed herein. Even if we were to ultimately prevail, such inquiries and/or actions could have a material adverse effect on us. The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities. We record accruals for such contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because the inherently unpredictable nature of legal proceedings may be exacerbated by various factors, including, but not limited to: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties, or; (vii) there is a wide range of potential outcomes. It is possible that the outcome of these matters could have a material adverse impact on our future results of operations, financial position, cash flows and, potentially, our reputation. In addition, various suits and claims arising against us in the ordinary course of business are pending. In the opinion of management, the outcome of such claims and litigation will not materially affect our consolidated financial position or results of operations. In addition to our long-term debt obligations as discussed in Note 4-Long-Term Debt and our operating lease obligations as discussed in Note 7-Lease Commitments, we have various other contractual commitments outstanding as of December 31, 2011 as follows: (i) other combined estimated future purchase obligations of $130 million related to a long-term contract with third-parties consisting primarily of certain revenue cycle data processing services for our acute care facilities ($58 million), expected costs to be paid to a third-party vendor in connection with the purchase and implementation of an electronic health records application for each of our acute care facilities ($66 million) and estimated minimum liabilities for physician commitments expected to be paid in the future ($6 million), and; (ii) combined estimated future payments of $227 million related to our non-contributory, defined benefit pension plan ($212 million consisting of estimated payments through 2088) and other retirement plan liabilities ($15 million). As of December 31, 2011 we were party to certain off balance sheet arrangements consisting of standby letters of credit and surety bonds. Our outstanding letters of credit and surety bonds as of December 31, 2011 totaled $79 million consisting of: (i) $62 million related to our self-insurance programs, and; (ii) $17 million of other debt and public utility guarantees.

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 14

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 9, 10, 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

+ Details

Relationship With Universal Health Realty Income Trust And Related Party Transactions

12 Months Ended

Dec. 31, 2011

Relationship With Universal Health Realty Income Trust And Related Party Transactions [Abstract]

Relationship With Universal Health Realty Income Trust And Related Party Transactions

9) RELATIONSHIP WITH UNIVERSAL HEALTH REALTY INCOME TRUST AND RELATED PARTY TRANSACTIONS

Relationship with Universal Health Realty Income Trust:

At December 31, 2011, we held approximately 6.2% of the outstanding shares of Universal Health Realty Income Trust (the "Trust"). We serve as Advisor to the Trust under an annually renewable advisory agreement pursuant to the terms of which we conduct the Trust's day-to-day affairs, provide administrative services and present investment opportunities. In addition, certain of our officers and directors are also officers and/or directors of the Trust. Management believes that it has the ability to exercise significant influence over the Trust, therefore we account for our investment in the Trust using the equity method of accounting. We earned an advisory fee from the Trust, which is included in net revenues in the accompanying consolidated statements of income, of approximately $2.0 million during 2011, $1.8 million during 2010 and $1.6 million during 2009.

Our pre-tax share of income from the Trust was $4.6 million during 2011, $1.0 million during 2010 and $1.1 million during 2009, and is included in net revenues in the accompanying consolidated statements of income for each year. Included in our share of the Trust's income for 2011 was approximately $3.7 million related to our share of the following: (i) an aggregate gain realized by the Trust during 2011 in connection with the sale of medical office buildings by various limited liability companies ("LLCs") in which the Trust formerly held noncontrolling, majority ownership interests; (ii) an aggregate gain recorded by the Trust during 2011 in connection with its purchases of third-party minority ownership interests in various LLCs in which the Trust formerly held noncontrolling majority ownership interests (the Trust now owns 100% of each of these entities), partially offset by; (iii) a provision for asset impairment recorded by the Trust during 2011 in connection with a medical office building located in Atlanta, Georgia.

The carrying value of our investment in the Trust was $9.9 million and $7.3 million at December 31, 2011 and 2010, respectively, and is included in other assets in the accompanying consolidated balance sheets. The market value of our investment in the Trust was $30.7 million at December 31, 2011 and $28.8 million at December 31, 2010, based on the closing price of the Trust's stock on the respective dates.

Total rent expense under the operating leases on the four hospital facilities with the Trust (as discussed below) was $16.3 million during 2011, $16.2 million during 2010 and $16.3 million during 2009. In addition, certain of our subsidiaries are tenants in several medical office buildings owned by limited liability companies in which the Trust holds either 100% of the ownership interest or various noncontrolling, majority ownership interests.

The Trust commenced operations in 1986 by purchasing certain properties from us and immediately leasing the properties back to our respective subsidiaries. Most of the leases were entered into at the time the Trust commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. Each lease also provided for additional or bonus rental, as discussed below. The base rents are paid monthly and the bonus rents are computed and paid on a quarterly basis, based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The leases with our subsidiaries are unconditionally guaranteed by us and are cross-defaulted with one another.

Pursuant to the terms of the leases with the Trust, we have the option to renew the leases at the lease terms described above by providing notice to the Trust at least 90 days prior to the termination of the then current term. In addition, we have rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. We also have the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at their appraised fair market value as well as purchase any or all of the four leased hospital properties at their appraised fair market value upon one month's notice should a change of control of the Trust occur.

On May 19, 2011, certain of our subsidiaries provided the required notice to the Trust exercising the 5-year renewal options on McAllen Medical Center, Wellington Regional Medical Center and Southwest Healthcare System, Inland Valley Campus which extended the lease terms to December, 2016.

The table below details the renewal options and terms for each of our four hospital facilities leased from the Trust, giving effect to the above-mentioned renewals:

Hospital Name

Type of Facility

Annual
Minimum
Rent

End of Lease Term

Renewal
Term
(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

The Bridgeway

Behavioral Health

930,000

December, 2014

(c)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal options at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

(c)	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

Split-dollar Life Insurance Agreements:

In December, 2010, our Board of Directors approved the Company's entering into supplemental life insurance plans and agreements on the lives of our chief executive officer and his wife. As a result of these agreements, based on actuarial tables and other assumptions, during the life expectancies of the insureds, we would pay approximately $25 million in premiums and certain trusts, owned by our chief executive officer, would pay approximately $8 million in premiums. Based on the projected premiums mentioned above, and assuming the policies remain in effect until the death of the insureds, we will be entitled to receive death benefit proceeds of no less than $33 million representing the $25 million of aggregate premiums paid by us as well as the $8 million of aggregate premiums paid by the trusts. During 2011, we paid approximately $1.4 million in premium payments and during the fourth quarter of 2010, we paid approximately $6 million in premium payments. These agreements did not have a material effect on our consolidated financial statements or results of operations during 2011. Included in our financial statements during 2010, was a pre-tax and after-tax expense of $9 million recorded during the fourth quarter of 2010 representing the present value of our projected premium funding commitment over the terms of the policies.

Other Related Party Transactions:

A member of our Board of Directors and member of the Executive Committee is Of Counsel to the law firm used by us as our principal outside counsel. This Board member is also the trustee of certain trusts for the benefit of our CEO and his family. This law firm also provides personal legal services to our CEO.

- Definition

The entire disclosure for related party transactions, including the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph k

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 3A

-Section 04

-Paragraph b

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 1-4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

+ Details

Pension Plan

12 Months Ended

Dec. 31, 2011

Pension Plan [Abstract]

Pension Plan

10) PENSION PLAN

We maintain contributory and non-contributory retirement plans for eligible employees. Our contributions to the contributory plan amounted to $21.7 million, $20.8 million and $20.4 million in 2011, 2010 and 2009, respectively. The non-contributory plan is a defined benefit pension plan which covers employees of one of our subsidiaries. The benefits are based on years of service and the employee's highest compensation for any five years of employment. Our funding policy is to contribute annually at least the minimum amount that should be funded in accordance with the provisions of ERISA.

The following table shows the reconciliation of the defined benefit pension plan as of December 31, 2011 and 2010:


	2011			2010
	(000s)
Change in plan assets:
Fair value of plan assets at beginning of year	$	73,402		$	61,451
Actual return (loss) on plan assets		5,689			10,027
Employer contributions		14,065			6,657
Benefits paid		(4,541	)		(4,256	)
Administrative expenses		(675	)		(477	)

Fair value of plan assets at end of year	$	87,940		$	73,402
Change in benefit obligation:
Benefit obligation at beginning of year	$	93,513		$	85,476
Service cost		1,162			1,140
Interest cost		5,047			4,958
Benefits paid		(4,541	)		(4,256	)
Actuarial (gain) loss		13,265			6,195

Benefit obligation at end of year	$	108,446		$	93,513
Amounts recognized in the Consolidated Balance Sheet:
Other noncurrent liabilities		20,506			20,110

Total liability at end of year	$	20,506		$	20,110

Additional year end information for Pension Plan
Projected benefit obligation	$	108,446		$	93,513
Accumulated benefit obligation		106,609			91,559
Fair value of plan assets		87,940			73,402


	2011			2010			2009
	(000s)
Components of net periodic cost (benefit)
Service cost	$	1,162		$	1,140		$	1,191
Interest cost		5,047			4,958			4,834
Expected return on plan assets		(6,566	)		(5,151	)		(3,927	)
Recognized actuarial loss		2,427			2,538			4,676

Net periodic cost	$	2,070		$	3,485		$	6,774


	2011		2010
Measurement Dates
Benefit obligations		12/31/2011		12/31/2010
Fair value of plan assets		12/31/2011		12/31/2010


	2011			2010
Weighted average assumptions as of December 31
Discount rate		4.40	%		5.54	%
Rate of compensation increase		4.00	%		4.00	%


	2011			2010			2009
Weighted-average assumptions for net periodic benefit cost calculations
Discount rate		5.54	%		5.96	%		5.87	%
Expected long-term rate at return on plan assets		8.00	%		8.00	%		8.00	%
Rate of compensation increase		4.00	%		4.00	%		4.00	%

The accumulated benefit obligation was $106,609 and $91,559 as of December 31, 2011 and 2010, respectively. The accumulated benefit obligation exceeded the fair value of plan assets as of December 31, 2011 and 2010. In 2011 and 2010, the accrued pension cost is included in non-current liabilities in the accompanying Consolidated Balance Sheet. We estimate that there will be $4,219 of net loss that will be amortized from accumulated other comprehensive income over the next fiscal year.

Our pension plans assets were $87,940 and $73,402 at December 31, 2011 and 2010, respectively. The market values of our pension plan assets at December 31, 2011 and December 31, 2010 by asset category are as follows:


December 31, 2011	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	18,921	$	—	$	18,921	$	—
U.S. Mid Cap		1,281		—		1,281		—
U.S. Small-Mid Cap		6,332		—		6,332		—
U.S. Small Cap		1,282		—		1,282		—
International Developed		8,692		—		8,692		—
Emerging Markets		3,123		—		3,123		—
Fixed income:
Long Duration Fixed Income		44,587		—		44,587		—
Real Estate:
REIT Fund		3,269		—		3,269		—
Tangible Assets:
Commodities		—		—		—		—
Cash/Currency:
Cash Equivalents		453		—		453		—

Total market value	$	87,940	$	—	$	87,940	$	—


December 31, 2010	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	22,010	$	—	$	22,010	$	—
U.S. Mid Cap		1,468		—		1,468		—
U.S. Small-Mid Cap		6,295		—		6,295		—
U.S. Small Cap		1,471		—		1,471		—
International Developed		10,353		—		10,353		—
Emerging Markets		3,709		—		3,709		—
Fixed income:
Core Fixed Income		11,542		—		11,542		—
Long Duration Fixed Income		11,421		—		11,421		—
Real Estate:
REIT Fund		3,740		—		3,740		—
Tangible Assets:
Commodities		—		—		—		—
Cash/Currency:
Cash Equivalents		1,393		—		1,393		—

Total market value	$	73,402	$	—	$	73,402	$	—

To develop the expected long-term rate of return on plan assets assumption, we considered the historical returns and the future expectations for returns for each asset class, as well as the target asset allocation of the pension portfolio.

The following table shows expected benefit payments for the years ended December 31, 2011 through 2021 for our defined pension plan. There will be benefit payments under this plan beyond 2021.


Estimated Future Benefit Payments (000s)
2012	$	5,100
2013		5,400
2014		5,664
2015		5,895
2016		6,117
2017-2021		33,216

Total	$	61,392


	2011			2010
Plan Assets
Asset Category
Equity securities		45	%		62	%
Fixed income securities		50	%		31	%
Other		5	%		7	%

Total		100	%		100	%

Investment Policy, Guidelines and Objectives have been established for the defined benefit pension plan. The investment policy is in keeping with the fiduciary requirements under existing federal laws and managed in accordance with the Prudent Investor Rule. Total portfolio risk is regularly evaluated and compared to that of the plan's policy target allocation and judged on a relative basis over a market cycle. The following asset allocation policy and ranges have been established in accordance with the overall risk and return objectives of the portfolio:


	Policy			As of 12/31/11			Permitted Range
Total Equity		46	%		45	%		43-49	%
Total Fixed Income		50	%		50	%		45-55	%
Other		4	%		5	%		0-10	%

In accordance with the investment policy, the portfolio will invest in high quality, large and small capitalization companies traded on national exchanges, and investment grade securities. The investment managers will not write or buy options for speculative purposes; securities may not be margined or sold short. The manager may employ futures or options for the purpose of hedging exposure, and will not purchase unregistered sectors, private placements, partnerships or commodities.

- Definition

The entire disclosure for pension and other postretirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Implementation Guide (Q and A)

-Number FAS88

-Paragraph 63

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-URI http://asc.fasb.org/topic&trid=2235017

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 158

-Paragraph 7, 21, 22

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph h

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph q

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 8

-Subparagraph m

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 106

-Paragraph 518

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 87

-Paragraph 264

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 03-2

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 30

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS106-2

-Paragraph 20, 21, 22

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Segment Reporting

12 Months Ended

Dec. 31, 2011

Segment Reporting [Abstract]

Segment Reporting

11) SEGMENT REPORTING

Our reportable operating segments consist of acute care hospital services and behavioral health care services. The "Other" segment column below includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting as well as the operating results for our other operating entities including outpatient surgery and radiation centers. The chief operating decision making group for our acute care hospital services and behavioral health care services is comprised of our Chief Executive Officer, the President and the Presidents of each operating segment. The Presidents for each operating segment also manage the profitability of each respective segment's various facilities. The operating segments are managed separately because each operating segment represents a business unit that offers different types of healthcare services or operates in different healthcare environments. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies included in this Annual Report on Form 10-K for the year ended December 31, 2011.


2011	Acute Care Hospital Services		Behavioral Health Services		Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	12,025,664	$	5,529,205		—		$	17,554,869
Gross outpatient revenues	$	5,629,420	$	608,785	$	53,240		$	6,291,445
Total net revenues	$	4,071,570	$	3,401,118	$	27,510		$	7,500,198
Income (loss) before income taxes	$	351,917	$	732,674	($	388,255	)	$	696,336
Total assets	$	2,852,549	$	4,383,432	$	429,264		$	7,665,245


2010	Acute Care Hospital Services		Behavioral Health Services		Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	10,890,171	$	2,566,366		—		$	13,456,537
Gross outpatient revenues	$	4,771,070	$	350,192	$	49,245		$	5,170,507
Total net revenues	$	3,901,815	$	1,635,455	$	30,915		$	5,568,185
Income (loss) before income taxes	$	363,427	$	353,203	($	288,533	)	$	428,097
Total assets	$	2,755,697	$	4,360,710	$	411,529		$	7,527,936


2009	Acute Care Hospital Services		Behavioral Health Services		Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	9,901,032	$	2,075,141		—		$	11,976,173
Gross outpatient revenues	$	4,100,427	$	282,473	$	62,353		$	4,445,253
Total net revenues	$	3,810,828	$	1,315,029	$	76,522		$	5,202,379
Income (loss) before income taxes	$	386,208	$	281,541	($	193,027	)	$	474,722
Total assets	$	2,748,175	$	998,508	$	217,780		$	3,964,463

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 131

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

+ Details

Quarterly Results

12 Months Ended

Dec. 31, 2011

Quarterly Results [Abstract]

Quarterly Results

12) QUARTERLY RESULTS (unaudited)

The following tables summarize the quarterly financial data for the two years ended December 31, 2011 and 2010:


2011	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,910,528	$	1,902,234	$	1,848,662	$	1,838,774	$	7,500,198
Net income	$	129,987	$	116,034	$	94,842	$	108,007	$	448,870
Less: Net income attributable to noncontrolling interests	$	15,794	$	12,385	$	9,788	$	12,736	$	50,703

Net income attributable to UHS	$	114,193	$	103,649	$	85,054	$	95,271	$	398,167

Earnings per share attributable to UHS-Basic:

Total basic earnings per share	$	1.17	$	1.06	$	0.87	$	0.99	$	4.09

Earnings per share attributable to UHS-Diluted:

Total diluted earnings per share	$	1.15	$	1.04	$	0.86	$	0.98	$	4.04

The 2011 quarterly financial data presented above includes the following:

Fourth Quarter:

•

(i) a favorable $10.4 million pre-tax reduction ($6.4 million, or $.07 per diluted share, net of taxes) to our professional and general liability self-insurance reserves relating to years prior to 2011, as discussed in Self-Insured Risks.


2010	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,347,153	$	1,338,315	$	1,323,264	$	1,559,453	$	5,568,185
Net income	$	82,762	$	76,415	$	65,802	$	50,816	$	275,795
Less: Net income attributable to noncontrolling interests	$	10,943	$	10,843	$	10,192	$	13,634	$	45,612

Net income attributable to UHS	$	71,819	$	65,572	$	55,610	$	37,182	$	230,183

Earnings per share attributable to UHS-Basic:

Total basic earnings per share	$	0.74	$	0.68	$	0.57	$	0.38	$	2.37

Earnings per share attributable to UHS-Diluted:

Total diluted earnings per share	$	0.73	$	0.67	$	0.57	$	0.38	$	2.34

The 2010 quarterly financial data presented above includes the following:

Second Quarter:

•

(i) a favorable $16.4 million pre-tax reduction ($10.2 million, or $.10 per diluted share, net of taxes) to our professional and general liability self-insurance reserves relating to years prior to 2010, as discussed in Self-Insured Risks, and; (ii) $18.2 million of pre-tax transaction costs ($11.3 million, or $.11 per diluted share, net of taxes) recorded in connection with our acquisition of Psychiatric Solutions, Inc. ("PSI") and;

Third Quarter:

•

(i) $3.9 million of pre-tax transaction costs ($2.4 million, or $.02 per diluted share, net of taxes) recorded in connection with our acquisition of "PSI" and; (ii) a favorable $4.3 million ($.04 per diluted share) discrete tax item recorded in connection with a settlement payment made to the government in connection with the investigation of our South Health Systems affiliates, and;

Fourth Quarter:

•

(i) a favorable $32.6 million pre-tax reduction ($17.9 million, or $.18 per diluted share, net of taxes) to our professional and general liability self-insurance reserves relating to years prior to 2010, as discussed in Self-Insured Risks, and; (ii) $31.1 million of pre-tax transaction costs ($24.9 million, or $.25 per diluted share, net of taxes) recorded in connection with our acquisition of "PSI" and; (iii) an unfavorable $6.7 million pre-tax ($4.1 million, or .$04 per diluted share, net of taxes) charge to write-off certain costs related to an acute care hospital construction project and; (iv) an unfavorable $9.2 million ($.09 per diluted share) charge in connection with split-dollar life insurance agreements on the lives of our Chief Executive Officer and his wife.

- Definition

The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.

+ References+ Details

Supplemental Condensed Consolidating Financial Information

12 Months Ended

Dec. 31, 2011

Supplemental Condensed Consolidating Financial Information [Abstract]

Supplemental Condensed Consolidating Financial Information

13) SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

Certain of our senior notes are guaranteed by a group of subsidiaries (the "Guarantors"). The Guarantors, each of which is a 100% directly owned subsidiary of Universal Health Services, Inc., fully and unconditionally guarantee the senior notes on a joint and several basis, subject to certain customary automatic release provisions.

The following financial statements present condensed consolidating financial data for (i) Universal Health Services, Inc. (on a parent company only basis), (ii) the combined Guarantors, (iii) the combined non guarantor subsidiaries (all other subsidiaries), (iv) an elimination column for adjustments to arrive at the information for the parent company, Guarantors, and non guarantors on a consolidated basis, and (v) the parent company and our subsidiaries on a consolidated basis.

Investments in subsidiaries are accounted for by the parent company and the Guarantors using the equity method for this presentation. Results of operations of subsidiaries are therefore classified in the parent company's and Guarantors' investment in subsidiaries accounts. The elimination entries set forth in the following condensed consolidating financial statements eliminate distributed and undistributed income of subsidiaries, investments in subsidiaries, and intercompany balances and transactions between the parent, Guarantors, and non guarantors.

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2011

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues	$	0		$	5,046,459		$	2,480,215		$	(26,476	)	$	7,500,198

Operating charges:
Salaries, wages and benefits		0			2,433,871			961,096			0			3,394,967
Other operating expenses		200			949,475			460,692			(24,687	)		1,385,680
Supplies expense		0			514,574			307,237			0			821,811
Provision for doubtful accounts		0			356,976			256,643			0			613,619
Depreciation and amortization		0			215,697			79,531			0			295,228
Lease and rental expense		0			62,118			31,436			(1,789	)		91,765

		200			4,532,711			2,096,635			(26,476	)		6,603,070

Income from operations		(200	)		513,748			383,580			0			897,128
Interest expense		195,404			90,417			(85,029	)		0			200,792
Interest (income) expense, affiliate		0			87,205			(87,205	)		0			0
Equity in net income of consolidated affiliates		(518,797	)		(157,009	)		0			675,806			0

Income before income taxes		323,193			493,135			555,814			(675,806	)		696,336
Provision for income taxes		(74,974	)		164,666			157,774			0			247,466

Net income		398,167			328,469			398,040			(675,806	)		448,870
Less: Income attributable to noncontrolling interests		0			0			50,703			0			50,703

Net income attributable to UHS	$	398,167		$	328,469		$	347,337		$	(675,806	)	$	398,167

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2010

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues	$	648		$	3,631,814		$	1,983,060		$	(47,337	)	$	5,568,185

Operating charges:
Salaries, wages and benefits		0			1,670,276			752,826			0			2,423,102
Other operating expenses		(255	)		670,043			381,689			(46,189	)		1,005,288
Supplies expense		0			438,901			294,192			0			733,093
Provision for doubtful accounts		0			290,152			256,757			0			546,909
Depreciation and amortization		0			154,597			69,318			0			223,915
Lease and rental expense		0			50,455			27,654			(1,148	)		76,961
Transaction costs		0			53,220			0			0			53,220

		(255	)		3,327,644			1,782,436			(47,337	)		5,062,488

Income from operations		903			304,170			200,624			0			505,697
Interest expense, net		70,283			6,729			588			0			77,600
Interest (income) expense, affiliate		0			60,876			(60,876	)		0			0
Equity in net income of consolidated affiliates		(271,944	)		(134,760	)		0			406,704			0

Income before income taxes		202,564			371,325			260,912			(406,704	)		428,097
Provision for income taxes		(27,619	)		134,547			45,374			0			152,302

Net income		230,183			236,778			215,538			(406,704	)		275,795
Less: Income attributable to noncontrolling interests		0			0			45,612			0			45,612

Net income attributable to UHS	$	230,183		$	236,778		$	169,926		$	(406,704	)	$	230,183

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF INCOME FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2009 (amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues	$	980		$	3,322,936		$	1,902,618		$	(24,155	)	$	5,202,379
Operating charges:
Salaries, wages and benefits		0			1,492,008			712,414			0			2,204,422
Other operating expenses		140			631,659			386,405			(23,281	)		994,923
Supplies expense		0			411,074			288,175			0			699,249
Provision for doubtful accounts		0			265,223			243,380			0			508,603
Depreciation and amortization		0			140,223			64,480			0			204,703
Lease and rental expense		0			45,366			26,831			(2,250	)		69,947

		140			2,985,553			1,721,685			(25,531	)		4,681,847

Income from operations		840			337,383			180,933			1,376			520,532
Interest expense, net		40,555			2,870			1,009			1,376			45,810
Interest (income) expense, affiliate		1,628			47,744			(49,372	)		0			0
Equity in net income of consolidated affiliates		(286,714	)		(125,784	)		0			412,498			0

Income before income taxes		245,371			412,553			229,296			(412,498	)		474,722
Provision for income taxes		(15,002	)		149,229			36,248			0			170,475

Net income		260,373			263,324			193,048			(412,498	)		304,247
Less: Income attributable to noncontrolling interests		0			0			43,874			0			43,874

Net income attributable to UHS	$	260,373		$	263,324		$	149,174		$	(412,498	)	$	260,373

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2011

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	33,221		$	8,008		$	0		$	41,229
Accounts receivable, net		8,891		663,593			297,318			0			969,802
Supplies		0		59,467			37,308			0			96,775
Other current assets		33,057		56,864			9,938			0			99,859
Deferred income taxes		67,189		41,755			322			(942	)		108,324
Current assets held for sale		0		48,916			0			0			48,916

Total current assets		109,137		903,816			352,894			(942	)		1,364,905

Investments in subsidiaries		5,213,573		1,181,849			0			(6,395,422	)		0
Intercompany receivable		669,112		0			74,155			(743,267	)		0
Intercompany note receivable		0		0			1,148,839			(1,148,839	)		0

Property and equipment		0		3,650,025			1,456,135			0			5,106,160
Less: accumulated depreciation		0		(1,184,283	)		(633,897	)		0			(1,818,180	)

		0		2,465,742			822,238			0			3,287,980

Other assets:
Goodwill		820		2,132,103			494,679			0			2,627,602
Deferred charges		103,434		5,972			2,374			0			111,780
Other		10,412		241,107			21,459			0			272,978

	$	6,106,488	$	6,930,589		$	2,916,638		$	(8,288,470	)	$	7,665,245

Liabilities and Stockholders' Equity
Current liabilities:
Current maturities of long-term debt	$	0	$	1,133		$	1,346		$	0		$	2,479
Accounts payable and accrued liabilities		14,201		616,026			201,898			0			832,125
Current liabilities held for sale		0		2,329			0			0			2,329
Federal and state taxes		0		0			620			(620	)		0

Total current liabilities		14,201		619,488			203,864			(620	)		836,933

Intercompany payable		0		743,267			0			(743,267	)		0
Other noncurrent liabilities		49,840		249,033			103,035			0			401,908
Long-term debt		3,594,182		3,616			53,630			0			3,651,428
Intercompany note payable		0		1,148,839			0			(1,148,839	)		0
Deferred income taxes		151,913		58,001			0			(322	)		209,592

Redeemable noncontrolling interests		0		0			218,266			0			218,266

UHS common stockholders' equity		2,296,352		4,108,345			2,287,077			(6,395,422	)		2,296,352
Noncontrolling interest		0		0			50,766			0			50,766

Total equity		2,296,352		4,108,345			2,337,843			(6,395,422	)		2,347,118

	$	6,106,488	$	6,930,589		$	2,916,638		$	(8,288,470	)	$	7,665,245

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2010

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	21,385		$	8,089		$	0		$	29,474
Accounts receivable, net		10,646		561,869			265,305			0			837,820
Supplies		0		57,069			37,261			0			94,330
Other current assets		51,161		69,903			8,996			0			130,060
Deferred income taxes		82,416		55,927			322			(17,831	)		120,834
Current assets held for sale		0		109,781			8,817			0			118,598

Total current assets		144,223		875,934			328,790			(17,831	)		1,331,116

Investments in subsidiaries		4,694,776		1,024,840			0			(5,719,616	)		0
Intercompany receivable		1,056,839		939,667			0			(1,996,506	)		0
Intercompany note receivable		0		0			3,071,860			(3,071,860	)		0

Property and equipment		0		3,492,263			1,361,709			0			4,853,972
Less: accumulated depreciation		0		(1,029,609	)		(571,396	)		0			(1,601,005	)

		0		2,462,654			790,313			0			3,252,967

Other assets:
Goodwill		820		2,153,366			435,728			0			2,589,914
Deferred charges		101,582		6,749			329			0			108,660
Other		7,612		214,694			22,973			0			245,279

	$	6,005,852	$	7,677,904		$	4,649,993		$	(10,805,813	)	$	7,527,936

Liabilities and Stockholders' Equity
Current liabilities:
Current maturities of long-term debt	$	559	$	1,357		$	1,533		$	0		$	3,449
Accounts payable and accrued liabilities		16,318		514,225			288,791			0			819,334
Current liabilities held for sale		0		3,343			173			0			3,516
Federal and state taxes		16,886		0			623			(17,509	)		0

Total current liabilities		33,763		518,925			291,120			(17,509	)		826,299

Intercompany payable		0		0			1,996,506			(1,996,506	)		0
Other noncurrent liabilities		13,672		252,568			114,409			0			380,649
Long-term debt		3,855,810		4,834			51,458			0			3,912,102
Intercompany note payable		0		3,071,860			0			(3,071,860	)		0
Deferred income taxes		123,835		49,841			0			(322	)		173,354

Redeemable noncontrolling interests		0		0			211,761			0			211,761

UHS common stockholders' equity		1,978,772		3,779,876			1,939,740			(5,719,616	)		1,978,772
Noncontrolling interest		0		0			44,999			0			44,999

Total equity		1,978,772		3,779,876			1,984,739			(5,719,616	)		2,023,771

	$	6,005,852	$	7,677,904		$	4,649,993		$	(10,805,813	)	$	7,527,936

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2011

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	(4,990	)	$	518,462		$	204,779		$	0	$	718,251

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(226,848	)		(58,834	)		0		(285,682	)
Proceeds received from sale of assets and businesses		0			0			67,592			0		67,592
Acquisition of property and businesses		0			0			(29,466	)		0		(29,466	)
Costs incurred for purchase and development of electronic health records application		0			(38,249	)		0			0		(38,249	)

Net cash used in investing activities		0			(265,097	)		(20,708	)		0		(285,805	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(382,060	)		(1,442	)		1,985			0		(381,517	)
Additional borrowings		98,100			0			0			0		98,100
Financing costs		(23,608	)		0			0			0		(23,608	)
Repurchase of common shares		(60,482	)		0			0			0		(60,482	)
Dividends paid		(19,466	)		0			0			0		(19,466	)
Issuance of common stock		4,779			0			0			0		4,779
Profit distributions to noncontrolling interests		0			0			(38,497	)		0		(38,497	)
Changes in intercompany balances with affiliates, net		387,727			(240,087	)		(147,640	)		0		0

Net cash (used in) provided by financing activities		4,990			(241,529	)		(184,152	)		0		(420,691	)

Increase (decrease) in cash and cash equivalents		0			11,836			(81	)		0		11,755
Cash and cash equivalents, beginning of period		0			21,385			8,089			0		29,474

Cash and cash equivalents, end of period	$	0		$	33,221		$	8,008		$	0	$	41,229

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2010

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	(139,226	)	$	342,633		$	297,937		$	0	$	501,344


Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(186,967	)		(52,307	)		0		(239,274	)
Acquisition of property and businesses		0			(1,958,904	)		606			0		(1,958,298	)
Proceeds received from sale of assets and businesses		0			21,460			0			0		21,460
Costs incurred for purchase and development of electronic health records application		0			(17,971	)		0			0		(17,971	)

Net cash used in investing activities		0			(2,142,382	)		(51,701	)		0		(2,194,083	)


Cash Flows from Financing Activities:
Reduction of long-term debt		(1,388,679	)		(753	)		(2,654	)		0		(1,392,086	)
Additional borrowings		3,266,146			0			0			0		3,266,146
Financing costs		(101,815	)		0			0			0		(101,815	)
Repurchase of common shares		(11,528	)		0			0			0		(11,528	)
Dividends paid		(19,422	)		0			0			0		(19,422	)
Issuance of common stock		3,594			0			0			0		3,594
Profit distributions to noncontrolling interests		0			0			(32,456	)		0		(32,456	)
Proceeds from sale of noncontrolling interest in majority owned business		0			0			600			0		600
Changes in intercompany balances with affiliates, net		(1,609,070	)		1,816,520			(207,450	)		0		0

Net cash (used in) provided by financing activities		139,226			1,815,767			(241,960	)		0		1,713,033

Increase (decrease) in cash and cash equivalents		0			16,018			4,276			0		20,294
Cash and cash equivalents, beginning of period		0			5,367			3,813			0		9,180

Cash and cash equivalents, end of period	$	0		$	21,385		$	8,089		$	0	$	29,474

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2009 (amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	(130,200	)	$	331,518		$	339,944		$	0	$	541,262
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(282,868	)		(96,880	)		0		(379,748	)
Acquisition of property and businesses		0			(12,499	)		0			0		(12,499	)
Proceeds received from sale of assets and businesses		0			8,952			818			0		9,770
Costs incurred for purchase and development of electronic health records application		0			(7,957	)		0			0		(7,957	)

Net cash used in investing activities		0			(294,372	)		(96,062	)		0		(390,434	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(58,779	)		(4,297	)		(3,423	)		0		(66,499	)
Additional borrowings		25,408			661			0			0		26,069
Repurchase of common shares		(63,288	)		0			0			0		(63,288	)
Dividends paid		(16,706	)		0			0			0		(16,706	)
Issuance of common stock		3,290			0			0			0		3,290
Profit distributions to noncontrolling interests		0			0			(29,866	)		0		(29,866	)
Capital contributions from noncontrolling interests		0			0			121			0		121
Purchase of noncontrolling interest in majority owned businesses		0			(229	)		0			0		(229	)
Changes in intercompany balances with affiliates, net		240,275			(30,129	)		(210,146	)		0		0

Net cash (used in) provided by financing activities		130,200			(33,994	)		(243,314	)		0		(147,108	)

Increase (decrease) in cash and cash equivalents		0			3,152			568			0		3,720
Cash and cash equivalents, beginning of period		0			2,215			3,245			0		5,460

Cash and cash equivalents, end of period	$	0		$	5,367		$	3,813		$	0	$	9,180

- Definition

The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.

+ References+ Details

Valuation And Qualifying Accounts

12 Months Ended

Dec. 31, 2011

Valuation And Qualifying Accounts [Abstract]

Valuation And Qualifying Accounts

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

(amounts in thousands)


Description	Balance at beginning of period		Charges to costs and expenses		Acquisitions of business		Write-off of uncollectible accounts			Balance at end of period
Allowance for doubtful accounts receivable:
Year ended December 31, 2011	$	248,622	$	613,619	$	—	$	(608,836	)	$	253,405

Year ended December 31, 2010	$	168,876	$	546,909	$	56,596	$	(523,759	)	$	248,622

Year ended December 31, 2009	$	162,975	$	508,603	$	—	$	(502,702	)	$	168,876

Business And Summary Of Significant Accounting Policies (Policy)

12 Months Ended

Dec. 31, 2011

Business And Summary Of Significant Accounting Policies [Abstract]

Principles Of Consolidation

Revenue Recognition

Provision For Doubtful Accounts

Concentration Of Revenues

Cash And Cash Equivalents

E) Cash and Cash Equivalents: We consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents.

Property And Equipment

Long-Lived Assets

Goodwill

Changes in the carrying amount of goodwill for the two years ended December 31, 2011 were as follows (in thousands):


	Acute Care Services			Behavioral Health Services			Total Consolidated
Balance, January 1, 2010	$	389,845		$	342,840		$	732,685
Goodwill acquired during the period		510			1,895,276			1,895,786
Goodwill divested during the period		(871	)		—			(871	)
Adjustments to goodwill (a)		—			(37,686	)		(37,686	)

Balance, January 1, 2011		389,484			2,200,430			2,589,914
Adjustments to goodwill (b)		—			37,688			37,688

Balance, December 31, 2011	$	389,484		$	2,238,118		$	2,627,602

(a)	The reduction to the Behavioral Health Services' goodwill consists primarily of a reclassification to "assets of facilities held for sale" and represents the goodwill attributable to a legacy facility which we agreed to divest pursuant to our agreement with the Federal Trade Commission.

(b)	Consists of adjustments to prior year purchase price allocations

Other Assets

Physician Guarantees And Commitments

Self-Insured Risks

Income Taxes

See Note 6 for additional disclosure regarding income taxes.

Other Noncurrent Liabilities

Redeemable Noncontrolling Interests and Noncontrolling Interest Policy

Comprehensive Income

The amounts recognized in AOCI for the two years ended December 31, 2011 were as follows (in thousands):


	Net Unrealized Gains (Losses) on Effective Cash Flow Hedges			Minimum Pension Liability			Total AOCI
Balance, January 1, 2010, net of income tax	$	(5,782	)	$	(15,471	)	$	(21,253	)
2010 activity:
Pre tax amount		1,060			743			1,803
Income tax effect		(408	)		(281	)		(689	)

Change, net of income tax		652			462			1,114

Balance, December 31, 2010, net of income tax		(5,130	)		(15,009	)		(20,139	)
2011 activity:
Pre tax amount		(37,813	)		(12,397	)		(50,210	)
Income tax effect		14,483			4,691			19,174

Change, net of income tax		(23,330	)		(7,706	)		(31,036	)

Balance, December 31, 2011, net of income tax	$	(28,460	)	$	(22,715	)	$	(51,175	)

Accounting For Derivative Financial Investments And Hedging Activities

Stock-Based Compensation

Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:


	Twelve Months Ended December 31,
	2011			2010			2009
Basic and diluted:
Net Income	$	448,870		$	275,795		$	304,247
Less: Net income attributable to noncontrolling interest		(50,703	)		(45,612	)		(43,874	)
Less: Net income attributable to unvested restricted share grants		(521	)		(918	)		(1,146	)

Net income attributable to UHS—basic and diluted	$	397,646		$	229,265		$	259,227

Basic earnings per share attributable to UHS:
Weighted average number of common shares—basic		97,199			96,786			97,794

Total basic earnings per share	$	4.09		$	2.37		$	2.65

Diluted earnings per share attributable to UHS:
Weighted average number of common shares		97,199			96,786			97,794
Net effect of dilutive stock options and grants based on the treasury stock method		1,338			1,187			481

Weighted average number of common shares and equivalents—diluted		98,537			97,973			98,275

Total diluted earnings per share	$	4.04		$	2.34		$	2.64

Fair Value Of Financial Instruments

Use Of Estimates

Mergers And Acquisitions

Business And Summary Of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2011

Business And Summary Of Significant Accounting Policies [Abstract]

Schedule Of Changes In The Carrying Amount Of Goodwill


	Acute Care Services			Behavioral Health Services			Total Consolidated
Balance, January 1, 2010	$	389,845		$	342,840		$	732,685
Goodwill acquired during the period		510			1,895,276			1,895,786
Goodwill divested during the period		(871	)		—			(871	)
Adjustments to goodwill (a)		—			(37,686	)		(37,686	)

Balance, January 1, 2011		389,484			2,200,430			2,589,914
Adjustments to goodwill (b)		—			37,688			37,688

Balance, December 31, 2011	$	389,484		$	2,238,118		$	2,627,602

(a)	The reduction to the Behavioral Health Services' goodwill consists primarily of a reclassification to "assets of facilities held for sale" and represents the goodwill attributable to a legacy facility which we agreed to divest pursuant to our agreement with the Federal Trade Commission.

(b)	Consists of adjustments to prior year purchase price allocations

Schedule Of Amounts Recognized In AOCI


	Net Unrealized Gains (Losses) on Effective Cash Flow Hedges			Minimum Pension Liability			Total AOCI
Balance, January 1, 2010, net of income tax	$	(5,782	)	$	(15,471	)	$	(21,253	)
2010 activity:
Pre tax amount		1,060			743			1,803
Income tax effect		(408	)		(281	)		(689	)

Change, net of income tax		652			462			1,114

Balance, December 31, 2010, net of income tax		(5,130	)		(15,009	)		(20,139	)
2011 activity:
Pre tax amount		(37,813	)		(12,397	)		(50,210	)
Income tax effect		14,483			4,691			19,174

Change, net of income tax		(23,330	)		(7,706	)		(31,036	)

Balance, December 31, 2011, net of income tax	$	(28,460	)	$	(22,715	)	$	(51,175	)

Schedule Of Computation Of Basic And Diluted Earnings Per Share


	Twelve Months Ended December 31,
	2011			2010			2009
Basic and diluted:
Net Income	$	448,870		$	275,795		$	304,247
Less: Net income attributable to noncontrolling interest		(50,703	)		(45,612	)		(43,874	)
Less: Net income attributable to unvested restricted share grants		(521	)		(918	)		(1,146	)

Net income attributable to UHS—basic and diluted	$	397,646		$	229,265		$	259,227

Basic earnings per share attributable to UHS:
Weighted average number of common shares—basic		97,199			96,786			97,794

Total basic earnings per share	$	4.09		$	2.37		$	2.65

Diluted earnings per share attributable to UHS:
Weighted average number of common shares		97,199			96,786			97,794
Net effect of dilutive stock options and grants based on the treasury stock method		1,338			1,187			481

Weighted average number of common shares and equivalents—diluted		98,537			97,973			98,275

Total diluted earnings per share	$	4.04		$	2.34		$	2.64

- Definition

Tabular disclosure of goodwill by reportable segment and in total. Disclosure details may include, but are not limited to, the carrying amount of goodwill, goodwill acquired during the year, goodwill impairment losses recognized, goodwill written-off due to the sale of a business unit, goodwill not yet allocated, and any other changes to goodwill.

+ References+ Details

Acquisitions And Divestitures (Tables)

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Acquisitions And Divestitures [Abstract]

Schedule Of Aggregate Net Purchase Price Of The Facilities That Were Allocated To Assets And Liabilities


	Amount (000s)
Property, plant & equipment	$	35,000
Other assets/deposits		11,000
Debt		(17,000	)

Cash paid in 2011 for acquisitions and deposits	$	29,000


	Amount (000s)
Working capital, net	$	60,000
Assets held for sale		67,000
Property, plant & equipment		932,000
Goodwill		1,921,000
Other assets		132,000
Income tax assets, net of deferred tax liabilities		(14,000	)
Debt		(1,082,000	)
Liabilities held for sale		(1,000	)
Redeemable noncontrolling interests		(5,000	)
Other liabilities		(52,000	)

Cash paid in 2010 for acquisitions	$	1,958,000


	Amount (000s)
Working capital, net	$	1,000
Property, plant & equipment		11,000

Cash paid in 2009 for acquisitions	$	12,000

Schedule Of Results Of Operations For The Former PSI Facilities, On A Combined Basis, Reflected As Discontinued Operations


	Year Ended December 31,
	2011			2010			2009
Net revenues	$	33,884		$	4,155		$	—
Income from discontinued operations		7,904			859			—
Gain on divestiture		442			—			—

Income from discontinued operations, before income tax expense		8,346			859			—
Income tax expense		(3,160	)		(318	)		—

Income from discontinued operations, net of income tax expense	$	5,186		$	541		$	—

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References+ Details

Long-Term Debt (Tables)

12 Months Ended

Dec. 31, 2011

Long-Term Debt [Abstract]

Summary Of Long-Term Debt


	December 31,
	2011			2010
	(amounts in thousands)
Long-term debt:
Notes payable and Mortgages payable (including obligations under capitalized leases of $9,982 in 2011 and $11,962 in 2010) and term loans with varying maturities through 2038; weighted average interest at 6.1% in 2011 and 6.5% in 2010 (see Note 7 regarding capitalized leases)	$	51,841		$	49,355
Revolving credit and demand notes		249,600			187,500
Term Loan A, net of unamortized discount of $6,103		1,020,375			1,042,322
Term Loan B, net of unamortized discount of $19,500		1,436,772			1,576,500
Revenue bonds, interest at floating rates of 0.2% and 0.3% at December 31, 2011 and 2010, respectively, with varying maturities through 2015		5,300			5,300
Accounts receivable securitization program		240,000			204,000
6.75% Senior Secured Notes due 2011, net of the unamortized discount of $9 in 2010, and fair market value adjustment of $559 in 2010.		—			200,550
7.125% Senior Secured Notes due 2016, including unamortized net premium of $19 in 2011 and $24 in 2010		400,019			400,024
7.00% Senior Unsecured Notes due 2018		250,000			250,000

		3,653,907			3,915,551
Less-Amounts due within one year		(2,479	)		(3,449	)

	$	3,651,428		$	3,912,102

Schedule Of Aggregate Maturities


	(000s)
2012	$	2,479
2013		242,638
2014		3,970
2015		1,290,085
2016		1,840,693
Later		274,042

Total	$	3,653,907

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(e),(f))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6584090&loc=d3e28878-108400

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

+ Details

Common Stock (Tables)

12 Months Ended

Dec. 31, 2011

Common Stock [Abstract]

Schedule Of Information Related To Stock Repurchase Programs


	Additional Shares Authorized For Repurchase		Total number of shares purchased(a)		Average price paid per share for forfeited restricted shares		Total number of shares purchased as part of publicly announced programs		Average price paid per share for shares purchased as part of publicly announced program		Aggregate purchase price paid (in thousands)		Maximum number of shares that may yet be purchased under the program
Balance as of January 1, 2009														4,713,548
2009		—		2,574,209	$	0.01		2,561,209	$	24.71	$	63,288		2,152,339
2010		—		301,933	$	0.01		293,933	$	39.22	$	11,528		1,858,406
2011		—		1,602,286	$	0.01		1,602,286	$	37.75	$	60,482		256,120

Total for three year period ended December 31, 2011		—		4,478,428	$	0.01		4,457,428	$	30.35	$	135,298

(a)	During 2010 and 2009, there were 8,000 and 13,000, respectively, of restricted shares that were forfeited by former employees pursuant to the terms of our restricted stock purchase plan which are included in the total number of shares purchased. No such forfeitures occurred during 2011.

Schedule Of Weighted-Average Assumptions Fair Value Of Option Grants


Year Ended December 31,	2011			2010			2009
Volatility		29	%		27	%		28	%
Interest rate		2	%		3	%		3	%
Expected life (years)		3.5			3.6			3.6
Forfeiture rate		9	%		10	%		10	%
Dividend yield		0.7	%		0.7	%		0.7	%

Schedule Of Stock Option Activity


Outstanding Options	Number of Shares			Average Option Price		Range (High-Low)
Balance, January 1, 2009		8,116,326		$	22.68	$	31.70 -$16.22
Granted		2,635,000		$	31.18	$	31.18 -$31.18
Exercised		(1,582,376	)	$	23.71	$	29.89 -$16.22
Cancelled		(366,500	)	$	22.84	$	29.89 -$16.22

Balance, January 1, 2010		8,802,450		$	25.03	$	31.70 -$16.22
Granted		94,000		$	30.40	$	32.28 -$30.32
Exercised		(2,000,250	)	$	24.87	$	31.70 -$16.22
Cancelled		(301,250	)	$	24.91	$	31.18 -$16.22

Balance, January 1, 2011		6,594,950		$	25.16	$	32.28 -$16.22
Granted		2,894,500		$	43.66	$	54.79 -$38.12
Exercised		(1,563,255	)	$	26.38	$	32.28 -$16.22
Cancelled		(367,250	)	$	32.60	$	46.97 -$16.22

Balance, December 31, 2011		7,558,945		$	31.63	$	54.79 -$16.22

Outstanding options vested and exercisable as of December 31, 2011		2,979,945		$	23.82	$	31.18 -$16.22

Schedule Of Information About Unvested Options


	Shares			Weighted Average Grant Date Fair Value
Unvested options as of January 1, 2011		3,799,250		$	5.80
Granted		2,894,500		$	11.62
Vested		(1,757,500	)	$	5.26
Cancelled		(357,250	)	$	8.19

Unvested options as of December 31, 2011		4,579,000		$	9.50

Schedule Of Information About All Outstanding Options And Exercisable Options


	Options Outstanding		Options Exercisable
Number		7,558,945		2,979,945
Weighted average exercise price	$	31.63	$	23.82
Aggregate intrinsic value as of December 31, 2011	$	67,870,455	$	44,833,019
Weighted average remaining contractual life		2.8		1.8

Schedule Of Weighted Average Remaining Contractual Life For Options Outstanding And Weighted Average Exercise Price Per Share For Exercisable Options


	Options Outstanding						Exercisable Options				Expected to Vest Options(a)
Exercise Price	Shares		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in Years)		Shares		Weighted Average Exercise Price Per Share		Shares		Weighted Average Exercise Price Per Share
$16.22 – $24.45		2,642,825	$	19.56		1.5		2,050,825	$	20.53		537,891	$	16.22
$25.32 – $29.26		29,500		26.80		1.1		17,750		26.59		10,676		27.12
$29.60 – $32.28		2,139,120		31.15		2.9		911,370		31.16		1,115,534		31.14
$38.12 – $43.67		2,728,000		43.59		4.1		—		N/A		2,478,661		43.59
$46.79 – $54.79		19,500		52.99		4.3		—		N/A		17,718		52.99

Total		7,558,945	$	31.63		2.8		2,979,945	$	23.82		4,160,480	$	36.71

(a)	Assumes a weighted average forfeiture rate of 9.14%.

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2011

Income Taxes [Abstract]

Schedule Of Components Of Income Tax Expense/(Benefit)


	Year Ended December 31,
	2011		2010		2009
Current
Federal	$	165,409	$	105,077	$	130,798
Foreign		300		2,555		—
State		22,901		16,547		18,976

		188,610		124,179		149,774
Deferred
Federal and foreign		53,056		26,419		18,524
State		5,800		1,704		2,177

		58,856		28,123		20,701

Total	$	247,466	$	152,302	$	170,475

Schedule Of Components Of Deferred Taxes


	Year Ended December 31,
	2011			2010
Deferred income tax assets:
Self-insurance reserves	$	115,201		$	121,249
Compensation accruals		49,717			53,855
State and foreign net operating loss carryforwards and other state and foreign deferred tax assets		52,506			46,338
Other currently non-deductible accrued liabilities		19,699			19,016
Net pension liability—OCI only		13,959			9,268
Doubtful accounts and other reserves		17,345			31,046
Other combined items—OCI only		17,684			3,196

		286,111			283,968
Less: Valuation Allowance		(42,143	)		(32,352	)

Net deferred income tax assets:		243,968			251,616
Deferred income tax liabilities:
Depreciable and amortizable assets		(342,655	)		(299,566	)
Other deferred tax liabilities		(2,581	)		(4,570	)

Net deferred income tax liabilities	$	(101,268	)	$	(52,520	)

Schedule Of Effective Tax Rates Calculation


	2011			2010			2009
Provision for income taxes	$	247,466		$	152,302		$	170,475
Income before income taxes		696,336			428,097			474,722

Effective tax rate		35.5	%		35.6	%		35.9	%

Schedule Of Reconciliation Between Federal Statutory Rate And Effective Tax Rate


	Year Ended December 31,
	2011			2010			2009
Federal statutory rate		35.0	%		35.0	%		35.0	%
State taxes, net of federal income tax benefit		2.9			3.1			3.2
Nondeductible transaction costs		—			1.3			—
Other items		0.4			0.4			1.4
Impact of income attributable to noncontrolling interests		(2.8	)		(4.2	)		(3.7	)

Effective tax rate		35.5	%		35.6	%		35.9	%

Schedule Of Net Deferred Tax Assets And Liabilities


	Year Ended December 31,
	2011			2010
Current deferred taxes
Assets	$	109,297		$	123,362
Liabilities		(973	)		(2,528	)

Total deferred taxes-current		108,324			120,834

Noncurrent deferred taxes
Assets		135,189			128,254
Liabilities		(344,781	)		(301,608	)

Total deferred taxes-noncurrent		(209,592	)		(173,354	)

Total deferred tax liabilities	$	(101,268	)	$	(52,520	)

Schedule Of Reconciliation Of Unrecognized Tax Benefits


	As of December 31,
	2011			2010			2009
Balance at January 1,	$	7,923		$	5,754		$	3,759
Additions based on tax positions related to the current year		750			1,219			750
Additions for tax positions of prior years		419			2,076			1,245
Reductions for tax positions of prior years		(1,628	)		(907	)		—
Settlements		(61	)		(219	)		—

Balance at December 31,	$	7,403		$	7,923		$	5,754

- Definition

Tabular disclosure of tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities (i.e., uncertain tax positions) and other types of income tax contingencies, including: (1) the policy on classification of interest and penalties; (2) a tabular reconciliation of the total amounts of unrecognized tax benefits at the beginning and end of the period; the total amount(s) of: (3) unrecognized tax benefits that, if recognized, would affect the effective tax rate, and (4) interest and penalties recognized in each of the income statement and balance sheet; (5) for positions for which it is reasonably possible that the total amounts unrecognized will significantly change within 12 months of the reporting date the: (i) nature of the uncertainty, (ii) nature of the event that could occur that would cause the change, and (iii) an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made; and (6) a description of tax years that remain subject to examination by major tax jurisdictions.

+ References+ Details

Lease Commitments (Tables)

12 Months Ended

Dec. 31, 2011

Lease Commitments [Abstract]

Schedule Of Summary Of Property Under Capital Lease


	As of December 31,
	2011			2010
Land, buildings and equipment	$	37,037		$	38,712
Less: accumulated amortization		(35,264	)		(35,627	)

	$	1,773		$	3,085

Schedule Of Future Minimum Rental Payments Under Lease Commitments


Year	Capital Leases			Operating Leases
	(000s)
2012	$	2,425		$	58,388
2013		2,277			42,717
2014		1,299			32,777
2015		1,212			26,806
2016		1,077			21,687
Later years		7,787			24,053

Total minimum rental	$	16,077		$	206,428

Less: Amount representing interest		(6,095	)

Present value of minimum rental commitments		9,982
Less: Current portion of capital lease obligations		(1,680	)

Long-term portion of capital lease obligations	$	8,302

Relationship With Universal Health Realty Income Trust And Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2011

Relationship With Universal Health Realty Income Trust And Related Party Transactions [Abstract]

Schedule Of Renewal Options And Terms Of Hospital Facilities Leased

Hospital Name

Type of Facility

Annual
Minimum
Rent

End of Lease Term

Renewal
Term
(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

The Bridgeway

Behavioral Health

930,000

December, 2014

(c)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal options at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

(c)	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

- Definition

Tabular disclosure of a lessee's leasing arrangements including: (1) the basis on which contingent rental payments are determined, (2) the existence and terms of renewal or purchase options and escalation clauses, (3) restrictions imposed by lease arrangements, such as those concerning dividends, additional debt, and further leasing, (4) rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions. Disclosure may also include the specific period used to amortize material leasehold improvements made at the inception of the lease or during the lease term. Additionally, for operating leases having initial or remaining noncancelable lease terms in excess of one year: (a) future minimum rental payments required as of the date of the latest balance sheet presented, in the aggregate and for each of the five succeeding fiscal years, (b) the total of minimum rentals to be received in the future under noncancelable subleases as of the date of the latest balance sheet presented, and (c) for all operating leases, rental expense for each period for which an income statement is presented, with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included.

+ References+ Details

Pension Plan (Tables)

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Pension Plan [Abstract]

Schedule Of Reconciliation Of Defined Benefit Pension Plan


	2011			2010
	(000s)
Change in plan assets:
Fair value of plan assets at beginning of year	$	73,402		$	61,451
Actual return (loss) on plan assets		5,689			10,027
Employer contributions		14,065			6,657
Benefits paid		(4,541	)		(4,256	)
Administrative expenses		(675	)		(477	)

Fair value of plan assets at end of year	$	87,940		$	73,402
Change in benefit obligation:
Benefit obligation at beginning of year	$	93,513		$	85,476
Service cost		1,162			1,140
Interest cost		5,047			4,958
Benefits paid		(4,541	)		(4,256	)
Actuarial (gain) loss		13,265			6,195

Benefit obligation at end of year	$	108,446		$	93,513
Amounts recognized in the Consolidated Balance Sheet:
Other noncurrent liabilities		20,506			20,110

Total liability at end of year	$	20,506		$	20,110

Additional year end information for Pension Plan
Projected benefit obligation	$	108,446		$	93,513
Accumulated benefit obligation		106,609			91,559
Fair value of plan assets		87,940			73,402

Schedule Of Components Of Net Periodic Cost (Benefit)


	2011			2010			2009
	(000s)
Components of net periodic cost (benefit)
Service cost	$	1,162		$	1,140		$	1,191
Interest cost		5,047			4,958			4,834
Expected return on plan assets		(6,566	)		(5,151	)		(3,927	)
Recognized actuarial loss		2,427			2,538			4,676

Net periodic cost	$	2,070		$	3,485		$	6,774

Schedule Of Measurement Dates


	2011		2010
Measurement Dates
Benefit obligations		12/31/2011		12/31/2010
Fair value of plan assets		12/31/2011		12/31/2010

Schedule Of Weighted Average Assumptions


	2011			2010
Weighted average assumptions as of December 31
Discount rate		4.40	%		5.54	%
Rate of compensation increase		4.00	%		4.00	%

Schedule Of Weighted-Average Assumptions For Net Periodic Benefit Cost Calculations


	2011			2010			2009
Weighted-average assumptions for net periodic benefit cost calculations
Discount rate		5.54	%		5.96	%		5.87	%
Expected long-term rate at return on plan assets		8.00	%		8.00	%		8.00	%
Rate of compensation increase		4.00	%		4.00	%		4.00	%

Schedule Of Market Values Of Pension Plan Assets


December 31, 2011	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	18,921	$	—	$	18,921	$	—
U.S. Mid Cap		1,281		—		1,281		—
U.S. Small-Mid Cap		6,332		—		6,332		—
U.S. Small Cap		1,282		—		1,282		—
International Developed		8,692		—		8,692		—
Emerging Markets		3,123		—		3,123		—
Fixed income:
Long Duration Fixed Income		44,587		—		44,587		—
Real Estate:
REIT Fund		3,269		—		3,269		—
Tangible Assets:
Commodities		—		—		—		—
Cash/Currency:
Cash Equivalents		453		—		453		—

Total market value	$	87,940	$	—	$	87,940	$	—


December 31, 2010	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	22,010	$	—	$	22,010	$	—
U.S. Mid Cap		1,468		—		1,468		—
U.S. Small-Mid Cap		6,295		—		6,295		—
U.S. Small Cap		1,471		—		1,471		—
International Developed		10,353		—		10,353		—
Emerging Markets		3,709		—		3,709		—
Fixed income:
Core Fixed Income		11,542		—		11,542		—
Long Duration Fixed Income		11,421		—		11,421		—
Real Estate:
REIT Fund		3,740		—		3,740		—
Tangible Assets:
Commodities		—		—		—		—
Cash/Currency:
Cash Equivalents		1,393		—		1,393		—

Total market value	$	73,402	$	—	$	73,402	$	—

Schedule Of Estimated Future Benefit Payments


Estimated Future Benefit Payments (000s)
2012	$	5,100
2013		5,400
2014		5,664
2015		5,895
2016		6,117
2017-2021		33,216

Total	$	61,392

Schedule Of Plan Assets Category


	2011			2010
Plan Assets
Asset Category
Equity securities		45	%		62	%
Fixed income securities		50	%		31	%
Other		5	%		7	%

Total		100	%		100	%

Schedule Of Asset Allocation Policy And Ranges For Overall Risk And Return Objectives Of Portfolio


	Policy			As of 12/31/11			Permitted Range
Total Equity		46	%		45	%		43-49	%
Total Fixed Income		50	%		50	%		45-55	%
Other		4	%		5	%		0-10	%

Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2011

Segment Reporting [Abstract]

Schedule Of Financial Information By Operating Segments


2011	Acute Care Hospital Services		Behavioral Health Services		Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	12,025,664	$	5,529,205		—		$	17,554,869
Gross outpatient revenues	$	5,629,420	$	608,785	$	53,240		$	6,291,445
Total net revenues	$	4,071,570	$	3,401,118	$	27,510		$	7,500,198
Income (loss) before income taxes	$	351,917	$	732,674	($	388,255	)	$	696,336
Total assets	$	2,852,549	$	4,383,432	$	429,264		$	7,665,245


2010	Acute Care Hospital Services		Behavioral Health Services		Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	10,890,171	$	2,566,366		—		$	13,456,537
Gross outpatient revenues	$	4,771,070	$	350,192	$	49,245		$	5,170,507
Total net revenues	$	3,901,815	$	1,635,455	$	30,915		$	5,568,185
Income (loss) before income taxes	$	363,427	$	353,203	($	288,533	)	$	428,097
Total assets	$	2,755,697	$	4,360,710	$	411,529		$	7,527,936


2009	Acute Care Hospital Services		Behavioral Health Services		Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	9,901,032	$	2,075,141		—		$	11,976,173
Gross outpatient revenues	$	4,100,427	$	282,473	$	62,353		$	4,445,253
Total net revenues	$	3,810,828	$	1,315,029	$	76,522		$	5,202,379
Income (loss) before income taxes	$	386,208	$	281,541	($	193,027	)	$	474,722
Total assets	$	2,748,175	$	998,508	$	217,780		$	3,964,463

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details

Quarterly Results (Tables)

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Quarterly Results [Abstract]

Schedule Of Quarterly Financial Data


2011	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,910,528	$	1,902,234	$	1,848,662	$	1,838,774	$	7,500,198
Net income	$	129,987	$	116,034	$	94,842	$	108,007	$	448,870
Less: Net income attributable to noncontrolling interests	$	15,794	$	12,385	$	9,788	$	12,736	$	50,703

Net income attributable to UHS	$	114,193	$	103,649	$	85,054	$	95,271	$	398,167

Earnings per share attributable to UHS-Basic:

Total basic earnings per share	$	1.17	$	1.06	$	0.87	$	0.99	$	4.09

Earnings per share attributable to UHS-Diluted:

Total diluted earnings per share	$	1.15	$	1.04	$	0.86	$	0.98	$	4.04


2010	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,347,153	$	1,338,315	$	1,323,264	$	1,559,453	$	5,568,185
Net income	$	82,762	$	76,415	$	65,802	$	50,816	$	275,795
Less: Net income attributable to noncontrolling interests	$	10,943	$	10,843	$	10,192	$	13,634	$	45,612

Net income attributable to UHS	$	71,819	$	65,572	$	55,610	$	37,182	$	230,183

Earnings per share attributable to UHS-Basic:

Total basic earnings per share	$	0.74	$	0.68	$	0.57	$	0.38	$	2.37

Earnings per share attributable to UHS-Diluted:

Total diluted earnings per share	$	0.73	$	0.67	$	0.57	$	0.38	$	2.34

Supplemental Condensed Consolidating Financial Information (Tables)

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Supplemental Condensed Consolidating Financial Information [Abstract]

Schedule Of Condensed Consolidating Statements Of Income


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues	$	0		$	5,046,459		$	2,480,215		$	(26,476	)	$	7,500,198

Operating charges:
Salaries, wages and benefits		0			2,433,871			961,096			0			3,394,967
Other operating expenses		200			949,475			460,692			(24,687	)		1,385,680
Supplies expense		0			514,574			307,237			0			821,811
Provision for doubtful accounts		0			356,976			256,643			0			613,619
Depreciation and amortization		0			215,697			79,531			0			295,228
Lease and rental expense		0			62,118			31,436			(1,789	)		91,765

		200			4,532,711			2,096,635			(26,476	)		6,603,070

Income from operations		(200	)		513,748			383,580			0			897,128
Interest expense		195,404			90,417			(85,029	)		0			200,792
Interest (income) expense, affiliate		0			87,205			(87,205	)		0			0
Equity in net income of consolidated affiliates		(518,797	)		(157,009	)		0			675,806			0

Income before income taxes		323,193			493,135			555,814			(675,806	)		696,336
Provision for income taxes		(74,974	)		164,666			157,774			0			247,466

Net income		398,167			328,469			398,040			(675,806	)		448,870
Less: Income attributable to noncontrolling interests		0			0			50,703			0			50,703

Net income attributable to UHS	$	398,167		$	328,469		$	347,337		$	(675,806	)	$	398,167


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues	$	648		$	3,631,814		$	1,983,060		$	(47,337	)	$	5,568,185

Operating charges:
Salaries, wages and benefits		0			1,670,276			752,826			0			2,423,102
Other operating expenses		(255	)		670,043			381,689			(46,189	)		1,005,288
Supplies expense		0			438,901			294,192			0			733,093
Provision for doubtful accounts		0			290,152			256,757			0			546,909
Depreciation and amortization		0			154,597			69,318			0			223,915
Lease and rental expense		0			50,455			27,654			(1,148	)		76,961
Transaction costs		0			53,220			0			0			53,220

		(255	)		3,327,644			1,782,436			(47,337	)		5,062,488

Income from operations		903			304,170			200,624			0			505,697
Interest expense, net		70,283			6,729			588			0			77,600
Interest (income) expense, affiliate		0			60,876			(60,876	)		0			0
Equity in net income of consolidated affiliates		(271,944	)		(134,760	)		0			406,704			0

Income before income taxes		202,564			371,325			260,912			(406,704	)		428,097
Provision for income taxes		(27,619	)		134,547			45,374			0			152,302

Net income		230,183			236,778			215,538			(406,704	)		275,795
Less: Income attributable to noncontrolling interests		0			0			45,612			0			45,612

Net income attributable to UHS	$	230,183		$	236,778		$	169,926		$	(406,704	)	$	230,183


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues	$	980		$	3,322,936		$	1,902,618		$	(24,155	)	$	5,202,379
Operating charges:
Salaries, wages and benefits		0			1,492,008			712,414			0			2,204,422
Other operating expenses		140			631,659			386,405			(23,281	)		994,923
Supplies expense		0			411,074			288,175			0			699,249
Provision for doubtful accounts		0			265,223			243,380			0			508,603
Depreciation and amortization		0			140,223			64,480			0			204,703
Lease and rental expense		0			45,366			26,831			(2,250	)		69,947

		140			2,985,553			1,721,685			(25,531	)		4,681,847

Income from operations		840			337,383			180,933			1,376			520,532
Interest expense, net		40,555			2,870			1,009			1,376			45,810
Interest (income) expense, affiliate		1,628			47,744			(49,372	)		0			0
Equity in net income of consolidated affiliates		(286,714	)		(125,784	)		0			412,498			0

Income before income taxes		245,371			412,553			229,296			(412,498	)		474,722
Provision for income taxes		(15,002	)		149,229			36,248			0			170,475

Net income		260,373			263,324			193,048			(412,498	)		304,247
Less: Income attributable to noncontrolling interests		0			0			43,874			0			43,874

Net income attributable to UHS	$	260,373		$	263,324		$	149,174		$	(412,498	)	$	260,373

Schedule Of Condensed Consolidating Balance Sheet


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	33,221		$	8,008		$	0		$	41,229
Accounts receivable, net		8,891		663,593			297,318			0			969,802
Supplies		0		59,467			37,308			0			96,775
Other current assets		33,057		56,864			9,938			0			99,859
Deferred income taxes		67,189		41,755			322			(942	)		108,324
Current assets held for sale		0		48,916			0			0			48,916

Total current assets		109,137		903,816			352,894			(942	)		1,364,905

Investments in subsidiaries		5,213,573		1,181,849			0			(6,395,422	)		0
Intercompany receivable		669,112		0			74,155			(743,267	)		0
Intercompany note receivable		0		0			1,148,839			(1,148,839	)		0

Property and equipment		0		3,650,025			1,456,135			0			5,106,160
Less: accumulated depreciation		0		(1,184,283	)		(633,897	)		0			(1,818,180	)

		0		2,465,742			822,238			0			3,287,980

Other assets:
Goodwill		820		2,132,103			494,679			0			2,627,602
Deferred charges		103,434		5,972			2,374			0			111,780
Other		10,412		241,107			21,459			0			272,978

	$	6,106,488	$	6,930,589		$	2,916,638		$	(8,288,470	)	$	7,665,245

Liabilities and Stockholders' Equity
Current liabilities:
Current maturities of long-term debt	$	0	$	1,133		$	1,346		$	0		$	2,479
Accounts payable and accrued liabilities		14,201		616,026			201,898			0			832,125
Current liabilities held for sale		0		2,329			0			0			2,329
Federal and state taxes		0		0			620			(620	)		0

Total current liabilities		14,201		619,488			203,864			(620	)		836,933

Intercompany payable		0		743,267			0			(743,267	)		0
Other noncurrent liabilities		49,840		249,033			103,035			0			401,908
Long-term debt		3,594,182		3,616			53,630			0			3,651,428
Intercompany note payable		0		1,148,839			0			(1,148,839	)		0
Deferred income taxes		151,913		58,001			0			(322	)		209,592

Redeemable noncontrolling interests		0		0			218,266			0			218,266

UHS common stockholders' equity		2,296,352		4,108,345			2,287,077			(6,395,422	)		2,296,352
Noncontrolling interest		0		0			50,766			0			50,766

Total equity		2,296,352		4,108,345			2,337,843			(6,395,422	)		2,347,118

	$	6,106,488	$	6,930,589		$	2,916,638		$	(8,288,470	)	$	7,665,245


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	21,385		$	8,089		$	0		$	29,474
Accounts receivable, net		10,646		561,869			265,305			0			837,820
Supplies		0		57,069			37,261			0			94,330
Other current assets		51,161		69,903			8,996			0			130,060
Deferred income taxes		82,416		55,927			322			(17,831	)		120,834
Current assets held for sale		0		109,781			8,817			0			118,598

Total current assets		144,223		875,934			328,790			(17,831	)		1,331,116

Investments in subsidiaries		4,694,776		1,024,840			0			(5,719,616	)		0
Intercompany receivable		1,056,839		939,667			0			(1,996,506	)		0
Intercompany note receivable		0		0			3,071,860			(3,071,860	)		0

Property and equipment		0		3,492,263			1,361,709			0			4,853,972
Less: accumulated depreciation		0		(1,029,609	)		(571,396	)		0			(1,601,005	)

		0		2,462,654			790,313			0			3,252,967

Other assets:
Goodwill		820		2,153,366			435,728			0			2,589,914
Deferred charges		101,582		6,749			329			0			108,660
Other		7,612		214,694			22,973			0			245,279

	$	6,005,852	$	7,677,904		$	4,649,993		$	(10,805,813	)	$	7,527,936

Liabilities and Stockholders' Equity
Current liabilities:
Current maturities of long-term debt	$	559	$	1,357		$	1,533		$	0		$	3,449
Accounts payable and accrued liabilities		16,318		514,225			288,791			0			819,334
Current liabilities held for sale		0		3,343			173			0			3,516
Federal and state taxes		16,886		0			623			(17,509	)		0

Total current liabilities		33,763		518,925			291,120			(17,509	)		826,299

Intercompany payable		0		0			1,996,506			(1,996,506	)		0
Other noncurrent liabilities		13,672		252,568			114,409			0			380,649
Long-term debt		3,855,810		4,834			51,458			0			3,912,102
Intercompany note payable		0		3,071,860			0			(3,071,860	)		0
Deferred income taxes		123,835		49,841			0			(322	)		173,354

Redeemable noncontrolling interests		0		0			211,761			0			211,761

UHS common stockholders' equity		1,978,772		3,779,876			1,939,740			(5,719,616	)		1,978,772
Noncontrolling interest		0		0			44,999			0			44,999

Total equity		1,978,772		3,779,876			1,984,739			(5,719,616	)		2,023,771

	$	6,005,852	$	7,677,904		$	4,649,993		$	(10,805,813	)	$	7,527,936

Schedule Of Condensed Consolidating Statements Of Cash Flows


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	(4,990	)	$	518,462		$	204,779		$	0	$	718,251

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(226,848	)		(58,834	)		0		(285,682	)
Proceeds received from sale of assets and businesses		0			0			67,592			0		67,592
Acquisition of property and businesses		0			0			(29,466	)		0		(29,466	)
Costs incurred for purchase and development of electronic health records application		0			(38,249	)		0			0		(38,249	)

Net cash used in investing activities		0			(265,097	)		(20,708	)		0		(285,805	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(382,060	)		(1,442	)		1,985			0		(381,517	)
Additional borrowings		98,100			0			0			0		98,100
Financing costs		(23,608	)		0			0			0		(23,608	)
Repurchase of common shares		(60,482	)		0			0			0		(60,482	)
Dividends paid		(19,466	)		0			0			0		(19,466	)
Issuance of common stock		4,779			0			0			0		4,779
Profit distributions to noncontrolling interests		0			0			(38,497	)		0		(38,497	)
Changes in intercompany balances with affiliates, net		387,727			(240,087	)		(147,640	)		0		0

Net cash (used in) provided by financing activities		4,990			(241,529	)		(184,152	)		0		(420,691	)

Increase (decrease) in cash and cash equivalents		0			11,836			(81	)		0		11,755
Cash and cash equivalents, beginning of period		0			21,385			8,089			0		29,474

Cash and cash equivalents, end of period	$	0		$	33,221		$	8,008		$	0	$	41,229


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	(139,226	)	$	342,633		$	297,937		$	0	$	501,344


Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(186,967	)		(52,307	)		0		(239,274	)
Acquisition of property and businesses		0			(1,958,904	)		606			0		(1,958,298	)
Proceeds received from sale of assets and businesses		0			21,460			0			0		21,460
Costs incurred for purchase and development of electronic health records application		0			(17,971	)		0			0		(17,971	)

Net cash used in investing activities		0			(2,142,382	)		(51,701	)		0		(2,194,083	)


Cash Flows from Financing Activities:
Reduction of long-term debt		(1,388,679	)		(753	)		(2,654	)		0		(1,392,086	)
Additional borrowings		3,266,146			0			0			0		3,266,146
Financing costs		(101,815	)		0			0			0		(101,815	)
Repurchase of common shares		(11,528	)		0			0			0		(11,528	)
Dividends paid		(19,422	)		0			0			0		(19,422	)
Issuance of common stock		3,594			0			0			0		3,594
Profit distributions to noncontrolling interests		0			0			(32,456	)		0		(32,456	)
Proceeds from sale of noncontrolling interest in majority owned business		0			0			600			0		600
Changes in intercompany balances with affiliates, net		(1,609,070	)		1,816,520			(207,450	)		0		0

Net cash (used in) provided by financing activities		139,226			1,815,767			(241,960	)		0		1,713,033

Increase (decrease) in cash and cash equivalents		0			16,018			4,276			0		20,294
Cash and cash equivalents, beginning of period		0			5,367			3,813			0		9,180

Cash and cash equivalents, end of period	$	0		$	21,385		$	8,089		$	0	$	29,474


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by operating activities	$	(130,200	)	$	331,518		$	339,944		$	0	$	541,262
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(282,868	)		(96,880	)		0		(379,748	)
Acquisition of property and businesses		0			(12,499	)		0			0		(12,499	)
Proceeds received from sale of assets and businesses		0			8,952			818			0		9,770
Costs incurred for purchase and development of electronic health records application		0			(7,957	)		0			0		(7,957	)

Net cash used in investing activities		0			(294,372	)		(96,062	)		0		(390,434	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(58,779	)		(4,297	)		(3,423	)		0		(66,499	)
Additional borrowings		25,408			661			0			0		26,069
Repurchase of common shares		(63,288	)		0			0			0		(63,288	)
Dividends paid		(16,706	)		0			0			0		(16,706	)
Issuance of common stock		3,290			0			0			0		3,290
Profit distributions to noncontrolling interests		0			0			(29,866	)		0		(29,866	)
Capital contributions from noncontrolling interests		0			0			121			0		121
Purchase of noncontrolling interest in majority owned businesses		0			(229	)		0			0		(229	)
Changes in intercompany balances with affiliates, net		240,275			(30,129	)		(210,146	)		0		0

Net cash (used in) provided by financing activities		130,200			(33,994	)		(243,314	)		0		(147,108	)

Increase (decrease) in cash and cash equivalents		0			3,152			568			0		3,720
Cash and cash equivalents, beginning of period		0			2,215			3,245			0		5,460

Cash and cash equivalents, end of period	$	0		$	5,367		$	3,813		$	0	$	9,180

Business And Summary Of Significant Accounting Policies (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Accounts, Notes, Loans and Financing Receivable [Line Items]
Amount charged at established rates for charity care and uninsured discounts	$ 956,000,000	$ 807,000,000	$ 671,000,000
Percentage of uninsured discount extended for unqualified charity patients	20.00%
Establishment of partial reserve in the allowance for doubtful accounts for self-pay balances outstanding from the date of discharge, in days	60
Establishment of fully reserve for self-pay balances outstanding from the date of discharge, in days	90
Establishment of fully reserve in the allowance for doubtful accounts for third party liability accounts from the date of discharge, in days	180
Net of allowance for doubtful accounts	253,000,000	249,000,000
Capitalize interest expense	400,000	7,600,000	11,600,000
Depreciation expense	268,500,000	202,800,000	184,600,000
Other intangible assets, net of accumulated amortization	97,000,000	100,000,000
Amount of estimated future payments related to physician-related contractual commitments	7,000,000	8,000,000
Amount of potential future financial obligations	6,000,000
Amount of potential future financial obligations year one	4,000,000
Amount of potential future financial obligations year two	2,000,000
Workers' compensation reserves analyses		4,000,000	7,000,000
Acute care facilities with outside owners holding noncontrolling minority interest	5
Redeemable noncontrolling interest balances	218,000,000	212,000,000
Noncontrolling interest balances	51,000,000	45,000,000
Net excess tax benefits generated	0	0	0
Anti-dilutive weighted average stock options excluded from computation of earnings per share	1,400,000	1,000	3,600,000
Charity care and uninsured discounts based on charges at established rates	956,000,000	807,000,000
Estimated cost of providing the charity services	173,000,000	158,000,000
Medicare And Medicaid [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of revenue	37.00%	38.00%	38.00%
Care Entities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of revenue	43.00%	46.00%	46.00%
Las Vegas, Nevada [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of revenue	16.00%	21.00%	22.00%
Illinois [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	54,000,000
Receivables due outstanding in excess of 60 days	$ 41,000,000
Receivables days in excess	60
McAllen/Edinburg, Texas [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of revenue	5.00%	6.00%	7.00%
Acute Care Facility [Member] \| Las Vegas, Nevada [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of noncontrolling, minority ownership interests held by outside owners	28.00%
Acute Care Facility [Member] \| Washington, D.C. [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of noncontrolling, minority ownership interests held by outside owners	20.00%
Acute Care Facility [Member] \| Laredo, Texas [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of noncontrolling, minority ownership interests held by outside owners	11.00%
Behavioral Health Care Facility [Member] \| Philadelphia, Pennsylvania [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Percentage of noncontrolling, minority ownership interests held by outside owners	20.00%
Buildings And Improvements [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Property and equipment, useful lives, minimum years	20
Property and equipment, useful lives, maximum years	40
Equipment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Property and equipment, useful lives, minimum years	3
Property and equipment, useful lives, maximum years	15

Business And Summary Of Significant Accounting Policies (Schedule Of Changes In The Carrying Amount Of Goodwill) (Details) (USD $)
In Thousands, unless otherwise specified

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Goodwill [Line Items]

Goodwill, Beginning Balance

$ 2,589,914

$ 732,685

Goodwill acquired during the period

1,895,786

Goodwill divested during the period

(871)

Adjustments to goodwill

37,688

^[1]

(37,686)

^[2]

Goodwill, Ending Balance

2,627,602

2,589,914

Acute Care Services [Member]

Goodwill [Line Items]

Goodwill, Beginning Balance

389,484

389,845

Goodwill acquired during the period

510

Goodwill divested during the period

(871)

Adjustments to goodwill

^[1]

^[2]

Goodwill, Ending Balance

389,484

Behavioral Health Services [Member]

Goodwill [Line Items]

Goodwill, Beginning Balance

2,200,430

342,840

Goodwill acquired during the period

1,895,276

Adjustments to goodwill

37,688

^[1]

(37,686)

^[2]

Goodwill, Ending Balance

$ 2,238,118

$ 2,200,430

[1]	Consists of adjustments to prior year purchase price allocations
[2]	The reduction to the Behavioral Health Services' goodwill consists primarily of a reclassification to "assets of facilities held for sale" and represents the goodwill attributable to a legacy facility which we agreed to divest pursuant to our agreement with the Federal Trade Commission.

- Definition

Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 68

-Subparagraph l

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13816-109267

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 72

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-Clause 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 34

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The aggregate amount of goodwill acquired in the period and allocated to the reportable segment. The value is stated at fair value based on the purchase price allocation.

+ References+ Details

- Definition

Write-off of the carrying amount of goodwill associated with all or a portion of a reporting unit that is sold in the period.

+ References+ Details

Business And Summary Of Significant Accounting Policies (Schedule Of Amounts Recognized In AOCI) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Business And Summary Of Significant Accounting Policies [Abstract]
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, beginning balance	$ (5,130)	$ (5,782)
Minimum Pension Liability, beginning balance	(15,009)	(15,471)
Total AOCI, beginning balance	(20,139)	(21,253)
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, Pre tax amount	(37,813)	1,060
Minimum Pension Liability, Pre tax amount	(12,397)	743
Total AOCI, Pre tax amount	(50,210)	1,803
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, Income tax effect	14,483	(408)
Minimum pension liability, income tax effect	4,691	(281)	5,667
Total AOCI, Income tax effect	19,174	(689)
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, Change, net of income tax	(23,330)	652
Minimum Pension Liability, Change, net of income tax	(7,706)	462	9,182
Total AOCI, Change, net of income tax	(31,036)	1,114
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, ending balance	(28,460)	(5,130)	(5,782)
Minimum Pension Liability, ending balance	(22,715)	(15,009)	(15,471)
Total AOCI, ending balance	$ (51,175)	$ (20,139)	$ (21,253)

Business And Summary Of Significant Accounting Policies (Schedule Of Computation Of Basic And Diluted Earnings Per Share) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Business And Summary Of Significant Accounting Policies [Abstract]
Income from continuing operations									$ 448,870	$ 275,795	$ 304,247
Less: Net income attributable to noncontrolling interest									(50,703)	(45,612)	(43,874)
Less: Net income attributable to unvested restricted share grants									(521)	(918)	(1,146)
Net income attributable to UHS - basic and diluted									$ 397,646	$ 229,265	$ 259,227
Weighted average number of common shares-basic									97,199	96,786	97,794
Total basic earnings per share	$ 0.99	$ 0.87	$ 1.06	$ 1.17	$ 0.38	$ 0.57	$ 0.68	$ 0.74	$ 4.09	$ 2.37	$ 2.65
Net effect of dilutive stock options and grants based on the treasury stock method									1,338	1,187	481
Weighted average number of common shares and equivalents-diluted									98,537	97,973	98,275
Total diluted earnings per share	$ 0.98	$ 0.86	$ 1.04	$ 1.15	$ 0.38	$ 0.57	$ 0.67	$ 0.73	$ 4.04	$ 2.34	$ 2.64

Acquisitions And Divestitures (Narrative) (Details) (USD $)	12 Months Ended			1 Months Ended	12 Months Ended			12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2010 Psychiatric Solutions, Inc. [Member]	Dec. 31, 2010 Psychiatric Solutions, Inc. [Member]	Dec. 31, 2009 Psychiatric Solutions, Inc. [Member]	Nov. 15, 2010 Psychiatric Solutions, Inc. [Member]	Dec. 31, 2009 Behavioral Health Care Facilities [Member]	Dec. 31, 2011 Knapp Medical Center [Member]	Dec. 31, 2011 2011 Acquisitions Of Assets And Businesses [Member]
Business Acquisition [Line Items]
Acquisition, total purchase price							$ 3,040,000,000
Acquisition, cash paid				1,958,000,000	1,958,000,000		1,960,000,000	12,000,000	29,000,000	29,000,000
Ownership interest percentage of acquisition	80.00%
Number of acute care hospital beds included in acquisition									226
Divested number of San Juan Capestrano hospital beds	108
Net cash proceeds from divestiture of assets and businesses	68,000,000	21,000,000	10,000,000
Debt assumed on the acquisition of businesses and real property				1,082,000,000	1,082,000,000		1,080,000,000		17,000,000
Previously held minority ownership interest, percentage	100.00%			20.00%	20.00%
Pro forma net revenues					7,300,000,000	7,010,000,000
Pro forma net income attributable to UHS					342,000,000	211,000,000
Pro forma net income attributable to UHS per diluted share					$ 3.47	$ 2.14
Transaction costs incurred						79,000,000
Transaction costs incurred, per diluted share						$ 0.81
Net revenues				$ 227,000,000
Number of beds acquired from behavioral health care facility								72

Acquisitions And Divestitures (Schedule Of Aggregate Net Purchase Price Of The Facilities That Were Allocated To Assets And Liabilities) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2010 Psychiatric Solutions, Inc. [Member]	Nov. 15, 2010 Psychiatric Solutions, Inc. [Member]	Dec. 31, 2009 Behavioral Health Care Facilities [Member]	Dec. 31, 2011 Knapp Medical Center [Member]
Business Acquisition [Line Items]
Working capital, net			$ 60,000		$ 1,000
Assets held for sale			67,000
Property, plant & equipment			932,000		11,000	35,000
Goodwill			1,921,000
Other assets/deposits						11,000
Other assets			132,000
Income tax assets, net of deferred tax liabilities			(14,000)
Debt			(1,082,000)	(1,080,000)		(17,000)
Liabilities held for sale	(2,329)	(3,516)	(1,000)
Redeemable noncontrolling interests	(218,000)	(212,000)	(5,000)
Other liabilities			(52,000)
Cash paid for acquisitions and deposits			$ 1,958,000	$ 1,960,000	$ 12,000	$ 29,000

Acquisitions And Divestitures (Schedule Of Results Of Operations For The Former PSI Facilities, On A Combined Basis, Reflected As Discontinued Operations) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Acquisitions And Divestitures [Abstract]
Net revenues	$ 33,884	$ 4,155
Income from discontinued operations	7,904	859
Gain on divestiture	442
Income from discontinued operations, before income tax expense	8,346	859
Income tax expense	(3,160)	(318)
Income from discontinued operations, net of income tax expense	$ 5,186	$ 541

- Definition

Pretax gain (loss), not previously recognized and resulting from the sale of a business component, which is recognized at the date of sale. A gain (loss) reflects the amount by which the consideration received exceeds (is exceeded by) the net carrying amount (reflecting previous provisions for loss on disposal, if any) of the disposal group.

+ References+ Details

- Definition

Overall income (loss) from a disposal group that is classified as a component of the entity, before income tax, reported as a separate component of income before extraordinary items. Includes the following (before income tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References+ Details

- Definition

Pretax income (loss) from operations of a business component (exclusive of any gain (loss) on disposal, or provision therefore) during the reporting period, until its disposal.

+ References+ Details

- Definition

Tax effect allocated to a disposal group that is classified as a component of the entity reported as a separate component of income before extraordinary items. Includes the tax effects of the following: income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 47

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 46

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32672-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b),(c)

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6909487&loc=d3e38679-109324

+ Details

- Definition

This element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 47

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 15

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 13

-Article 7

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.12)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.14)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Financial Instruments (Details) (USD $)				3 Months Ended						3 Months Ended
Financial Instruments (Details) (USD $)	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2007	Mar. 31, 2011 Interest Rate Cap [Member]	Dec. 31, 2010 Interest Rate Cap [Member]	Dec. 31, 2010 Interest Rate Swaps [Member]	Dec. 31, 2007 Interest Rate Swaps [Member]	Mar. 31, 2011 Forward Starting Interest Rate Cap From December 2011 To December 2012 [Member]	Mar. 31, 2011 Forward Starting Interest Rate Cap From December 2012 To December 2013 [Member]	Mar. 31, 2011 Forward Starting Interest Rate Cap [Member]	Mar. 31, 2011 Forward Starting Interest Rate Swaps [Member]	Mar. 31, 2011 1.91% Forward Starting Interest Rate Swaps [Member]	Mar. 31, 2011 2.50% Forward Starting Interest Rate Swaps [Member]	Mar. 31, 2011 1.96% Forward Starting Interest Rate Swaps [Member]	Mar. 31, 2011 1.32% Forward Starting Interest Rate Swaps [Member]	Dec. 31, 2010 2.38% Forward Starting Interest Rate Swaps [Member]	Dec. 31, 2007 4.76% Forward Starting Interest Rate Swaps [Member]	Dec. 31, 2007 4.87% Forward Starting Interest Rate Swaps [Member]	Dec. 31, 2011 Other Current Liabilities [Member]	Dec. 31, 2010 Other Current Liabilities [Member]	Dec. 31, 2011 Other Noncurrent Liabilities [Member]	Dec. 31, 2010 Other Noncurrent Liabilities [Member]
Derivative [Line Items]
Number of interest rate swaps			2		3	4
Total notional amount of interest rate cash flow hedges				$ 275,000,000	$ 1,000,000,000		$ 150,000,000	$ 450,000,000	$ 400,000,000		$ 425,000,000	$ 225,000,000	$ 100,000,000	$ 25,000,000	$ 75,000,000	$ 600,000,000	$ 75,000,000
Interest rate percentage above which counterparty agrees to pay the difference				2.25%	2.25%					7.00%
Premium paid on interest rate cap				30,000	240,000					740,000
Maturity date of interest rate cash flow hedges				Dec. 01, 2011	Dec. 01, 2011							May 01, 2015	Dec. 01, 2014	Dec. 01, 2013	Dec. 01, 2012	May 01, 2015	Oct. 01, 2012	Oct. 01, 2011
Number of additional forward starting interest rate swaps											6
Fixed rate payable on interest rate swap												1.91%	2.50%	1.96%	1.32%	2.38%	4.76%	4.87%
Reduction in the notional amount of interest rate swap																	50,000,000
Fair value of our interest rate swaps, liability	$ 48,000,000	$ 10,000,000																	$ 4,000,000	$ 2,000,000	$ 44,000,000	$ 8,000,000

Long-Term Debt (Narrative) (Details) (USD $)	1 Months Ended		12 Months Ended									0 Months Ended		12 Months Ended	0 Months Ended	12 Months Ended		12 Months Ended		12 Months Ended							1 Months Ended	12 Months Ended				12 Months Ended							12 Months Ended
Long-Term Debt (Narrative) (Details) (USD $)	Mar. 15, 2011	Oct. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Nov. 15, 2010	Dec. 31, 2009	Dec. 31, 2011 ABR-Based Loans [Member]	Oct. 31, 2010 Commercial Paper Rate Plus [Member]	Dec. 31, 2011 Credit Agreement And Securitization [Member]	Dec. 31, 2010 Credit Agreement And Securitization [Member]	Dec. 31, 2009 Credit Agreement And Securitization [Member]	Oct. 29, 2010 7.00% Senior Unsecured Notes [Member]	Sep. 29, 2010 7.00% Senior Unsecured Notes [Member]	Dec. 31, 2011 7.00% Senior Unsecured Notes [Member]	Jun. 30, 2006 7.125% Coupon Rate Senior Notes Due 2016 [Member]	Dec. 31, 2011 7.125% Coupon Rate Senior Notes Due 2016 [Member]	Jun. 30, 2008 7.125% Coupon Rate Senior Notes Due 2016 [Member]	Dec. 31, 2011 6.75% Coupon Rate Senior Notes [Member]	Dec. 31, 2001 6.75% Coupon Rate Senior Notes [Member]	Dec. 31, 2011 Matures October 1, 2014 [Member]	Dec. 31, 2011 Matures October 1, 2015 [Member]	Dec. 31, 2011 Matures October 1, 2016 [Member]	Dec. 31, 2011 Revolving Credit Facility [Member]	Nov. 15, 2010 Revolving Credit Facility [Member]	Dec. 31, 2011 Letters Of Credit [Member]	Nov. 15, 2010 Letters Of Credit [Member]	Mar. 31, 2011 Term Loan B Facility [Member]	Dec. 31, 2011 Term Loan B Facility [Member]	Dec. 31, 2010 Term Loan B Facility [Member]	Nov. 15, 2010 Term Loan B Facility [Member]	Dec. 31, 2011 Term Loan B Facility [Member] Eurodollar-Based Loans [Member]	Dec. 31, 2011 Term Loan B Facility [Member] Minimum [Member]	Dec. 31, 2011 Term Loan B Facility [Member] Maximum [Member]	Dec. 31, 2011 Term Loan A Facility [Member]	Dec. 31, 2010 Term Loan A Facility [Member]	Nov. 15, 2010 Term Loan A Facility [Member]	Dec. 31, 2011 Short-Term, On-Demand Credit Facility [Member]	Dec. 31, 2011 Term Loan A Facility [Member] Eurodollar-Based Loans [Member]	Dec. 31, 2011 Term Loan A Facility [Member] Minimum [Member] One Month Eurodollar Rate Plus Index Based Loans [Member]	Dec. 31, 2011 Term Loan A Facility [Member] Minimum [Member] One, Two, Three, Six Month Eurodollar Rate Plus Index Based Loans [Member]	Dec. 31, 2011 Term Loan A Facility [Member] Maximum [Member] One Month Eurodollar Rate Plus Index Based Loans [Member]	Dec. 31, 2011 Term Loan A Facility [Member] Maximum [Member] One, Two, Three, Six Month Eurodollar Rate Plus Index Based Loans [Member]	Dec. 31, 2011 Term Loan B Facility [Member]	Dec. 31, 2011 Term Loan B Facility [Member] Minimum [Member] One Month Eurodollar Rate Plus Index Based Loans [Member]	Dec. 31, 2011 Term Loan B Facility [Member] Minimum [Member] One, Two, Three, Six Month Eurodollar Rate Plus Index Based Loans [Member]	Dec. 31, 2011 Term Loan B Facility [Member] Maximum [Member] One Month Eurodollar Rate Plus Index Based Loans [Member]	Dec. 31, 2011 Term Loan B Facility [Member] Maximum [Member] One, Two, Three, Six Month Eurodollar Rate Plus Index Based Loans [Member]
Debt Instrument [Line Items]
Line of credit facility amount outstanding					$ 3,450,000,000																			$ 800,000,000		$ 125,000,000		$ 1,436,772,000	$ 1,576,500,000	$ 1,600,000,000				$ 1,020,375,000	$ 1,042,322,000	$ 1,050,000,000
Variable interest rate								0.475%
Principal payments																											125,000,000	16,000,000						26,000,000
Line of credit facility, maturity date																												November 15, 2016						November 15, 2015
Credit agreement, interest rate description	Upon the effectiveness of the Amendment, borrowings under the Credit Agreement bear interest at the ABR rate which is defined as the rate per annum equal to, at our election (1) the greatest of (a) the lender's prime rate, (b) the weighted average of the federal funds rate, plus 0.5% and (c) one month Eurodollar rate plus 1%, in each case, plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 0.50% to 1.25% for revolving credit and Term Loan A borrowings and 1.75% to 2.00% for Term Loan B borrowings or (2) the one, two, three or six month Eurodollar rate (at our election), plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 1.50% to 2.25% for revolving credit and Term Loan A borrowings and ranging from 2.75% to 3.00% for Term Loan B borrowings. The current applicable margins are 0.75% for ABR-based loans, 1.75% for Eurodollar-based loans under the revolving credit and Term Loan A facilities and 2.75% under the Term Loan B facility	The interest rate on the borrowings is based on the commercial paper rate plus a spread of 0.475% and there is a facility fee of 0.375% required on 102% on the Commitments
Credit facility fee, percentage		0.375%
Rate adjustment to weighted average federal funds rate for credit facility borrowings																							0.50%
Rate adjustment to one month Eurodollar rate on credit facility borrowings																							1.00%
Current applicable margins							0.75%																								2.75%							1.75%
Consolidated leverage ratio																																							0.50%	1.50%	1.25%	2.25%		1.75%	2.75%	2.00%	3.00%
Fee paid in accordance with the terms of the credit agreement																																											1.00%
Accounts receivable securitization program credit facility, borrowing capacity		240,000,000
Accounts receivable securitization program credit facility original amount		200,000,000
Accounts receivable securitization program credit facility, maturity date		Oct. 25, 2013
Accounts receivable securitization program credit facility, amount outstanding			240,000,000
Available borrowing capacity									482,000,000
Amount outstanding																									69,000,000												9,000,000
Outstanding borrowings under a short-term, on-demand credit facility			9,000,000
Senior notes, issued													250,000,000		250,000,000		150,000,000		200,000,000
Interest rate													7.00%		7.125%		7.125%		6.75%
Senior notes, maturity date														October 1, 2018		June 30, 2016		November 15, 2011		October 1, 2014	October 1, 2015	October 1, 2016
Treasury rate plus, basis points													50
Unsecured notes make-whole redemption price, percent																				103.50%	101.75%	100.00%
Average amounts outstanding under Credit Agreement, Prior Credit Agreement, demand notes and accounts receivable securitization programs									2,900,000,000	610,000,000	287,000,000
Maximum amounts outstanding at any month-end									3,030,000,000	3,110,000,000	356,000,000
Effective interest rate			4.60%	5.00%		3.90%			3.40%	3.40%	1.70%
Commitment percentage for facility fee		102.00%
Minimum Eurodollar rate for the term loan B facility																																1.00%	1.50%
Senior notes, repayment terms												payable semiannually in arrears on April 1st and October 1st of each year.			Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year
Fair value of debt			$ 3,700,000,000	$ 3,960,000,000
Ownership percentage in directly owned subsidiary			100.00%

Long-Term Debt (Summary Of Long-Term Debt) (Details) (USD $) In Thousands, unless otherwise specified								12 Months Ended						12 Months Ended		12 Months Ended		12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Nov. 15, 2010	Dec. 31, 2011 Parent [Member]	Dec. 31, 2010 Parent [Member]	Dec. 31, 2011 Notes Payable And Mortgages Payable [Member]	Dec. 31, 2010 Notes Payable And Mortgages Payable [Member]	Dec. 31, 2011 Revenue Bonds [Member]	Dec. 31, 2010 Revenue Bonds [Member]	Dec. 31, 2011 Accounts Receivable Securitization Program [Member]	Dec. 31, 2010 Accounts Receivable Securitization Program [Member]	Dec. 31, 2011 6.75% Senior Secured Notes Due 2011 [Member]	Dec. 31, 2010 6.75% Senior Secured Notes Due 2011 [Member]	Dec. 31, 2011 7.125% Senior Secured Notes due 2016 [Member]	Dec. 31, 2010 7.125% Senior Secured Notes due 2016 [Member]	Dec. 31, 2011 7.00% Senior Unsecured Notes due 2018 [Member]	Dec. 31, 2010 7.00% Senior Unsecured Notes due 2018 [Member]	Dec. 31, 2011 Term Loans With Varying Maturities [Member]	Dec. 31, 2011 Revolving Credit And Demand Notes [Member]	Dec. 31, 2010 Revolving Credit And Demand Notes [Member]	Dec. 31, 2011 Term Loan A Facility [Member]	Dec. 31, 2010 Term Loan A Facility [Member]	Nov. 15, 2010 Term Loan A Facility [Member]	Dec. 31, 2011 Term Loan B Facility [Member]	Dec. 31, 2010 Term Loan B Facility [Member]	Nov. 15, 2010 Term Loan B Facility [Member]
Debt Instrument [Line Items]
Notes payable and Mortgages payable (including obligations under capitalized leases of $9,982 in 2011 and $11,962 in 2010) and term loans with varying maturities through 2038; weighted average interest at 6.1% in 2011 and 6.5% in 2010 (see Note 7 regarding capitalized leases)						$ 51,841	$ 49,355
Line of credit facility amount outstanding			3,450,000																249,600	187,500	1,020,375	1,042,322	1,050,000	1,436,772	1,576,500	1,600,000
Revenue bonds, interest at floating rates of 0.2% and 0.3% at December 31, 2011 and 2010, respectively, with varying maturities through 2015								5,300	5,300
Accounts receivable securitization program	240,000									240,000	204,000
Senior Notes													200,550	400,019	400,024	250,000	250,000
Long-term debt	3,653,907	3,915,551
Less-Amounts due within one year	(2,479)	(3,449)
Long-term debt, net	3,651,428	3,912,102		3,594,182	3,855,810
Obligations under capital lease						9,982	11,962
Weighted average interest						6.10%	6.50%
Unamortized discount													9								6,103			19,500
Interest at floating rates								0.20%	0.30%
Fair market value adjustments													559
Unamortized net premium														$ 19	$ 24
Interest rate												6.75%		7.125%		7.00%
Debt instruments, maturity date								2015						2016		2018		2038

Long-Term Debt (Schedule Of Aggregate Maturities) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Long-Term Debt [Abstract]
2012	$ 2,479	$ 3,449
2013	242,638
2014	3,970
2015	1,290,085
2016	1,840,693
Later	274,042
Total	$ 3,653,907	$ 3,915,551

- Definition

Including current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date. May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.

+ References+ Details

Common Stock (Narrative) (Details) (USD $)	1 Months Ended	3 Months Ended								12 Months Ended															12 Months Ended				12 Months Ended											12 Months Ended				12 Months Ended				12 Months Ended					12 Months Ended				12 Months Ended
Common Stock (Narrative) (Details) (USD $)	Nov. 30, 2009	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2011 Class B Common [Member]	Dec. 31, 2011 Outstanding Stock Options [Member]	Dec. 31, 2010 Outstanding Stock Options [Member]	Dec. 31, 2009 Outstanding Stock Options [Member]	Dec. 31, 2011 Restricted Stock [Member]	Dec. 31, 2010 Restricted Stock [Member]	Dec. 31, 2009 Restricted Stock [Member]	Dec. 31, 2011 Amended And Restated 1992 Stock Option Plan [Member]	Dec. 31, 2011 Stock Incentive Plan [Member]	Dec. 31, 2010 Stock Incentive Plan [Member]	Dec. 31, 2009 Stock Incentive Plan [Member]	Dec. 31, 2011 Stock Incentive Plan [Member] Class B Common [Member]	Dec. 31, 2011 2001 Plan [Member]	Dec. 31, 2010 2001 Plan [Member]	Dec. 31, 2009 2001 Plan [Member]	Dec. 31, 2010 2001 Plan [Member] Class B Common [Member]	Dec. 31, 2011 2010 Plan [Member]	Dec. 31, 2011 Employee Stock Purchase Plan [Member]	Dec. 31, 2010 Employee Stock Purchase Plan [Member]	Dec. 31, 2009 Employee Stock Purchase Plan [Member]	Dec. 31, 2011 Long-Term Incentive Plans [Member]	Dec. 31, 2010 Long-Term Incentive Plans [Member]	Dec. 31, 2009 Long-Term Incentive Plans [Member]	Dec. 31, 2011 Chief Executive Officer ("CEO") And Chairman Of The Board [Member]	Dec. 31, 2011 Chief Executive Officer ("CEO") And Chairman Of The Board [Member] Class B Common Stock 2010 [Member]	Dec. 31, 2010 Chief Executive Officer ("CEO") And Chairman Of The Board [Member] Class B Common Stock 2010 [Member]	Mar. 31, 2010 Chief Executive Officer ("CEO") And Chairman Of The Board [Member] Class B Common Stock 2010 [Member]	Dec. 31, 2011 Chief Executive Officer [Member] Class B Common Stock 2009 [Member]	Dec. 31, 2010 Chief Executive Officer [Member] Class B Common Stock 2009 [Member]	Dec. 31, 2009 Chief Executive Officer [Member] Class B Common Stock 2009 [Member]	Mar. 31, 2009 Chief Executive Officer [Member] Class B Common Stock 2009 [Member]	Dec. 31, 2011 Chief Executive Officer [Member] Class B Common Stock 2008 [Member]	Dec. 31, 2010 Chief Executive Officer [Member] Class B Common Stock 2008 [Member]	Dec. 31, 2009 Chief Executive Officer [Member] Class B Common Stock 2008 [Member]	Mar. 31, 2008 Chief Executive Officer [Member] Class B Common Stock 2008 [Member]	Dec. 31, 2011 Chief Executive Officer [Member] Class B Common Stock 2007 [Member]	Dec. 31, 2010 Chief Executive Officer [Member] Class B Common Stock 2007 [Member]	Dec. 31, 2009 Chief Executive Officer [Member] Class B Common Stock 2007 [Member]	Dec. 31, 2008 Chief Executive Officer [Member] Class B Common Stock 2007 [Member]	Dec. 31, 2007 Chief Executive Officer [Member] Class B Common Stock 2007 [Member]	Dec. 31, 2011 Various Employees [Member] Class B Common Stock 2007 [Member]	Dec. 31, 2010 Various Employees [Member] Class B Common Stock 2007 [Member]	Dec. 31, 2009 Various Employees [Member] Class B Common Stock 2007 [Member]	Dec. 31, 2007 Various Employees [Member] Class B Common Stock 2007 [Member]	Dec. 31, 2010 Various Officers And Employees [Member] Class B Common Stock 2006 [Member]	Dec. 31, 2009 Various Officers And Employees [Member] Class B Common Stock 2006 [Member]	Dec. 31, 2006 Various Officers And Employees [Member] Class B Common Stock 2006 [Member]
Percentage of stock dividend	100.00%
Dividends declared and paid, per share										$ 0.20	$ 0.2	$ 0.17
Dividends declared and paid										$ 19,000,000	$ 19,000,000	$ 17,000,000
Stock repurchase programs authorized to purchase, shares		10,000,000								10,000,000
Excess tax benefit										0	0	0
Compensation cost recognized										18,200,000	16,800,000	13,100,000		15,800,000	13,300,000	9,900,000	2,000,000	3,100,000	2,800,000										198,000	461,000	339,000	316,000	2,400,000	3,500,000	3,200,000		375,000	355,000		556,000	556,000	482,000		375,000	375,000	375,000		333,000	375,000				120,000	135,000	135,000		1,300,000	1,500,000
Compensation cost recognized, pre-tax charge														15,800,000	13,300,000	9,900,000
Compensation cost recognized, after-tax														9,800,000	8,300,000	6,200,000	1,200,000	2,000,000	1,800,000										947,000
Stock-based compensation plans expired																				July of 2005						March, 2010
Earnings per share diluted		$ 0.98	$ 0.86	$ 1.04	$ 1.15	$ 0.38	$ 0.57	$ 0.67	$ 0.73	$ 4.04	$ 2.34	$ 2.64		$ 0.10	$ 0.08	$ 0.06
Shares reserved													6,000,000											23,000,000				2,400,000
Stock options granted during period (net of cancellations)										2,894,500	94,000	2,635,000									2,747,500	82,750	2,400,500
Weighted-average grant date fair value of option granted																					$ 11.62	$ 7.84	$ 7.93
Percentage of discount provided to eligible employees for purchase of shares under employee stock purchase plan										10.00%
Stock issued under employee stock purchase plan																														98,366	94,955	138,870
Stock issued during period, net of cancellations										700,000																1,200,000
Fully vested shares										1,757,500															78,133	313,770	31,638									12,368				27,462	27,463			15,546	15,548	15,548		15,341	15,341	15,340	15,340
Issuance of restricted shares approved, shares													21,500																										49,472				109,850				62,190					61,362				22,250			247,000
Restricted shares price, per share													$ 53.21																										$ 30.32				$ 20.26				$ 24.12					$ 24.45				$ 29.62			$ 25.71
Issuance of restricted shares, value													1,100,000																										1,500,000				2,200,000				1,500,000					1,500,000				659,000			6,400,000
Estimated compensation cost																																					770,000			630,000				15,000									42,000
Total in-the-money value of all stock options exercised during the year										$ 28,900,000	$ 26,800,000	$ 10,200,000
Issuance upon conversion of shares													31,167,268

Common Stock (Schedule Of Information Related To Stock Repurchase Programs) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Class of Stock [Line Items]

Additional Shares Authorized For Repurchase

Total number of shares purchased

4,478,428

^[1]

Average price paid per share for forfeited restricted shares

$ 0.01

Total number of shares purchased as part of publicly announced programs

4,457,428

Average price paid per share for shares purchased as part of publicly announced program

$ 30.35

Aggregate purchase price paid

$ 135,298

Maximum number of shares that may yet be purchased under the program

4,713,548

Restricted shares forfeited under stock purchase plan

8,000

13,000

Stock Repurchase Programs 2009 [Member]

Class of Stock [Line Items]

Additional Shares Authorized For Repurchase

Total number of shares purchased

2,574,209

^[1]

Average price paid per share for forfeited restricted shares

$ 0.01

Total number of shares purchased as part of publicly announced programs

2,561,209

Average price paid per share for shares purchased as part of publicly announced program

$ 24.71

Aggregate purchase price paid

63,288

Maximum number of shares that may yet be purchased under the program

2,152,339

Stock Repurchase Programs 2010 [Member]

Class of Stock [Line Items]

Additional Shares Authorized For Repurchase

Total number of shares purchased

301,933

^[1]

Average price paid per share for forfeited restricted shares

$ 0.01

Total number of shares purchased as part of publicly announced programs

293,933

Average price paid per share for shares purchased as part of publicly announced program

$ 39.22

Aggregate purchase price paid

11,528

Maximum number of shares that may yet be purchased under the program

1,858,406

Stock Repurchase Programs 2011 [Member]

Class of Stock [Line Items]

Additional Shares Authorized For Repurchase

Total number of shares purchased

1,602,286

^[1]

Average price paid per share for forfeited restricted shares

$ 0.01

Total number of shares purchased as part of publicly announced programs

1,602,286

Average price paid per share for shares purchased as part of publicly announced program

$ 37.75

Aggregate purchase price paid

$ 60,482

Maximum number of shares that may yet be purchased under the program

256,120

[1]	During 2010 and 2009, there were 8,000 and 13,000, respectively, of restricted shares that were forfeited by former employees pursuant to the terms of our restricted stock purchase plan which are included in the total number of shares purchased. No such forfeitures occurred during 2011.

- Definition

The number of shares purchased on the open market during the period for issuance to employees under the plan.

+ References+ Details

- Definition

Number of shares related to Restricted Stock Award forfeited during the period.

+ References+ Details

Common Stock (Schedule Of Weighted-Average Assumptions Fair Value Of Option Grants) (Details) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Common Stock [Abstract]
Volatility	$ 29.00%	$ 27.00%	$ 28.00%
Interest rate	$ 2.00%	$ 3.00%	$ 3.00%
Expected life (years)	$ 3.5	$ 3.6	$ 3.6
Forfeiture rate	$ 9.00%	$ 10.00%	$ 10.00%
Dividend yield	$ 0.70%	$ 0.70%	$ 0.70%

- Definition

The period of time an equity-based award is expected to be outstanding. An equity-based award's expected term is generally determined based on, among other factors, the instrument's contractual term and the effects of employees' expected exercise and post-vesting employment termination behavior.

+ References+ Details

Common Stock (Schedule Of Stock Option Activity) (Details) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2010 31.70 - $16.22 [Member]	Dec. 31, 2009 31.70 - $16.22 [Member]	Dec. 31, 2008 31.70 - $16.22 [Member]	Dec. 31, 2009 31.18 - $31.18 [Member]	Dec. 31, 2009 29.89 - $16.22 [Member]	Dec. 31, 2010 32.28 - $30.32 [Member]	Dec. 31, 2011 31.18 - $16.22 [Member]	Dec. 31, 2010 31.18 - $16.22 [Member]	Dec. 31, 2011 32.28 - $16.22 [Member]	Dec. 31, 2010 32.28 - $16.22 [Member]	Dec. 31, 2011 54.79 -$38.12 [Member]	Dec. 31, 2011 46.97 -$16.22 [Member]	Dec. 31, 2011 54.79 -$16.22 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Option, Number of shares, beginning balance	6,594,950	8,802,450	8,116,326
Granted, Number of Shares	2,894,500	94,000	2,635,000
Exercised, Number of Shares	(1,563,255)	(2,000,250)	(1,582,376)
Cancelled, Number of Shares	(367,250)	(301,250)	(366,500)
Outstanding Option, Number of shares, ending balance	7,558,945	6,594,950	8,802,450
Outstanding Option, Average Option Price, beginning balance	$ 25.16	$ 25.03	$ 22.68
Granted, Average Option Price	$ 43.66	$ 30.40	$ 31.18
Exercised, Average Option Price	$ 26.38	$ 24.87	$ 23.71
Cancelled, Average Option Price	$ 32.60	$ 24.91	$ 22.84
Outstanding Option, Average Option Price, ending balance	$ 31.63	$ 25.16	$ 25.03
Outstanding options vested and exercisable, Number of Shares	2,979,945
Outstanding options vested and exercisable, Average Option Price	$ 23.82
Range, High				$ 31.70	$ 31.70	$ 31.70	$ 31.18	$ 29.89	$ 32.28	$ 31.18	$ 31.18	$ 32.28	$ 32.28	$ 54.79	$ 46.97	$ 54.79
Range, Low				$ 16.22	$ 16.22	$ 16.22	$ 31.18	$ 16.22	$ 30.32	$ 16.22	$ 16.22	$ 16.22	$ 16.22	$ 38.12	$ 16.22	$ 16.22

Common Stock (Schedule Of Information About Unvested Options) (Details) (USD $)	12 Months Ended
	Dec. 31, 2011
Common Stock [Abstract]
Unvested options, Shares, beginning balance	3,799,250
Granted, Shares	2,894,500
Vested, Shares	(1,757,500)
Cancelled, Shares	(357,250)
Unvested options, Shares, ending balance	4,579,000
Unvested options, Weighted Average Grant Date Fair Value Per Share, beginning balance	$ 5.80
Granted, Weighted Average Grant Date Fair Value Per Share	$ 11.62
Vested, Weighted Average Grant Date Fair Value Per Share	$ 5.26
Canceled, Weighted Average Grant Date Fair Value Per Share	$ 8.19
Unvested options, Weighted Average Grant Date Fair Value Per Share, ending balance	$ 9.50

- Definition

The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References+ Details

- Definition

The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.

+ References+ Details

- Definition

The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.

+ References+ Details

- Definition

The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.

+ References+ Details

Common Stock (Schedule Of Information About All Outstanding Options And Exercisable Options) (Details) (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Common Stock [Abstract]
Number, Options Outstanding	7,558,945	6,594,950	8,802,450	8,116,326
Weighted average exercise price, Options Outstanding	$ 31.63	$ 25.16	$ 25.03	$ 22.68
Aggregate intrinsic value, Options Outstanding	$ 67,870,455
Weighted average remaining contractual life, Options Outstanding	2.8
Number, Options Exercisable	2,979,945
Weighted Average Exercise Price, Options Exercisable	$ 23.82
Aggregate intrinsic value, Options Exercisable	$ 44,833,019
Weighted average remaining contractual life, Options Exercisable	1.8

- Definition

The number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options.

+ References+ Details

Common Stock (Schedule Of Weighted Average Remaining Contractual Life For Options Outstanding And Weighted Average Exercise Price Per Share For Exercisable Options) (Details) (USD $)

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options Outstanding, Shares

7,558,945

6,594,950

8,802,450

8,116,326

Options Outstanding, Weighted Average Exercise Price Per Share

$ 31.63

$ 25.16

$ 25.03

$ 22.68

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

2.8

Exercisable Options, Shares

2,979,945

Weighted average exercise price per share, Options Exercisable

$ 23.82

Expected to Vest Options , Shares

4,160,480

^[1]

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 36.71

^[1]

Weighted average forfeiture rate

9.14%

$16.22 - $24.45 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options Outstanding, Shares

2,642,825

Options Outstanding, Weighted Average Exercise Price Per Share

$ 19.56

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

1.5

Exercisable Options, Shares

2,050,825

Weighted average exercise price per share, Options Exercisable

$ 20.53

Expected to Vest Options , Shares

537,891

^[1]

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 16.22

^[1]

Range, Low

$ 16.22

Range, High

$ 24.45

$25.32 - $29.26 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options Outstanding, Shares

29,500

Options Outstanding, Weighted Average Exercise Price Per Share

$ 26.80

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

1.1

Exercisable Options, Shares

17,750

Weighted average exercise price per share, Options Exercisable

$ 26.59

Expected to Vest Options , Shares

10,676

^[1]

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 27.12

^[1]

Range, Low

$ 25.32

Range, High

$ 29.26

$29.60 - $32.28 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options Outstanding, Shares

2,139,120

Options Outstanding, Weighted Average Exercise Price Per Share

$ 31.15

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

2.9

Exercisable Options, Shares

911,370

Weighted average exercise price per share, Options Exercisable

$ 31.16

Expected to Vest Options , Shares

1,115,534

^[1]

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 31.14

^[1]

Range, Low

$ 29.60

Range, High

$ 32.28

$38.12 - $43.67 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options Outstanding, Shares

2,728,000

Options Outstanding, Weighted Average Exercise Price Per Share

$ 43.59

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

4.1

Expected to Vest Options , Shares

2,478,661

^[1]

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 43.59

^[1]

Range, Low

$ 38.12

Range, High

$ 43.67

$46.79 - $54.79 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options Outstanding, Shares

19,500

Options Outstanding, Weighted Average Exercise Price Per Share

$ 52.99

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

4.3

Expected to Vest Options , Shares

17,718

^[1]

Expected to Vest Options, Weighted Average Exercise Price Per Share

$ 52.99

^[1]

Range, Low

$ 46.79

Range, High

$ 54.79

[1]	Assumes a weighted average forfeiture rate of 9.14%.

Income Taxes (Narrative) (Details) (USD $)	12 Months Ended
Income Taxes (Narrative) (Details) (USD $)	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Taxes [Line Items]
Unfavorable discrete tax items		$ 4,000,000
Charge incurred from life insurance agreements		9,000,000
Favorable discrete tax items	1,000,000	4,000,000
Future taxable income, amount	881,000,000
Deferred state tax benefit (net of the federal benefit)	5,800,000	1,704,000	2,177,000
Net operating losses	52,506,000	46,338,000
Deferred federal and state tax benefit	25,000,000	51,000,000
Valuation allowances	39,000,000	28,000,000
Increase in estimated liabilities for uncertain tax positions due to tax positions taken in current years	750,000	1,219,000	750,000
Increase in estimated liabilities for uncertain tax positions due to tax positions taken in the prior years	419,000	2,076,000	1,245,000
Decrease in estimated liabilities for uncertain tax positions due to the lapse of the statute of limitations	2,000,000
Impact of unrecognized tax benefits, if recognized	5,000,000	5,000,000
Accrued interest and penalties	1,000,000	1,000,000
Period of expiration of the statute of limitations for certain jurisdictions	within the next twelve months
Increase in estimated liabilities for uncertain tax positions	1,000,000	3,000,000
Minimum [Member]
Income Taxes [Line Items]
Foreign and U.S. state and local jurisdictions have statutes of limitations, in years	3
Maximum [Member]
Income Taxes [Line Items]
Foreign and U.S. state and local jurisdictions have statutes of limitations, in years	4
Net Operating Losses [Member]
Income Taxes [Line Items]
Increase in valuation allowance	11,000,000
Foreign Net Operating Losses [Member]
Income Taxes [Line Items]
Increase in valuation allowance	3,000,000	4,000,000
State [Member]
Income Taxes [Line Items]
Deferred state tax benefit (net of the federal benefit)	44,000,000
State [Member] \| Minimum [Member]
Income Taxes [Line Items]
Net operating loss carryforwards expiration date	2012
State [Member] \| Maximum [Member]
Income Taxes [Line Items]
Net operating loss carryforwards expiration date	2031
Psychiatric Solutions, Inc. [Member]
Income Taxes [Line Items]
Unfavorable discrete tax items		5,000,000
Deferred federal tax benefits	1,000,000
Deferred foreign tax benefit	3,000,000
Psychiatric Solutions, Inc. [Member] \| Federal [Member]
Income Taxes [Line Items]
Net operating loss carryforwards expiration date	2022
Net operating losses	2,000,000
Psychiatric Solutions, Inc. [Member] \| Foreign [Member]
Income Taxes [Line Items]
Net operating loss carryforwards expiration date	2021
Net operating losses	$ 8,000,000

Income Taxes (Schedule Of Components Of Income Tax Expense/(Benefit)) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Taxes [Abstract]
Current, Federal	$ 165,409	$ 105,077	$ 130,798
Current, Foreign	300	2,555
Current, State	22,901	16,547	18,976
Current, Total	188,610	124,179	149,774
Deferred, Federal and foreign	53,056	26,419	18,524
Deferred, State	5,800	1,704	2,177
Deferred, Total	58,856	28,123	20,701
Provision for income taxes	$ 247,466	$ 152,302	$ 170,475

- Definition

The component of income tax expense for the period representing amounts paid or payable (or refundable) as determined by applying the provisions of enacted federal tax law to the domestic taxable Income or Loss from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Paragraph Question 1-7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6509736

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The component of income tax expense for the period representing amounts paid or payable (or refundable) as determined by applying the provisions of foreign enacted tax law to the foreign taxable Income or Loss from continuing operations.

+ References+ Details

- Definition

The component of income tax expense for the period representing amounts of income taxes paid or payable (or refundable) for the period for all income tax obligations as determined by applying the provisions of relevant enacted tax laws to relevant amounts of taxable Income or Loss from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6509736

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

+ Details

- Definition

The component of income tax expense for the period representing amounts paid or payable (or refundable) as determined by applying the provisions of enacted state and local tax law to relevant amounts of taxable Income or Loss from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6509736

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

+ Details

- Definition

The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

+ Details

- Definition

The component of total income tax expense for the period comprised of the increase (decrease) in the entity's state and local deferred tax assets and liabilities attributable to continuing operations as determined by applying the provisions of the applicable enacted tax laws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 8, 16, 17, 289

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.

+ References+ Details

Income Taxes (Schedule Of Components Of Deferred Taxes) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Income Taxes [Abstract]
Self-insurance reserves	$ 115,201	$ 121,249
Compensation accruals	49,717	53,855
State and foreign net operating loss carryforwards and other state and foreign deferred tax assets	52,506	46,338
Other currently non-deductible accrued liabilities	19,699	19,016
Net pension liability-OCI only	13,959	9,268
Doubtful accounts and other reserves	17,345	31,046
Other combined items-OCI only	17,684	3,196
Deferred income tax assets, Gross	286,111	283,968
Less: Valuation Allowance	(42,143)	(32,352)
Net deferred income tax assets	243,968	251,616
Depreciable and amortizable assets	(342,655)	(299,566)
Other deferred tax liabilities	(2,581)	(4,570)
Total deferred tax liabilities	$ (101,268)	$ (52,520)

Income Taxes (Schedule Of Effective Tax Rates Calculation) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Taxes [Abstract]
Provision for income taxes	$ 247,466	$ 152,302	$ 170,475
Income before income taxes	$ 696,336	$ 428,097	$ 474,722
Effective tax rate	35.50%	35.60%	35.90%

- Definition

A ratio calculated by dividing the reported amount of income tax expense attributable to continuing operations for the period by GAAP-basis pretax income from continuing operations.

+ References+ Details

- Definition

The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.

+ References+ Details

Income Taxes (Schedule Of Reconciliation Between The Federal Statutory Rate And The Effective Tax Rate) (Details)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Taxes [Abstract]
Federal statutory rate	35.00%	35.00%	35.00%
State taxes, net of federal income tax benefit	2.90%	3.10%	3.20%
Nondeductible transaction costs		1.30%
Other items	0.40%	0.40%	1.40%
Impact of income attributable to noncontrolling interests	(2.80%)	(4.20%)	(3.70%)
Effective tax rate	35.50%	35.60%	35.90%

- Definition

A ratio calculated by dividing the reported amount of income tax expense attributable to continuing operations for the period by GAAP-basis pretax income from continuing operations.

+ References+ Details

- Definition

The domestic federal statutory tax rate applicable under enacted tax laws to the Company's pretax income from continuing operations for the period. The "statutory" tax rate is the regular tax rate if there are alternative tax systems.

+ References+ Details

Income Taxes (Schedule Of Net Deferred Tax Assets And Liabilities) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Income Taxes [Abstract]
Current deferred taxes, Assets	$ 109,297	$ 123,362
Current deferred taxes, Liabilities	(973)	(2,528)
Total deferred taxes-current	108,324	120,834
Noncurrent deferred taxes, Assets	135,189	128,254
Noncurrent deferred taxes, Liabilities	(344,781)	(301,608)
Total deferred taxes-noncurrent	(209,592)	(173,354)
Total deferred tax liabilities	$ (101,268)	$ (52,520)

- Definition

For entities that net deferred tax assets and tax liabilities, represents the unclassified net amount of deferred tax assets and liabilities as of the balance sheet date, which result from applying the applicable enacted tax rate to net temporary differences and carryforwards pertaining to assets or liabilities. A temporary difference is a difference between the tax basis of an asset or liability and its carrying amount in the financial statements prepared in accordance with generally accepted accounting principles that will reverse in ensuing periods.

+ References+ Details

- Definition

For entities that net deferred tax assets and tax liabilities, represents the net amount of deferred tax assets (after reduction for valuation allowance) and liabilities as of the balance sheet date, which result from applying the applicable enacted tax rate to net temporary differences and carryforwards pertaining to assets or liabilities that are classified as current in the financial statements, or that are expected to reverse in the next twelve months (or normal operating cycle, if longer). A temporary difference is a difference between the tax basis of an asset or liability and its carrying amount in the financial statements prepared in accordance with generally accepted accounting principles that will reverse in ensuing periods. In a classified statement of financial position, an enterprise separates deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, are classified according to the expected reversal date of the temporary difference.

+ References+ Details

- Definition

For entities that net deferred tax assets and tax liabilities, represents the net amount of deferred tax assets (after reduction for valuation allowance) and liabilities as of the balance sheet date, which result from applying the applicable enacted tax rate to net temporary differences and carryforwards pertaining to assets or liabilities that are classified as noncurrent in the financial statements, or that are expected to reverse after the next twelve months (or beyond the normal operating cycle, if longer). A temporary difference is a difference between the tax basis of an asset or liability and its carrying amount in the financial statements prepared in accordance with generally accepted accounting principles that will reverse in ensuing periods. In a classified statement of financial position, an enterprise separates deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, are classified according to the expected reversal date of the temporary difference.

+ References+ Details

- Definition

The current portion of the aggregate tax effects as of the balance sheet date of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after deducting the allocated valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, are classified according to the expected reversal date of the temporary difference. An unrecognized tax benefit that is directly related to a position taken in a tax year that results in a net operating loss carryforward is presented as a reduction of the related deferred tax asset.

+ References+ Details

- Definition

The noncurrent portion as of the balance sheet date of the aggregate carrying amount of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after the valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, is classified according to the expected reversal date of the temporary difference.

+ References+ Details

- Definition

Represents the current portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. A current taxable temporary difference is a difference between the tax basis and the carrying amount of a current asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise separates deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, is classified according to the expected reversal date of the temporary difference.

+ References+ Details

- Definition

Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise separates deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, are classified according to the expected reversal date of the temporary difference.

+ References+ Details

Income Taxes (Schedule Of Reconciliation Of Unrecognized Tax Benefits) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Taxes [Abstract]
Balance at January 1,	$ 7,923	$ 5,754	$ 3,759
Additions based on tax positions related to the current year	750	1,219	750
Additions for tax positions of prior years	419	2,076	1,245
Reductions for tax positions of prior years	(1,628)	(907)
Settlements	(61)	(219)
Balance at December 31,	$ 7,403	$ 7,923	$ 5,754

Lease Commitments (Narrative) (Details) (USD $)	12 Months Ended
Lease Commitments (Narrative) (Details) (USD $)	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Lease Commitments [Abstract]
Assumed capital lease obligations upon the acquisition of facilities		$ 7,100,000	$ 700,000
Number of hospital facilities	4

- Definition

The amount of acquisition cost of a business combination allocated to capital lease obligations assumed from the acquired entity.

+ References+ Details

Lease Commitments (Schedule Of Summary Of Property Under Capital Lease) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Lease Commitments [Abstract]
Land, buildings and equipment	$ 37,037	$ 38,711
Less: accumulated amortization	(35,264)	(35,627)
Property under capital lease, Total	$ 1,773	$ 3,085

- Definition

Property, plant, or equipment held under lease agreements classified as an asset.

+ References+ Details

- Definition

The total charge for the use of long-lived depreciable assets subject to a lease meeting the criteria for capitalization.

+ References+ Details

Lease Commitments (Schedule Of Future Minimum Rental Payments Under Lease Commitments) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011
Lease Commitments [Abstract]
Capital Leases, 2012	$ 2,425
Capital Leases, 2013	2,277
Capital Leases, 2014	1,299
Capital Leases, 2015	1,212
Capital Leases, 2016	1,077
Capital Leases, Later years	7,787
Capital Leases, Total minimum rental	16,077
Less: Amount representing interest	(6,095)
Present value of minimum rental commitments	9,982
Less: Current portion of capital lease obligations	(1,680)
Long-term portion of capital lease obligations	8,302
Operating Leases, 2012	58,388
Operating Leases, 2013	42,717
Operating Leases, 2014	32,777
Operating Leases, 2015	26,806
Operating Leases, 2016	21,687
Operating Leases, Later years	24,053
Operating Leases, Total minimum rental	$ 206,428

Commitments And Contingencies (Professional And General Liability) (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended			12 Months Ended								10 Months Ended	12 Months Ended
	Dec. 31, 2011 PSI Subsidiaries [Member]	Dec. 31, 2011 PSI Subsidiaries [Member] Minimum [Member]	Dec. 31, 2011 PSI Subsidiaries [Member] Maximum [Member]	Dec. 31, 2011 Professional And General Liability [Member]	Dec. 31, 2007 Professional And General Liability [Member]	Dec. 31, 2011 Professional And General Liability [Member] Minimum [Member]	Dec. 31, 2011 Professional And General Liability [Member] Maximum [Member]	Dec. 31, 2011 Professional And General Liability [Member] PSI Subsidiaries [Member]	Dec. 31, 2010 Professional And General Liability [Member] PSI Subsidiaries [Member]	Dec. 31, 2009 Professional And General Liability [Member] PSI Subsidiaries [Member]	Oct. 31, 2010 Professional And General Liability [Member] PSI Subsidiaries [Member] Minimum [Member]	Oct. 31, 2010 Professional And General Liability [Member] PSI Subsidiaries [Member] Maximum [Member]	Dec. 31, 2011 Professional And General Liability [Member] PSI Subsidiaries [Member] Maximum [Member]	Dec. 31, 2011 Professional And General Liability [Member] Legacy Subsidiaries [Member] Maximum [Member]	Dec. 31, 2011 Professional And General Liability [Member] Subsidiaries [Member]	Dec. 31, 2011 Professional And General Liability [Member] Subsidiaries [Member] Minimum [Member]	Dec. 31, 2011 Professional And General Liability [Member] Subsidiaries [Member] Maximum [Member]
Loss Contingencies [Line Items]
Self-insured exposure per occurrence				$ 10									$ 3	$ 10
Commercial insured exposure per occurrence					20	10	200
Percentage of liability for claims paid under commercially insured coverage				10.00%											10.00%
Liability for claims paid pursuant to commercially insured coverage, amount						10	60
Commercial self-insured retention		3	10								3					10	60
Commercial self-insured retention cap	200											75
Total liability claims accrual including estimated claims related to facilities acquired								292	289
Professional and general claims included in current liabilities								60
Other current liabilities									60
Reduction in professional and general liability self-insurance reserves relating to prior years								$ 11	$ 49	$ 23
Weighting given to company-specific metrics									75.00%	50.00%
General industry metrics									25.00%	50.00%

Commitments And Contingencies (Property Insurance And Other) (Details) (USD $)	12 Months Ended
	Dec. 31, 2011
Loss Contingencies [Line Items]
Commercial property insurance for catastrophic losses limit per occurrence	$ 1,000,000,000
Commercial property insurance for catastrophic losses deductible limit per occurrence	250,000
Combined estimated future purchase obligations	130,000,000
Combined estimated future payments related to non contributory	227,000,000
Defined benefit pension plan estimated payments through 2088	212,000,000
Other retirement plan liabilities	15,000,000
Earthquake [Member]
Loss Contingencies [Line Items]
Commercial property insurance for catastrophic losses limit per occurrence	250,000,000
Commercial property insurance for catastrophic losses deductible limit per occurrence	250,000
Revenue Cycle Data Processing Services [Member]
Loss Contingencies [Line Items]
Combined estimated future purchase obligations	58,000,000
Electronic Health Records Application [Member]
Loss Contingencies [Line Items]
Combined estimated future purchase obligations	66,000,000
Estimated Minimum Liabilities For Physician Commitments [Member]
Loss Contingencies [Line Items]
Combined estimated future purchase obligations	6,000,000
Minimum [Member] \| Windstorms [Member]
Loss Contingencies [Line Items]
Commercial property insurance for catastrophic losses, deductible rate	3.00%
Minimum [Member] \| Earthquake [Member]
Loss Contingencies [Line Items]
Commercial property insurance for catastrophic losses, deductible rate	1.00%
Minimum [Member] \| Flood [Member]
Loss Contingencies [Line Items]
Commercial property insurance for catastrophic losses deductible limit per occurrence	250,000
Maximum [Member] \| Windstorms [Member]
Loss Contingencies [Line Items]
Commercial property insurance for catastrophic losses, deductible rate	5.00%
Maximum [Member] \| Earthquake [Member]
Loss Contingencies [Line Items]
Commercial property insurance for catastrophic losses, deductible rate	5.00%
Maximum [Member] \| Flood [Member]
Loss Contingencies [Line Items]
Commercial property insurance for catastrophic losses deductible limit per occurrence	500,000
Facilities Located In Fault Zones [Member] \| Earthquake [Member]
Loss Contingencies [Line Items]
Commercial property insurance for catastrophic losses limit per occurrence	100,000,000
Letters Of Credit And Surety Bonds [Member]
Loss Contingencies [Line Items]
Off-balance sheet contingent obligation	79,000,000
Letters Of Credit And Surety Bonds [Member] \| Self-Insurance Programs [Member]
Loss Contingencies [Line Items]
Off-balance sheet contingent obligation	62,000,000
Letters Of Credit And Surety Bonds [Member] \| Other Debt Guarantees [Member]
Loss Contingencies [Line Items]
Off-balance sheet contingent obligation	17,000,000
Puerto Rico [Member] \| Earthquake [Member]
Loss Contingencies [Line Items]
Commercial property insurance for catastrophic losses deductible limit per occurrence	$ 25,000,000

- Definition

This represents the entire liability recognized in the balance sheet that is associated with the defined benefit pension plans.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.15)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.15)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6410544&loc=d3e1703-114919

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e1928-114920

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e2410-114920

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e2417-114920

+ Details

- Definition

This represents the entire liability recognized in the balance sheet that is associated with other postretirement defined benefit plans (excluding pension plans).

+ References

+ Details

- Definition

The carrying amount of the long-term purchase obligation as of the balance sheet date, which equals the sum of all payments due.

+ References+ Details

Relationship With Universal Health Realty Income Trust And Related Party Transactions (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2011 years days	Dec. 31, 2010	Dec. 31, 2009
Revenue, Major Customer [Line Items]
Rent expense under the operating leases		$ 16.3	$ 16.2	$ 16.3
Lease renewal period, years		5
Notice period on renewal of lease		90
Period of rights of refusal to leased facilities		180
Death benefit proceeds		33
Payments to acquire life insurance policies	6.0	1.4
Net of tax present value of projected premium funding commitment	9		9
Universal Health Services Inc [Member]
Revenue, Major Customer [Line Items]
Payments to acquire life insurance policies		25.0
Universal Health Realty Income Trust [Member]
Revenue, Major Customer [Line Items]
Trust outstanding shares held, percentage	6.20%		6.20%
Advisory fee from the trust		2.0	1.8	1.6
Pre-tax share of income from trust		4.6	1.0	1.1
Share of income included in the share of trust		3.7
Current ownership percentage of the trust		100.00%
Carrying value of investment in trust	7.3	9.9	7.3
Market value of investment in trust	28.8	30.7	28.8
Payments to acquire life insurance policies		$ 8.0
Minimum [Member]
Revenue, Major Customer [Line Items]
Lease initial terms		13
Maximum [Member]
Revenue, Major Customer [Line Items]
Lease initial terms		15

Relationship With Universal Health Realty Income Trust And Related Party Transactions (Schedule Of Renewal Options And Terms Of Hospital Facilities Leased) (Details) (USD $)

12 Months Ended

Dec. 31, 2011

Revenue, Major Customer [Line Items]

Number of 5-year renewal options at fair market value lease rates

two

McAllen Medical Center [Member] | Acute Care Hospital Services [Member]

Revenue, Major Customer [Line Items]

Annual Minimum Rent

$ 5,485,000

End of Lease Term

December, 2016

Renewal Term (years)

^[1]

Number of 5-year renewal options at existing lease rates

three

Wellington Regional Medical Center [Member] | Acute Care Hospital Services [Member]

Revenue, Major Customer [Line Items]

Annual Minimum Rent

3,030,000

End of Lease Term

December, 2016

Renewal Term (years)

^[2]

Number of 5-year renewal options at existing lease rates

one

Southwest Healthcare System, Inland Valley Campus [Member] | Acute Care Hospital Services [Member]

Revenue, Major Customer [Line Items]

Annual Minimum Rent

2,648,000

End of Lease Term

December, 2016

Renewal Term (years)

^[2]

The Bridgeway [Member] | Behavioral Health Services [Member]

Revenue, Major Customer [Line Items]

Annual Minimum Rent

$ 930,000

End of Lease Term

December, 2014

Renewal Term (years)

^[3]

Number of 5-year renewal options at fair market value lease rates

two

[1]	We have three 5-year renewal options at existing lease rates (through 2031).
[2]	We have one 5-year renewal options at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
[3]	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

- Definition

This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.

+ References+ Details

Pension Plan (Narrative) (Details) (USD $)	12 Months Ended
Pension Plan (Narrative) (Details) (USD $)	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Pension Plan [Abstract]
Amount of contributions to contributory plan	$ 21,700,000	$ 20,800,000	$ 20,400,000
Accumulated benefit obligation	106,609	91,559
Estimated net loss that will be amortized from accumulated other comprehensive income over the next fiscal year	4,219
Fair value of plan assets	$ 87,940,000	$ 73,402,000	$ 61,451,000

- Definition

For defined benefit pension plans, the actuarial present value of benefits (whether vested or nonvested) attributed by the pension benefit formula to employee service rendered before a specified date and based on employee service and compensation (if applicable) before that date. The accumulated benefit obligation differs from the projected benefit obligation in that it includes no assumption about future compensation levels. For plans with flat-benefit or nonpay-related pension benefit formulas, the accumulated benefit obligation and the projected benefit obligation are the same.

+ References+ Details

- Definition

The aggregate amount in accumulated other comprehensive income expected to be recognized as a component of net periodic benefit cost over the fiscal year that follows the most recent annual statement of financial position presented, including the net gain (loss), net prior service cost or credit, and net transition asset or obligation.

+ References+ Details

- Definition

Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets.

+ References+ Details

Pension Plan (Schedule Of Reconciliation Of Defined Benefit Pension Plan) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Pension Plan [Abstract]
Fair value of plan assets at beginning of year	$ 73,402	$ 61,451
Actual return (loss) on plan assets	5,689	10,027
Employer contributions	14,065	6,657
Benefits paid	(4,541)	(4,256)
Administrative expenses	(675)	(477)
Fair value of plan assets at end of year	87,940	73,402	61,451
Benefit obligation at beginning of year	93,513	85,476
Service cost	1,162	1,140	1,191
Interest cost	5,047	4,958	4,834
Actuarial (gain) loss	13,265	6,195
Benefit obligation at end of year	108,446	93,513	85,476
Other noncurrent liabilities	20,506	20,110
Total liability at end of year	20,506	20,110
Projected benefit obligation	108,446	93,513
Accumulated benefit obligation	106,609	91,559
Fair value of plan assets	$ 87,940	$ 73,402	$ 61,451

Pension Plan (Schedule Of Components Of Net Periodic Cost (Benefit)) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Pension Plan [Abstract]
Service cost	$ 1,162	$ 1,140	$ 1,191
Interest cost	5,047	4,958	4,834
Expected return on plan assets	(6,566)	(5,151)	(3,927)
Recognized actuarial loss	2,427	2,538	4,676
Net periodic cost	$ 2,070	$ 3,485	$ 6,774

- Definition

An amount calculated as a basis for determining the extent of delayed recognition of the effects of changes in the fair value of assets. The expected return on plan assets is determined based on the expected long-term rate of return on plan assets and the market-related value of plan assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph h

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 106

-Paragraph 518

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 87

-Paragraph 264

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)(3)

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Expected Return on Plan Assets

-URI http://asc.fasb.org/extlink&oid=6512136

-Topic 715

-SubTopic 30

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Expected Return on Plan Assets

-URI http://asc.fasb.org/extlink&oid=6512171

-Topic 715

-SubTopic 60

+ Details

- Definition

The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.

+ References+ Details

- Definition

The actuarial present value of benefits attributed by the pension benefit formula to services rendered by employees during the period. The portion of the expected postretirement benefit obligation attributed to employee service during the period. The service cost component is a portion of the benefit obligation and is unaffected by the funded status of the plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 106

-Paragraph 518

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 87

-Paragraph 264

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph a, h

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)(1)

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Service Cost (Component of Net Periodic Pension Cost)

-URI http://asc.fasb.org/extlink&oid=6525008

+ Details

Pension Plan (Schedule Of Weighted Average Assumptions) (Details)	Dec. 31, 2011	Dec. 31, 2010
Pension Plan [Abstract]
Discount rate	4.40%	5.54%
Rate of compensation increase	4.00%	4.00%

Pension Plan (Schedule Of Weighted-Average Assumptions For Net Periodic Benefit Cost Calculations) (Details)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Pension Plan [Abstract]
Discount rate	5.54%	5.96%	5.87%
Expected long-term rate at return on plan assets	8.00%	8.00%	8.00%
Rate of compensation increase	4.00%	4.00%	4.00%

- Definition

An assumption as to the rate of return on plan assets reflecting the average rate of earnings expected on the funds invested or to be invested to provide for the benefits included in the benefit obligation.

+ References+ Details

Pension Plan (Schedule Of Market Values Of Pension Plan Assets) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 87,940	$ 73,402	$ 61,451
U.S. Large Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	18,921	22,010
U.S. Mid Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,281	1,468
U.S. Small-Mid Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6,332	6,295
U.S. Small Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,282	1,471
International Developed [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8,692	10,353
Emerging Markets [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3,123	3,709
Core Fixed Income [Member] \| Fixed Income [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		11,542
Long Duration Fixed Income [Member] \| Fixed Income [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	44,587	11,421
REIT Fund [Member] \| Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3,269	3,740
Cash Equivalents [Member] \| Cash/Currency [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	453	1,393
Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 1 [Member] \| U.S. Large Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 1 [Member] \| U.S. Mid Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 1 [Member] \| U.S. Small-Mid Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 1 [Member] \| U.S. Small Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 1 [Member] \| International Developed [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 1 [Member] \| Emerging Markets [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 1 [Member] \| Core Fixed Income [Member] \| Fixed Income [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 1 [Member] \| Long Duration Fixed Income [Member] \| Fixed Income [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 1 [Member] \| REIT Fund [Member] \| Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 1 [Member] \| Commodities [Member] \| Tangible Assets [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 1 [Member] \| Cash Equivalents [Member] \| Cash/Currency [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	87,940	73,402
Level 2 [Member] \| U.S. Large Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	18,921	22,010
Level 2 [Member] \| U.S. Mid Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,281	1,468
Level 2 [Member] \| U.S. Small-Mid Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6,332	6,295
Level 2 [Member] \| U.S. Small Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,282	1,471
Level 2 [Member] \| International Developed [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8,692	10,353
Level 2 [Member] \| Emerging Markets [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3,123	3,709
Level 2 [Member] \| Core Fixed Income [Member] \| Fixed Income [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		11,542
Level 2 [Member] \| Long Duration Fixed Income [Member] \| Fixed Income [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	44,587	11,421
Level 2 [Member] \| REIT Fund [Member] \| Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3,269	3,740
Level 2 [Member] \| Cash Equivalents [Member] \| Cash/Currency [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	453	1,393
Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 3 [Member] \| U.S. Large Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 3 [Member] \| U.S. Mid Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 3 [Member] \| U.S. Small-Mid Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 3 [Member] \| U.S. Small Cap [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 3 [Member] \| International Developed [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 3 [Member] \| Emerging Markets [Member] \| Equities [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 3 [Member] \| Core Fixed Income [Member] \| Fixed Income [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 3 [Member] \| Long Duration Fixed Income [Member] \| Fixed Income [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 3 [Member] \| REIT Fund [Member] \| Real Estate [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 3 [Member] \| Commodities [Member] \| Tangible Assets [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets
Level 3 [Member] \| Cash Equivalents [Member] \| Cash/Currency [Member]
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets

- Definition

+ References+ Details

Pension Plan (Schedule Of Estimated Future Benefit Payments) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011
Pension Plan [Abstract]
2012	$ 5,100
2013	5,400
2014	5,664
2015	5,895
2016	6,117
2017-2021	33,216
Total	$ 61,392

Pension Plan (Schedule Of Plan Assets Category) (Details)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Pension Plan [Abstract]
Equity securities	45.00%	62.00%
Fixed income securities	50.00%	31.00%
Other	5.00%	7.00%
Total	100.00%	100.00%

Pension Plan (Schedule Of Asset Allocation Policy And Ranges For Overall Risk And Return Objectives Of Portfolio) (Details)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Defined Benefit Plan Disclosure [Line Items]
Total Equity	45.00%	62.00%
Total Equity, Permitted Range, maximum	49.00%
Total Equity, Permitted Range, minimum	43.00%
Total Fixed Income	50.00%	31.00%
Total Fixed Income, Permitted Range, maximum	55.00%
Total Fixed Income, Permitted Range, minimum	45.00%
Other	5.00%	7.00%
Other, Permitted Range, maximum	10.00%
Other, Permitted Range, minimum	0.00%
Policy [Member]
Defined Benefit Plan Disclosure [Line Items]
Total Equity	46.00%
Total Fixed Income	50.00%
Other	4.00%

Segment Reporting (Schedule Of Financial Information By Operating Segments) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Gross inpatient revenues	$ 17,554,869	$ 13,456,537	$ 11,976,173
Gross outpatient revenues	6,291,445	5,170,507	4,445,253
Total net revenues	7,500,198	5,568,185	5,202,379
Income (loss) before income taxes	696,336	428,097	474,722
Total assets	7,665,245	7,527,936	3,964,463
Acute Care Hospital Services [Member]
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Gross inpatient revenues	12,025,664	10,890,171	9,901,032
Gross outpatient revenues	5,629,420	4,771,070	4,100,427
Total net revenues	4,071,570	3,901,815	3,810,828
Income (loss) before income taxes	351,917	363,427	386,208
Total assets	2,852,549	2,755,697	2,748,175
Behavioral Health Services [Member]
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Gross inpatient revenues	5,529,205	2,566,366	2,075,141
Gross outpatient revenues	608,785	350,192	282,473
Total net revenues	3,401,118	1,635,455	1,315,029
Income (loss) before income taxes	732,674	353,203	281,541
Total assets	4,383,432	4,360,710	998,508
Other [Member]
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Gross outpatient revenues	53,240	49,245	62,353
Total net revenues	27,510	30,915	76,522
Income (loss) before income taxes	(388,255)	(288,533)	(193,027)
Total assets	$ 429,264	$ 411,529	$ 217,780

Quarterly Results (Narrative) (Details) (USD $)	3 Months Ended
Quarterly Results (Narrative) (Details) (USD $)	Dec. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010
Quarterly Results [Abstract]
Favorable pre-tax reduction	$ 10,400,000	$ 32,600,000		$ 16,400,000
Tax reduction per diluted share	$ 0.07	$ 0.18		$ 0.10
Favorable after-tax reduction	6,400,000	17,900,000		10,200,000
Pre-tax transaction cost		31,100,000	3,900,000	18,200,000
Transaction cost per share		$ 0.25	$ 0.02	$ 0.11
After tax transaction cost		24,900,000	2,400,000	11,300,000
Favorable discrete tax			4,300,000
Discrete tax per share			$ 0.04
Unfavorable pre-tax charge to write-off costs related to acute care hospital construction project		6,700,000
Charge to write-off costs related to acute care hospital construction project diluted per share		$ 4.00
Unfavorable after tax charge to write-off costs related to acute care hospital construction project		4,100,000
Unfavorable charge recorded for split-dollar life insurance agreements		9,200,000
Unfavorable charge recorded for split-dollar life insurance agreements diluted per share		$ 0.09

Quarterly Results (Schedule Of Quarterly Financial Data) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Quarterly Results [Abstract]
Net revenues	$ 1,838,774	$ 1,848,662	$ 1,902,234	$ 1,910,528	$ 1,559,453	$ 1,323,264	$ 1,338,315	$ 1,347,153	$ 7,500,198	$ 5,568,185
Net income	108,007	94,842	116,034	129,987	50,816	65,802	76,415	82,762	448,870	275,795	304,247
Less: Net income attributable to noncontrolling interests	12,736	9,788	12,385	15,794	13,634	10,192	10,843	10,943	50,703	45,612	43,874
Net income attributable to UHS	$ 95,271	$ 85,054	$ 103,649	$ 114,193	$ 37,182	$ 55,610	$ 65,572	$ 71,819	$ 398,167	$ 230,183	$ 260,373
Earnings per share attributable to UHS-Basic: Total basic earnings per share	$ 0.99	$ 0.87	$ 1.06	$ 1.17	$ 0.38	$ 0.57	$ 0.68	$ 0.74	$ 4.09	$ 2.37	$ 2.65
Earnings per share attributable to UHS-Diluted: Total diluted earnings per share	$ 0.98	$ 0.86	$ 1.04	$ 1.15	$ 0.38	$ 0.57	$ 0.67	$ 0.73	$ 4.04	$ 2.34	$ 2.64

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 36, 37, 38

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 20

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 7

-Paragraph 18

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=6945512&loc=d3e4984-109258

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

- Definition

The portion of net Income or Loss attributable to the noncontrolling interest (if any) deducted in order to derive the portion attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A1, A4, A5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A1, A4, A5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 5

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Supplemental Condensed Consolidating Financial Information (Schedule Of Condensed Consolidating Statements Of Income) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Net revenues									$ 7,500,198	$ 5,568,185	$ 5,202,379
Salaries, wages and benefits									3,394,967	2,423,102	2,204,422
Other operating expenses									1,385,680	1,005,288	994,923
Supplies expense									821,811	733,093	699,249
Provision for doubtful accounts									613,619	546,909	508,603
Depreciation and amortization									295,228	223,915	204,703
Lease and rental expense									91,765	76,961	69,947
Transaction costs										53,220
Total operating charges									6,603,070	5,062,488	4,681,847
Income from operations									897,128	505,697	520,532
Interest expense									200,792	77,600	45,810
Interest (income) expense, affiliate									0	0	0
Equity in net income of consolidated affiliates									0	0	0
Income before income taxes									696,336	428,097	474,722
Provision for income taxes									247,466	152,302	170,475
Net income	108,007	94,842	116,034	129,987	50,816	65,802	76,415	82,762	448,870	275,795	304,247
Less: Net income attributable to noncontrolling interests	12,736	9,788	12,385	15,794	13,634	10,192	10,843	10,943	50,703	45,612	43,874
Net income attributable to UHS	95,271	85,054	103,649	114,193	37,182	55,610	65,572	71,819	398,167	230,183	260,373
Parent [Member]
Net revenues									0	648	980
Salaries, wages and benefits									0	0	0
Other operating expenses									200	(255)	140
Supplies expense									0	0	0
Provision for doubtful accounts									0	0	0
Depreciation and amortization									0	0	0
Lease and rental expense									0	0	0
Transaction costs										0
Total operating charges									200	(255)	140
Income from operations									(200)	903	840
Interest expense									195,404	70,283	40,555
Interest (income) expense, affiliate									0	0	1,628
Equity in net income of consolidated affiliates									(518,797)	(271,944)	(286,714)
Income before income taxes									323,193	202,564	245,371
Provision for income taxes									(74,974)	(27,619)	(15,002)
Net income									398,167	230,183	260,373
Less: Net income attributable to noncontrolling interests									0	0	0
Net income attributable to UHS									398,167	230,183	260,373
Guarantors [Member]
Net revenues									5,046,459	3,631,814	3,322,936
Salaries, wages and benefits									2,433,871	1,670,276	1,492,008
Other operating expenses									949,475	670,043	631,659
Supplies expense									514,574	438,901	411,074
Provision for doubtful accounts									356,976	290,152	265,223
Depreciation and amortization									215,697	154,597	140,223
Lease and rental expense									62,118	50,455	45,366
Transaction costs										53,220
Total operating charges									4,532,711	3,327,644	2,985,553
Income from operations									513,748	304,170	337,383
Interest expense									90,417	6,729	2,870
Interest (income) expense, affiliate									87,205	60,876	47,744
Equity in net income of consolidated affiliates									(157,009)	(134,760)	(125,784)
Income before income taxes									493,135	371,325	412,553
Provision for income taxes									164,666	134,547	149,229
Net income									328,469	236,778	263,324
Less: Net income attributable to noncontrolling interests									0	0	0
Net income attributable to UHS									328,469	236,778	263,324
Non Guarantors [Member]
Net revenues									2,480,215	1,983,060	1,902,618
Salaries, wages and benefits									961,096	752,826	712,414
Other operating expenses									460,692	381,689	386,405
Supplies expense									307,237	294,192	288,175
Provision for doubtful accounts									256,643	256,757	243,380
Depreciation and amortization									79,531	69,318	64,480
Lease and rental expense									31,436	27,654	26,831
Transaction costs										0
Total operating charges									2,096,635	1,782,436	1,721,685
Income from operations									383,580	200,624	180,933
Interest expense									(85,029)	588	1,009
Interest (income) expense, affiliate									(87,205)	(60,876)	(49,372)
Equity in net income of consolidated affiliates									0	0	0
Income before income taxes									555,814	260,912	229,296
Provision for income taxes									157,774	45,374	36,248
Net income									398,040	215,538	193,048
Less: Net income attributable to noncontrolling interests									50,703	45,612	43,874
Net income attributable to UHS									347,337	169,926	149,174
Consolidating Adjustments [Member]
Net revenues									(26,476)	(47,337)	(24,155)
Salaries, wages and benefits									0	0	0
Other operating expenses									(24,687)	(46,189)	(23,281)
Supplies expense									0	0	0
Provision for doubtful accounts									0	0	0
Depreciation and amortization									0	0	0
Lease and rental expense									(1,789)	(1,148)	(2,250)
Transaction costs										0
Total operating charges									(26,476)	(47,337)	(25,531)
Income from operations									0	0	1,376
Interest expense									0	0	1,376
Interest (income) expense, affiliate									0	0	0
Equity in net income of consolidated affiliates									675,806	406,704	412,498
Income before income taxes									(675,806)	(406,704)	(412,498)
Provision for income taxes									0	0	0
Net income									(675,806)	(406,704)	(412,498)
Less: Net income attributable to noncontrolling interests									0	0	0
Net income attributable to UHS									$ (675,806)	$ (406,704)	$ (412,498)

Supplemental Condensed Consolidating Financial Information (Schedule Of Condensed Consolidating Balance Sheet) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Cash and cash equivalents	$ 41,229	$ 29,474
Accounts receivable, net	969,802	837,820
Supplies	96,775	94,330
Other current assets	99,859	130,060
Deferred income taxes	108,324	120,834
Current assets held for sale	48,916	118,598
Total current assets	1,364,905	1,331,116
Investments in subsidiaries	0	0
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	5,106,160	4,853,972
Accumulated depreciation	(1,818,180)	(1,601,005)
Property and equipment, net	3,287,980	3,252,967
Goodwill	2,627,602	2,589,914	732,685
Deferred charges	111,780	108,660
Other	272,978	245,279
Total assets	7,665,245	7,527,936
Current maturities of long-term debt	2,479	3,449
Accounts payable and accrued liabilities	832,125	819,334
Current liabilities held for sale	2,329	3,516
Federal and state taxes	0	0
Total current liabilities	836,933	826,299
Intercompany payable	0	0
Other noncurrent liabilities	401,908	380,649
Long-term debt	3,651,428	3,912,102
Intercompany note payable	0	0
Deferred income taxes	209,592	173,354
Reedemable noncontrolling interest	218,266	211,761
UHS common stockholders' equity	2,296,352	1,978,772
Noncontrolling interest	50,766	44,999
Total equity	2,347,118	2,023,771	1,792,394	1,584,488
Total liabilities and stockholders' equity	7,665,245	7,527,936
Parent [Member]
Cash and cash equivalents	0	0
Accounts receivable, net	8,891	10,646
Supplies	0	0
Other current assets	33,057	51,161
Deferred income taxes	67,189	82,416
Current assets held for sale	0	0
Total current assets	109,137	144,223
Investments in subsidiaries	5,213,573	4,694,776
Intercompany receivable	669,112	1,056,839
Intercompany note receivable	0	0
Property and equipment	0	0
Accumulated depreciation	0	0
Property and equipment, net	0	0
Goodwill	820	820
Deferred charges	103,434	101,582
Other	10,412	7,612
Total assets	6,106,488	6,005,852
Current maturities of long-term debt	0	559
Accounts payable and accrued liabilities	14,201	16,318
Current liabilities held for sale	0	0
Federal and state taxes	0	16,886
Total current liabilities	14,201	33,763
Intercompany payable	0	0
Other noncurrent liabilities	49,840	13,672
Long-term debt	3,594,182	3,855,810
Intercompany note payable	0	0
Deferred income taxes	151,913	123,835
Reedemable noncontrolling interest	0	0
UHS common stockholders' equity	2,296,352	1,978,772
Noncontrolling interest	0	0
Total equity	2,296,352	1,978,772
Total liabilities and stockholders' equity	6,106,488	6,005,852
Guarantors [Member]
Cash and cash equivalents	33,221	21,385
Accounts receivable, net	663,593	561,869
Supplies	59,467	57,069
Other current assets	56,864	69,903
Deferred income taxes	41,755	55,927
Current assets held for sale	48,916	109,781
Total current assets	903,816	875,934
Investments in subsidiaries	1,181,849	1,024,840
Intercompany receivable	0	939,667
Intercompany note receivable	0	0
Property and equipment	3,650,025	3,492,263
Accumulated depreciation	(1,184,283)	(1,029,609)
Property and equipment, net	2,465,742	2,462,654
Goodwill	2,132,103	2,153,366
Deferred charges	5,972	6,749
Other	241,107	214,694
Total assets	6,930,589	7,677,904
Current maturities of long-term debt	1,133	1,357
Accounts payable and accrued liabilities	616,026	514,225
Current liabilities held for sale	2,329	3,343
Federal and state taxes	0	0
Total current liabilities	619,488	518,925
Intercompany payable	743,267	0
Other noncurrent liabilities	249,033	252,568
Long-term debt	3,616	4,834
Intercompany note payable	1,148,839	3,071,860
Deferred income taxes	58,001	49,841
Reedemable noncontrolling interest	0	0
UHS common stockholders' equity	4,108,345	3,779,876
Noncontrolling interest	0	0
Total equity	4,108,345	3,779,876
Total liabilities and stockholders' equity	6,930,589	7,677,904
Non Guarantors [Member]
Cash and cash equivalents	8,008	8,089
Accounts receivable, net	297,318	265,305
Supplies	37,308	37,261
Other current assets	9,938	8,996
Deferred income taxes	322	322
Current assets held for sale	0	8,817
Total current assets	352,894	328,790
Investments in subsidiaries	0	0
Intercompany receivable	74,155	0
Intercompany note receivable	1,148,839	3,071,860
Property and equipment	1,456,135	1,361,709
Accumulated depreciation	(633,897)	(571,396)
Property and equipment, net	822,238	790,313
Goodwill	494,679	435,728
Deferred charges	2,374	329
Other	21,459	22,973
Total assets	2,916,638	4,649,993
Current maturities of long-term debt	1,346	1,533
Accounts payable and accrued liabilities	201,898	288,791
Current liabilities held for sale	0	173
Federal and state taxes	620	623
Total current liabilities	203,864	291,120
Intercompany payable	0	1,996,506
Other noncurrent liabilities	103,035	114,409
Long-term debt	53,630	51,458
Intercompany note payable	0	0
Deferred income taxes	0	0
Reedemable noncontrolling interest	218,266	211,761
UHS common stockholders' equity	2,287,077	1,939,740
Noncontrolling interest	50,766	44,999
Total equity	2,337,843	1,984,739
Total liabilities and stockholders' equity	2,916,638	4,649,993
Consolidating Adjustments [Member]
Cash and cash equivalents	0	0
Accounts receivable, net	0	0
Supplies	0	0
Other current assets	0	0
Deferred income taxes	(942)	(17,831)
Current assets held for sale	0	0
Total current assets	(942)	(17,831)
Investments in subsidiaries	(6,395,422)	(5,719,616)
Intercompany receivable	(743,267)	(1,996,506)
Intercompany note receivable	(1,148,839)	(3,071,860)
Property and equipment	0	0
Accumulated depreciation	0	0
Property and equipment, net	0	0
Goodwill	0	0
Deferred charges	0	0
Other	0	0
Total assets	(8,288,470)	(10,805,813)
Current maturities of long-term debt	0	0
Accounts payable and accrued liabilities	0	0
Current liabilities held for sale	0	0
Federal and state taxes	(620)	(17,509)
Total current liabilities	(620)	(17,509)
Intercompany payable	(743,267)	(1,996,506)
Other noncurrent liabilities	0	0
Long-term debt	0	0
Intercompany note payable	(1,148,839)	(3,071,860)
Deferred income taxes	(322)	(322)
Reedemable noncontrolling interest	0	0
UHS common stockholders' equity	(6,395,422)	(5,719,616)
Noncontrolling interest	0	0
Total equity	(6,395,422)	(5,719,616)
Total liabilities and stockholders' equity	$ (8,288,470)	$ (10,805,813)

Supplemental Condensed Consolidating Financial Information (Schedule Of Condensed Consolidating Statements Of Cash Flows) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Net cash provided by operating activities	$ 718,251	$ 501,344	$ 541,262
Property and equipment additions, net of disposals	(285,682)	(239,274)	(379,748)
Proceeds received from sale of assets and businesses	67,592	21,460	9,770
Acquisition of property and businesses	(29,466)	(1,958,298)	(12,499)
Costs incurred for purchase and development of electronic health records application	(38,249)	(17,971)	(7,957)
Net cash used in investing activities	(285,805)	(2,194,083)	(390,434)
Reduction of long-term debt	(381,517)	(1,392,086)	(66,499)
Additional borrowings	98,100	3,266,146	26,069
Financing costs	(23,608)	(101,815)
Repurchase of common shares	(60,482)	(11,528)	(63,288)
Dividends paid	(19,466)	(19,422)	(16,706)
Issuance of common stock	4,779	3,594	3,290
Profit distributions to noncontrolling interests	(38,497)	(32,456)	(29,866)
Proceeds from sale of noncontrolling interests in majority owned business		600
Capital contributions from noncontrolling interests			121
Purchase of noncontrolling interests in majority owned businesses		(600)	(229)
Changes in intercompany balances with affiliates, net	0	0	0
Net cash (used in) provided by financing activities	(420,691)	1,713,033	(147,108)
Increase (decrease) in cash and cash equivalents	11,755	20,294	3,720
Cash and cash equivalents, beginning of period	29,474	9,180	5,460
Cash and cash equivalents, end of period	41,229	29,474	9,180
Parent [Member]
Net cash provided by operating activities	(4,990)	(139,226)	(130,200)
Property and equipment additions, net of disposals	0	0	0
Proceeds received from sale of assets and businesses	0	0	0
Acquisition of property and businesses	0	0	0
Costs incurred for purchase and development of electronic health records application	0	0	0
Net cash used in investing activities	0	0	0
Reduction of long-term debt	(382,060)	(1,388,679)	(58,779)
Additional borrowings	98,100	3,266,146	25,408
Financing costs	(23,608)	(101,815)
Repurchase of common shares	(60,482)	(11,528)	(63,288)
Dividends paid	(19,466)	(19,422)	(16,706)
Issuance of common stock	4,779	3,594	3,290
Profit distributions to noncontrolling interests	0	0	0
Proceeds from sale of noncontrolling interests in majority owned business		0
Capital contributions from noncontrolling interests			0
Purchase of noncontrolling interests in majority owned businesses			0
Changes in intercompany balances with affiliates, net	387,727	(1,609,070)	240,275
Net cash (used in) provided by financing activities	4,990	139,226	130,200
Increase (decrease) in cash and cash equivalents	0	0	0
Cash and cash equivalents, beginning of period	0	0	0
Cash and cash equivalents, end of period	0	0	0
Guarantors [Member]
Net cash provided by operating activities	518,462	342,633	331,518
Property and equipment additions, net of disposals	(226,848)	(186,967)	(282,868)
Proceeds received from sale of assets and businesses	0	21,460	8,952
Acquisition of property and businesses	0	(1,958,904)	(12,499)
Costs incurred for purchase and development of electronic health records application	(38,249)	(17,971)	(7,957)
Net cash used in investing activities	(265,097)	(2,142,382)	(294,372)
Reduction of long-term debt	(1,442)	(753)	(4,297)
Additional borrowings	0	0	661
Financing costs	0	0
Repurchase of common shares	0	0	0
Dividends paid	0	0	0
Issuance of common stock	0	0	0
Profit distributions to noncontrolling interests	0	0	0
Proceeds from sale of noncontrolling interests in majority owned business		0
Capital contributions from noncontrolling interests			0
Purchase of noncontrolling interests in majority owned businesses			(229)
Changes in intercompany balances with affiliates, net	(240,087)	1,816,520	(30,129)
Net cash (used in) provided by financing activities	(241,529)	1,815,767	(33,994)
Increase (decrease) in cash and cash equivalents	11,836	16,018	3,152
Cash and cash equivalents, beginning of period	21,385	5,367	2,215
Cash and cash equivalents, end of period	33,221	21,385	5,367
Non Guarantors [Member]
Net cash provided by operating activities	204,779	297,937	339,944
Property and equipment additions, net of disposals	(58,834)	(52,307)	(96,880)
Proceeds received from sale of assets and businesses	67,592	0	818
Acquisition of property and businesses	(29,466)	606	0
Costs incurred for purchase and development of electronic health records application	0	0	0
Net cash used in investing activities	(20,708)	(51,701)	(96,062)
Reduction of long-term debt	1,985	(2,654)	(3,423)
Additional borrowings	0	0	0
Financing costs	0	0
Repurchase of common shares	0	0	0
Dividends paid	0	0	0
Issuance of common stock	0	0	0
Profit distributions to noncontrolling interests	(38,497)	(32,456)	(29,866)
Proceeds from sale of noncontrolling interests in majority owned business		600
Capital contributions from noncontrolling interests			121
Purchase of noncontrolling interests in majority owned businesses			0
Changes in intercompany balances with affiliates, net	(147,640)	(207,450)	(210,146)
Net cash (used in) provided by financing activities	(184,152)	(241,960)	(243,314)
Increase (decrease) in cash and cash equivalents	(81)	4,276	568
Cash and cash equivalents, beginning of period	8,089	3,813	3,245
Cash and cash equivalents, end of period	8,008	8,089	3,813
Consolidating Adjustments [Member]
Net cash provided by operating activities	0	0	0
Property and equipment additions, net of disposals	0	0	0
Proceeds received from sale of assets and businesses	0	0	0
Acquisition of property and businesses	0	0	0
Costs incurred for purchase and development of electronic health records application	0	0	0
Net cash used in investing activities	0	0	0
Reduction of long-term debt	0	0	0
Additional borrowings	0	0	0
Financing costs	0	0
Repurchase of common shares	0	0	0
Dividends paid	0	0	0
Issuance of common stock	0	0	0
Profit distributions to noncontrolling interests	0	0	0
Proceeds from sale of noncontrolling interests in majority owned business		0
Capital contributions from noncontrolling interests			0
Purchase of noncontrolling interests in majority owned businesses			0
Changes in intercompany balances with affiliates, net	0	0	0
Net cash (used in) provided by financing activities	0	0	0
Increase (decrease) in cash and cash equivalents	0	0	0
Cash and cash equivalents, beginning of period	0	0	0
Cash and cash equivalents, end of period	$ 0	$ 0	$ 0

Valuation And Qualifying Accounts (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Valuation And Qualifying Accounts [Abstract]
Balance at beginning of period	$ 248,622	$ 168,876	$ 162,975
Charges to costs and expenses	613,619	546,909	508,603
Acquisition of business		56,596
Write-off of uncollectible accounts	(608,836)	(523,759)	(502,702)
Balance at end of period	$ 253,405	$ 248,622	$ 168,876

Pension Plan (Schedule Of Measurement Dates) (Details)	12 Months Ended
Pension Plan (Schedule Of Measurement Dates) (Details)	Dec. 31, 2011	Dec. 31, 2010
Benefit Obligations [Member]
Defined Benefit Plan Disclosure [Line Items]
Measurement Dates	12/31/2011	12/31/2010
Fair Value Of Plan Assets [Member]
Defined Benefit Plan Disclosure [Line Items]
Measurement Dates	12/31/2011	12/31/2010

Supplemental Condensed Consolidating Financial Information (Narrative) (Details)	Dec. 31, 2011
Condensed Financial Statements, Captions [Line Items]
Ownership percentage in directly owned subsidiary	100.00%
7% Senior Notes Due 2018 [Member]
Condensed Financial Statements, Captions [Line Items]
Ownership percentage in directly owned subsidiary	100.00%